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  IIIAbstract 
The circovirus Beak and feather disease virus (BFDV) causes psittacine beak and 
feather disease (PBFD) that is characterised by a chronic disease process 
associated with feather abnormalities, beak deformities and eventual death in 
various species of birds in the order Psittaciformes.  This disease is seen in captive 
and wild psittacine species in Australia and several other countries and is a 
significant threat to the survival of some endangered psittacine species.   
This thesis reports on genetic studies that have furthered the understanding of the 
diversity of BFDV present within Australia.  These studies have optimised methods 
of detecting BFDV.  They have also resulted in the production of an immunogenic 
and antigenic recombinant BFDV Capsid protein that could lead to alternate 
methods of producing viral antigen for serological tests and the development of a 
BFDV vaccine. 
To assess the optimal method of the detection of BFDV infection, feather and blood 
samples were submitted by referring veterinarians throughout Australia from 
psittacine birds tentatively diagnosed with PBFD or with a history of being in contact 
with PBFD-affected birds.  These samples were examined by 3 procedures 
commonly used to detect BFDV infection: a polymerase chain reaction (PCR) assay 
and haemagglutination (HA) for the detection of virus, and haemagglutination 
inhibition (HI) tests for the detection of virus antibody in response to infection.  Of 
the samples examined from 623 psittacine birds, the prevalence of BFDV DNA in 
feather samples detected by PCR was 18.85%. There was a strong correlation 
between PCR and HA testing of feather samples, although possible false-positive 
and false-negative PCR and HA results were obtained in some samples.  Of the 143 
birds that were PCR feather-positive only 2 had detectable HI antibody and these 
birds were also HA feather-negative, which suggests that they were developing 
immunity to recent infection. All birds with HI antibody were feather HA negative.   
  IVDespite the rare occurrence of PBFD in cockatiels (Nymphicus hollandicus), 2 of the 
13 samples collected from this species were PCR and HA positive indicating that 
this species can be infected with BFDV.   
Three studies were undertaken to further our understanding of the genetics of BFDV 
in Australian avifauna: sequence analysis of the BFDV detected in a grey cockatiel 
(Nymphicus hollandicus), a species normally considered resistant to infection with 
BFDV; analysis of the genome of BFDV present in lorikeets (Trichoglossus sp.) in 
Australia; and analysis of the genome of BFDV detected in endangered swift parrots 
(Lathamus discolor).  Sequence analysis of the entire genome of the cockatiel BFDV 
isolate revealed that it clustered phylogenetically with 2 other viruses, one from a 
sulphur crested cockatoo (SCC1-AUS) and one from a Major Mitchell cockatoo 
(MMC-AUS), which suggests that this isolate from the grey cockatiel was not a 
cockatiel-specific biotype. Phylogenetic analysis of the ORF V1 of BFDV detected in 
7 lorikeets demonstrated these 7 isolates clustered phylogenetically with other 
BFDV isolates obtained from Loriidae species elsewhere in the world and confirmed 
the presence of a loriid-specific genotype. Phylogenetic analysis of the sequence 
data generated from ORF V1 of virus detected in 2 endangered swift parrots 
provided evidence they were also infected with BFDV genotypes derived from other 
species of birds, one isolate clustering with viruses from a Loriidae genotype and the 
other with isolates derived from species of Cacatuidae and Psittacidae.  
As part of this research, a baculovirus expression system was successfully 
developed for the production of recombinant BFDV Capsid protein.  Inoculation of 
this protein into chickens resulted in the development of HI antibody, which 
demonstrated its immunogenicity. When used as an antigen in HI tests it detected 
antibody in virus-infected birds, which demonstrated its antigenicity. This protein 
offers potential application as an antigen for the development of serological tests 
and as an immunogen for incorporation into vaccines for control of PBFD.
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 Chapter 1.  General introduction 
Circoviruses are non-enveloped, icosahedral viruses with a small, circular, single- 
stranded DNA genome in the family Circoviridae.  The Circoviridae family currently 
comprises Chicken anaemia virus, Porcine circovirus, Beak and feather disease 
virus (BFDV) and a number of other avian species detected in pigeons, geese, 
starlings, ducks, canaries, gulls and ravens.  Infections with each circovirus are 
associated with diseases in which virus-induced damage to lymphoid tissue and 
immunosuppression are common features.   
The BFDV-associated disease in psittacine species is designated psittacine beak 
and feather disease (PBFD) and was originally described in Australia.  However, the 
disease is not limited to Australian psittacine birds and it is known to occur in every 
continent.  The worldwide trade in birds, and specifically psittacine species, has 
almost certainly contributed to the widespread distribution of the disease. 
This thesis reports on studies undertaken to further our understanding of the 
characteristics of BFDV.  These studies included an investigation of the most 
optimal method for the detection of BFDV infection, further genetic characterisation 
of BFDV present in Australia, and preliminary studies that could lead to the future 
development of a BFDV vaccine. Chapter 2 provides a review of the literature 
relating to circoviruses in general and particularly PBFD to provide background to 
the research conducted.  Features of the BFDV genome are described in the review, 
with particular emphasis on the major open reading frames (ORF) and proteins 
encoded by them, and include ORF C1 encoding the capsid protein which was 
hypothesised to have potential application as vaccine.  
Feather and blood samples from 679 birds were examined by PCR, 
haemagglutination (HA) and haemagglutination inhibition (HI) tests to identify BFDV 
infection. These samples were submitted by referring veterinarians throughout 
  1Australia from psittacine birds tentatively diagnosed with PBFD, or with a history of 
being in contact with PBFD-affected birds. The results were analysed to determine 
the relative sensitivity and specificity of the assays as diagnostic methods.  These 
results are reported in Chapter 3. 
Chapter 4 reports on additional genetic studies undertaken to further our 
understanding of the genetic diversity of BFDV in Australia. This additional 
information included the determination of the nucleotide sequence of the ORF V1 of 
BFDV in 7 lorikeets (Trichoglossus sp.) and 2 swift parrots (Lathamus discolor) 
together with a comparison of these sequences with 36 previously described BFDV 
ORF V1 sequences from other psittacine birds from Australia, USA, UK, Germany, 
South Africa, Portugal, Austria and New Zealand.  BFDV was also identified in a 
grey cockatiel (Nymphicus hollandicus), a species traditionally considered resistant 
to BFDV infection.  Chapter 4 includes a report of the genomic sequence of this 
cockatiel virus and a discussion of the relationship between this cockatiel isolate of 
BFDV and other isolates of BFDV.   
Chapter 5 reports on preliminary studies undertaken that could lead to the 
development of a recombinant protein vaccine.  These investigations included the 
use of a baculovirus expression system for the production of a recombinant BFDV 
Capsid protein and demonstration of the immunogenicity and antigenicity of the 
recombinant protein. 
Chapter 6 provides a general discussion of the significance of the research results 
reported in the thesis. 
  2Chapter 2.  Review of the literature 
This chapter presents a review of literature relevant to the research project.  The 
review encompasses background information on the taxonomy, structure and 
genomic composition of the circoviruses but with particular emphasis on Beak and 
feather disease virus (BFDV), which is the virus associated with psittacine beak and 
feather disease (PBFD).   
When describing the genomic sequence of the circoviruses and the encoded 
proteins, the convention for numbering nucleotide positions previously described by 
Bassami et al. (1998) was used.  The naming of genes follows the convention where 
genes and open reading frames (ORFs) are written in lowercase italics and gene 
products (proteins) are not italicised and have the first letter in uppercase. 
Introduction and history of PBFD 
Due to the inadequate knowledge of the disease and its aetiology, early confusion 
occurred and has resulted in various terms being used in the literature to describe 
the disease.  In addition to PBFD (Perry, 1981; Perry, 1983; Pass and Perry, 1984a; 
Pass and Perry, 1984b; Smith, 1986; Cooper et al., 1987; Wylie and Pass, 1987; 
Perry, 1988; Huff et al., 1988; Jergens et al., 1988; Gough et al., 1989; Kock, 1989; 
McOrist, 1989; Pass, 1989; Ritchie et al., 1989a; Ritchie et al., 1989; Ritchie et al., 
1989c; Kock, 1990; Latimer et al., 1990; Loupal et al., 1990; Ritchie et al., 1990a; 
Ritchie et al., 1990b; Latimer et al., 1991a; Latimer et al., 1991b; Todd et al., 1991; 
Ritchie et al., 1991a; Ritchie et al., 1991b; Wylie, 1991; Ritchie et al., 1992a; Ritchie 
et al., 1992b; Kock et al., 1993; Latimer et al., 1993; Raidal et al., 1993b; Raidal 
et al., 1993c; Pass et al., 1994) and psittacine circovirus disease (Cross, 1996), the 
disease has been referred to as French moult (Cayley, 1933; Beach, 1965; Rogers, 
1967; Arnall and Keymer, 1975; Taylor, 1982; Perry, 1983; Lowenstine, 1984), 
psittacine combined beak and feather disease syndrome (Perry, 1981), non-
  3responsive fungal dermatitis, cockatoo feather picking, moult disease, feather 
maturation syndrome, adrenal gland insufficiency (Harrison, 1986), beak rot (Perry, 
1975; Perry, 1979), beak disease (Kew, 1978), sulphur crested syndrome (Schultz, 
1978), cockatoo feather and beak disease (Jacobson et al., 1986), cockatoo beak 
and maturation syndrome (Ryan, 1987), feather and beak dyskeratogenesis 
(Graham, 1985; Graham, 1987; Graham, 1990), feather and beak disease or FBD 
(Baig et al., 1992; Lowenstine, 1984). 
The BFDV has been reported in a variety of both New and Old World psittaciformes 
and it is probable that all psittacine species are susceptible (Jacobson et al., 1986; 
Latimer et al., 1990). The virus is endemic in and the most common viral disease of 
wild psittaciformes in Australia (Pass and Perry, 1984a; Pass and Perry, 1984b; 
Wylie, 1991; Raidal et al., 1993b; Raidal et al., 1993c), illustrated by anecdotal and 
clinical data (Perry, 1981; Pass and Perry, 1985; Raidal et al., 1993c), historical data 
(Ashby, 1907) and limited epidemiological studies (McOrist et al., 1984; Raidal et al., 
1993c). PBFD has also been reported in captive psittacine birds in many countries 
other than Australia, including the Middle East (Lester and Gerlach, 1986), Africa 
(Kock, 1989; Kock, 1990), Europe (Desmidt et al., 1993; Baker, 1996), North 
America (Ritchie et al., 1989a; Latimer et al., 1991a), South America (Werther et al., 
1998), Thailand (Kiatipattanasakul-Banlunara et al., 2002) and Germany (Rahaus 
and Wolff, 2003). The export of birds captured from the wild has been the most likely 
cause of the occurrence of the disease in many countries.  This can be illustrated by 
the spread of PBFD from Asian cockatoos as a result of events such as the 
exportation of wild caught fledglings from Asia to the USA (Lowenstine, 1984; 
Jacobson et al., 1986; Raidal, 1994). 
PBFD has probably been present in Australia for more than 100 years since 
abnormal feathering in a number of wild red-rumped parrots (Psephotus 
haematonotus) was recognised in 1888 in South Australia (reported by Ashby, 
  41907).  The disease was first designated as psittacine beak and feather disease by 
Perry (1981) to describe what he considered as the most easily recognisable 
disease of psittaciformes.  The first detailed description of the disease in various 
species of cockatoos in Australia was subsequently provided by Pass and Perry 
(1984a).   
Early reports, published before the identification of BFDV as the aetiological agent of 
PBFD, suggested a number of agents as possible causes of the disease, including 
hereditary, nutritional and hormonal factors (Rogers, 1967; Arnall and Keymer, 1975; 
Lafeber, 1977; Perry, 1981; Rosskopf and Woerpel, 1981; Taylor, 1982; Lowenstine, 
1984; Smith, 1986). It was because of the similarity between PBFD and 
reticuloendotheliosis virus-induced Nakanuke syndrome, that the agent of PBFD 
was suggested to be a virus (Perry, 1981). Subsequent pathological, 
epidemiological (McOrist et al., 1984; Pass and Perry, 1984b; Jacobson et al., 1986; 
Smith, 1986) and virological studies (Wylie and Pass, 1987; Ritchie et al., 1989c; 
Wylie, 1991) indicated that the disease agent was a novel virus identified as a 
circovirus that has now been classified as a member of the family Circoviridae. 
BFDV is one of the smallest known viruses (Ritchie et al., 1989c) with a spherical, 
possibly icosahedral symmetry; 14-16 nm in diameter, non-enveloped and with a 
circular singular-stranded DNA (ss DNA) genome less than 2 kb in length (Ritchie 
et al., 1989c). Polyacrylamide gel electrophoresis (PAGE) revealed 3 major proteins 
associated with BFDV, with molecular weights of 26.3 kilodaltons (kDa), 23.7 kDa 
and 15.9 kDa (Ritchie et al., 1990a) although in a subsequent report, rigorously 
purified viruses prepared from feather material collected from 4 genera of psittacine 
birds were found to contain only 2 major proteins, one 26 kDa and the other 23 kDa 
(Ritchie et al., 1990a). The largest protein which is encoded by ORF1 is a replication 
protein (Figure 2.1) and the smaller the capsid protein (Bassami et al., 1998).  
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Based on the host species infected, size of the virion and characteristics of the 
genome, this family includes Chicken anaemia virus (CAV) classified in the genus 
Gyrovirus, and Porcine circovirus (PCV) and BFDV and other BFDV-like viruses in 
the genus Circovirus (Pringle, 1999a; Pringle, 1999b). While new species of 
circoviruses continue to be identified, particularly those from birds, there are 
currently only 6 official members of the Circovirus genus including the 2 porcine 
circoviruses, PCV1 (Meehan et al., 1997) and PCV2 (Hamel et al., 1998; Meehan 
et al., 1998), BFDV (Bassami et al., 1998; Niagro et al., 1998) (Figure 2.1), Canary 
circovirus (CaCV) (Phenix et al., 2001), Pigeon circovirus (PiCV) (Mankertz et al., 
2000a; Todd et al., 2001b) and Goose circovirus (GoCV) (Todd et al., 2001b). 
Another circovirus tentatively classified in the genus Circovirus is Duck circovirus 
(DuCV) (Hattermann et al., 2003). In the future, it is likely that additional avian 
circoviruses suspected to occur, based on histopathological evidence and 
sequence analysis, will be included.  These additional circoviruses include putative 
circoviruses identified in doves (Raidal and Riddoch, 1997), finches (Mysore et al., 
1995), gulls (Twentyman et al., 1999), Australian ravens (Stewart et al., 2006), 
starlings (Johne et al., 2006) and ostriches (Eisenberg et al., 2003). 
There is phylogenetic evidence suggesting that BFDV-like circoviruses
 are 
descendants of a recombinant virus that inherited the 5'
 portion of its rep and its 
origin of virion-sense replication
 from a plant-infecting nanovirus or geminivirus 
(Niagro et al., 1998; Gibbs and Weiller, 1999). The circovirus species, however, 
appear to be distinct from the plant viruses, and no common antigenic determinants 
have been detected in BFDV and PCV, or in any circovirus and CAV (Todd et al., 
1991), although a low level of cross-hybridisation has been observed between some 
members of the circovirus genus, such as that reported between BFDV and pigeon 
circovirus (Todd et al., 2000). 
  6Human circovirus-like viruses have been identified, including Torque Teno virus 
(TTV) identified initially in the serum of a Japanese patient with post-transfusion 
hepatitis (Todd et al., 2000).  TTV and the TTV-like mini virus (TLMV) share 
similarities in genome organization with CAV and their taxonomic position is 
currently under consideration (Raue et al., 2004). 
 
                          
 
Figure 2.1.  Schematic diagram of the BFDV double-stranded replicative form (RF) 
illustrating the location of potential ORFs (modified from Bassami et al., 1998). Only 2 of 
these potential ORFs (ORF C1 and ORF V2) are transcribed.   
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The genomes of many circoviruses such as PCV1, PCV2 and BFDV have been 
sequenced.  They have ambisense genomes, with proteins encoded from both the 
viral and complementary DNA strands of the double-stranded replicative form (RF) 
(Niagro et al., 1998). The complete genome sequence of several BFDV isolates has 
been reported (Bassami et al., 1998; Niagro et al., 1998; de Kloet and de Kloet, 
2004; Heath et al., 2004). Bassami et al. (1998) reported that the genome contained 
1993 nucleotides, and 7 potential open reading frames (ORF), 3 in the virion (V) 
strand and 4 in the complementary (C) strand of the RF, encoding potential proteins 
>8.7 kDa (Figure 2.1 and Table 2.1).  Niagro et al. (1998) identified only 3 of these 
ORF (V1, C1 and C2).   
 
 
Table 2.1. Characterisation of ORFs specified by PCV2, PCV1 and BFDV (from Todd et al., 
2001a).   
 
PCV2 PCV1  BFDV 
ORF  Position 
(nt) 
No of 
amino 
acids 
Position 
(nt) 
No of amino 
acids 
Amino acid 
identity 
(PCV1/PCV2) 
Position 
(nt) 
No of 
amino 
acids 
Amino acid 
identity 
(PCV1/BFDV) 
V1(Rep) 51-995 314  47-983  312  82%  131-997  289  45% 
V2     1163-1448  95   543-843  106   
V3     1670-79  56   1049-1366  101   
C1(capsid)  1735-1034  233 1723-1024  233  62%  1978-1238  247  29.1% 
C2 671-357  104  658-40  206  62%  544-65  160   
C3 565-386  59  552-207  155  83%  1021-758  88   
C4     1518-1332  62    1278-1021  86   
 
  8The inability to propagate BFDV in cell culture has made a comprehensive 
transcription analysis difficult, although from RNA extracted from feather pulp of 
infected birds, Niagro et al. (1998) reported that transcripts synthesised on both RF 
strands were produced.  The largest ORFs, V1 and C1, are initiated close to a small 
non-coding region containing a distinctive stem-loop containing a nonanucleotide 
motif.  The V1 and C1 ORFs of BFDV correspond to those occurring in PCV, and the 
V1 and C1 ORFs of BFDV and PCV1 share 45.6% and 29.1% amino acid (aa) 
identities, respectively (Bassami et al., 1998).  
The stem-loop structure is located between nucleotides 1976 and 1993 of the BFDV 
genome (Figure 2. 2).  The nonanucleotide motif (TAGTATTAC) is located at the 
apex of the stem-loop structure and was thought to be the starting point of viral plus-
strand synthesis during rolling circle replication (Meehan et al., 1997; Bassami et al., 
1998; Mankertz et al., 1998a).  
The ORF V1 of BFDV 
The ORF V1 is 867 nucleotides long, is located on the viral strand and was 
predicted to encode a 33.3 kDa protein product (Bassami et al., 1998). This putative 
protein features all sequence motifs associated with proteins involved in rolling circle 
replication (RCR).  A P-loop motif and ATP/GTP binding motifs were found in 
proteins with helices activity (Hodgeman, 1988). A potential pyrophosphatase 
domain was also found in the predicted aa sequence of this protein (Niagro et al., 
1998). There is a high aa similarity of 45.6% between the product of BFDV ORF V1 
and replication-associated protein of PCV, Subterranean clover stunt virus and Faba 
bean necrotic yellows virus (Bassami et al., 1998). There is, however, recent 
evidence of considerable genetic diversity in this region of Australian BFDV strains 
obtained from different psittacine birds (Bassami et al., 1998). Ypelaar et al. (1999) 
reported that in a comparison of 10 BFDV isolates obtained from different psittacine 
species and collected from different parts of Australia, the nucleotide sequence 
  9identity of a 717 bp region within the ORF V1 ranged in identity from 88 to 99%. 
Based on sequence data obtained from the ORF V1 encoding the Rep protein, 
evidence of specificity of BFDV strains for some individual Australian psittacine 
species has been observed (Ritchie et al., 2003). The sequence variation of PCR 
amplified fragments of ORF V1 indicate that PCR-based diagnosis of the presence 
of BFDV in aviary birds may not correlate well with the presence of disease (Hess 
et al., 2004). 
The ORF C1 of BFDV 
The ORF C1 with 741 nucleotides is located on the complementary strand of the 
double-stranded (ds) RF (nucleotide position 1978-1238) and encodes a potential 
28.9 kDa Capsid protein (Bassami et al., 1998) approximating the size of the 30 kDa 
protein expressed by ORF C1 of PCV2 (Nawagitgul et al., 2000), and similar to the 
size of the protein in purified virus particles (Liu et al., 2001). Bassami et al. (1998) 
demonstrated that the equivalent ORF in PCV has 29.1% sequence similarity with 
the ORF C1 of BFDV. The origin of replication of this ORF is within the stem-loop 
structure in both PCV and BFDV (Bassami et al., 1998). The ORF C1-encoded 
BFDV and PCV proteins product feature a highly conserved 14 aa sequence close 
to the C-terminus with an adjacent myristylation site (Bassami et al., 1998; Niagro 
et al., 1998). The highly conserved nature of this motif suggests it is important for 
protein function.   
Electron microscopic examination of the recombinant PCV ORF C1-encoded protein 
(Nawagitgul et al., 2000) detected a self assembling protein forming capsid-like 
particles.  Similar results were reported by Liu et al. (2001).  These reports provide 
experimental proof that PCV2 ORF C1 encodes a capsid protein.  
Nucleotide sequence analysis of an ORF C1 gene fragment of 31 BFDV samples 
amplified by real-time PCR (RT-PCR) techniques indicated that there is 84.1 to 
100% identity at the nucleotide level and 83.3 to 100% similarity at the aa level 
  10(Raue et al., 2004).  Analysis of 19 BFDV strains from South Africa compared with 
24 previously described sequences from Australasia and America indicated that the 
average distances between the southern African isolates and the Australian BFDV 
isolates ranged from 8.3 to 10.8%, providing evidence of a unique (specific) 
genotype of BFDV in southern Africa (Heath et al., 2004). 
An examination by de Kloet and de Kloet (2004) of the genetic relationships 
between the ORF C1 of 58 strains of BFDV from different geographical locations 
showed these clustered into 6 groups.  They suggested that each group evolved 
within different psittacine species and that they may cause disease or be 
asymptomatic within species in a subfamily-specific manner.  This is in agreement 
with the report that strains infecting lories (Loriinae) and those causing the acute 
form of PBFD in African grey parrots (Psittacus erithacus) are of a specific genotype 
(Raue et al., 2004).  
ORF C1 encodes the capsid protein of BFDV and this protein is likely to induce an 
antibody response in virus-infected birds.  Serological tests based on a recombinant 
capsid protein should therefore be a useful tool for assessing the BFDV-infection 
status of individual birds and for epidemiological surveys.  The strain variation in the 
C1 gene (Bassami et al., 2001; Raue et al., 2004) could limit the broad applicability 
of a single serological test based on only one protein antigen if this equated to 
differences in antigenicity, for which there is currently no evidence. However, based 
on nucleotide sequence data, there is evidence of 76.3 to 83.2% aa variation in the 
capsid protein (Johne et al., 2004) and while there is no evidence of antigenic 
variability this needs to be investigated further (Johne et al., 2004).  The capsid 
protein of BFDV is a major constituent of infectious virus particles
 and is therefore a 
likely target for immune surveillance.  Comparison of relative fixation rates
 of 
synonymous and non-synonymous mutations revealed that the capsid is under 
positive selection (Heath et al., 2004). Different serotypes of
 BFDV have not yet 
  11been identified, but the possibility that
 antigenically distinct subgroups of BFDV 
could exist should
 not be ignored during the design of vaccines (Bassami et al., 
2001; Heath et al., 2004).  
Other ORFs of BFDV 
Other ORFs potentially encode additional proteins (Bassami et al., 1998). ORF V2, 
common to all BFDV isolates,
 has been described but it is unclear if the 
transcriptional
 product of this ORF plays a role in the replication of the virus (Martin 
and Rybicki, 2000).  The ORF 5 varies in size in different isolates: 303 nucleotides in 
some BFDV strains detected in Australia and potentially encoding a protein of 101 
aa, but 474 nucleotides (nt) in other strains and potentially encoding a protein of 158 
aa (Bassami et al., 2001).  
Mode of replication of circoviruses 
The protein-coding capacity of BFDV and all other circoviruses is limited due to its 
small genome and replication is heavily dependent on the host cell (Todd et al., 
2000).  These viruses do not possess the means to manipulate the cell cycle in a 
manner similar to larger DNA viruses such as adenoviruses (Todd et al., 2001a) and 
their mode of replication is similar to that of the autonomously replicating 
parvoviruses (Studdert, 1993; Tischer et al., 1995) in the sense that replication 
occurs in the nucleus of the host cell and is highly dependant on cellular functions 
during the S-phase of the cell cycle (Studdert, 1993; Tischer et al., 1995).  Detailed 
studies of the mode of replication of BFDV are very limited and most of what we 
know about their replication is deduced from our understanding of the replication of 
other viruses with small, circular ss DNA genomes such as some bacteriophages 
and plant geminiviruses (Hanley-Bowdoin et al., 1999; Todd et al., 2001a).  
Circoviruses (Tischer et al., 1995) use rolling circle replication (RCR) for replication 
of the genome, typical of many other single-stranded DNA viruses with a circular 
  12genome (Gronenborn, 2004; Gutierrez et al., 2004). Various motifs in the Rep of 
BFDV are characteristic of viruses that replicate using this mechanism (Bassami 
et al., 1998; Niagro et al., 1998), including the stem-loop structure and the 
nonanucleotide motif therein.  There is high sequence homology within the 
nonanucleotide motif of the various circoviruses and circovirus-like viruses 
(Arguello-Astorga, 1994; Bassami et al., 1998) as is shown in Table 2.1.  However, 
there is some variation, for example the nonanucleotide motif possessed by PCV2 
differs from those of PCV1 and BFDV in that the T residue at the first nucleotide 
position is changed to an A residue (Mankertz et al., 2000b). The nonanucleotide 
(TAGTATTAC) motif contains the origin of replication and mutation of this element 
abolishes replication (Mankertz et al., 1997). The sequence and location of 
nonanucleotide element at the apex of the putative stem loop are very similar to ss 
DNA viruses of bacterial origin, including ϕX174, and with ss DNA plant viruses 
(Meehan et al., 1997; Niagro et al., 1998). 
While the CAV genome does not possess a stem-loop structure it does have a 
nonanucleotide motif very similar to BFDV (Claessens et al., 1991; Bassami et al., 
1998). In CAV, the nonanucleotide motif is semi-conserved and is located some 100 
nucleotides downstream of a distinctive G:C-rich inverted repeat sequence, which 
occurs close to the termination of the ORF C1 (Claessens et al., 1991; Bassami 
et al., 1998). While there is no significant homology between any CAV protein with 
Rep proteins specified by the other animal and plant circular ss DNA viruses, the 50 
kDa Capsid protein encoded by the CAV genome also contains the 3 peptide motifs 
found in proteins involved in RCR (Ilyina and Koonin, 1992). CAV, however, unlike 
the other animal circoviruses, plant nanoviruses and geminiviruses, does not contain 
the GKS box or P-loop capable of binding dinucleotide triphosphates (dNTPs) 
(Desbiez et al., 1995). It has been suggested by Niagro et al. (1998) that CAV DNA 
replication probably depends on a host cell topoisomerase or helices to provide local 
  13bending and/or unwinding functions.  
The ORF V1 of PCV and BFDV encodes a putative replication-associated protein 
(Rep) required for the regulation of gene expression as well as DNA replication 
(Tischer et al., 1995; Mankertz et al., 1998b).  The encoded Rep contains three 
peptide motifs commonly found and required for RCR and a GKS box or P-loop 
motif which may be involved in nucleotide binding (Meehan et al., 1997; Bassami 
et al., 1998; Niagro et al., 1998). Analysis of the predicted amino acid sequences 
indicated that BFDV and PCV1 Rep (Meehan et al., 1997; Bassami et al., 1998; 
Niagro et al., 1998) have a striking similarity to geminivirus Rep proteins and to the 
putative Rep proteins found in plant nanoviruses (Table 2.2), suggesting that PCV, 
BFDV, BBTV and SCSV encode Rep proteins that originated from a common 
ancestor (Bassami et al., 1998).  
The ORF C1 on the complementary DNA strand is flanked by eukaryotic control and 
polyadenylation signals and encodes a capsid protein (Niagro et al., 1998). 
Protamine-like DNA binding properties have been observed in the amino terminus of 
the protein and are probably instrumental in protecting the packaged viral DNA 
(Niagro et al., 1998).  
 
 
  14Table 2.2.  Edited alignment of selected domains of the Rep proteins of PCV (Accession No. 
U49189), BFDV (Accession No. AF080560), BBTV (Accession No. 12586), SCSV (Accession No. 
U16731), MSV (Accession No. AF003952) (Boevink et al., 1995), BCTV (Accession No. U56975) 
BGMV (Accession No. M88686) and TPCTV (Accession No. X84735). Motifs indicated by red 
letters in columns I, II and III are three typical domains involved in RCR and red letters in the 
motifs in column IV indicate the nucleotide-binding site (P-loop motif). 
 
                  I                          II                    III                            IV                               
PCV    -FTLNN-   -GRT AHLQGF-   -YCSK-   -G . PPGCGKS-  
 
BFDV   -FTLNN-   -G . T PHLQGY-   -YCSK-   -G . PPGCGKS-  
 
BBTV   -FTLNN-   -G . QKHLQGY-   -YCSK-   -GPNGNEGKS-  
 
SCSV   -FTLNY-   -G . QKHLQGF-   -YCCK-   -GSDGGEGKT-  
 
MSV   -FLTYP-   -G . SL HLHAL-   -Y I LK-   -G . PTRTGKS-  
 
BCTV   -FLTYP-   -G . SL HLHAL-   -Y I EK-   -G . DSRTGKT-  
 
BGMV   -FLTYP-   -G . EP HLHVL-   -Y I EK-   -G . DSRTGKT-  
 
TPCTV  -FLTYP-   -G . SLHLHAL-   -Y I EK-   -G . DSRTGKT- 
 
 
The location of the ORFs, the stem-loop structure with the nonanucleotide motif, the 
3 motifs in the Rep protein required for RCR, the P-loop motif and polyadenylation 
(poly A) signal downstream of ORF V1 and ORF C1, have all been detected in 
BFDV (Bassami et al., 2001).  The poly A signals are downstream of the stop codon 
for ORF V1 at nucleotides 1019-1024 and 1196-1210.  The complementary strand of 
the RF contains a poly A signal, AATAAA at nucleotides 758-763, only one 
nucleotide downstream of ORF C1 (Bassami et al., 1998).  Two potential TATA 
boxes are present in the viral strand: TATA at nucleotides 86-89 and TATAAAA at 
nucleotides 680-686 upstream of the start codon for ORF V1 (Figure 2.2). 
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                                     (a)                                                                                    
(b) 
                TPCTV 
BFDV TAGTATTAC
SCSV TAGTATTAC 
BBTV TAGTATTAC 
BCTV TAATATTAC 
CAV TACTATTCC 
PCV TAGTATTAC 
BGMV TAATATTAC 
TAATATTAC 
MSV TAATATTAC 
  ** * **** 
 
Figure 2.2. (a) Sequence of the hairpin loop structure present in the BFDV genome, containing the 
nonanucleotide motif (bold) and the octanucleotide repeat sequence (underlined). (b) Alignment of the 
nonanucleotide motifs of BFDV, PCV, CFDV, SCSV, BBTV Taiwanese isolate, BBTV-Australian isolate, 
Geminivirus subgroups I, II and III and CAV. From Bassami et al. (1998). 
 
The circular ds RF is an essential intermediate in both the transcription of mRNA 
and replication of the circovirus DNA genome, and multiple forms have been 
detected. Open and closed circular RF species have been detected by Southern blot 
hybridisation in PK15 cells infected with PCV1 (Meehan et al., 1997; Tischer and 
Buhk, 1988), PCV2 (Meehan et al., 1998) and CAV-infected MSB1 cells (Noteborn 
et al., 1991; Meehan et al., 1992). More than one type of DNA has been detected in   
PCV1-infected pig kidney cells, including relaxed and open circular 11S RF, ss 
genomic 13S DNA and 5S DNA (Tischer and Buhk, 1988). The 5S single strand 
DNA was of the same sense as the encapsidated virus strand, was detectable in 
both infected cells and purified virus particles, and contained a central deletion of 
100-200 nucleotides (Mankertz et al., 1997). Virus particles harbouring 5S DNA 
were thought to be defective viruses unable to produce the full complement of the 
  16virus proteins but which contained the sequence elements necessary to facilitate 
DNA replication.  
Viral DNA enters the nucleus during cellular mitosis (Tischer et al., 1995; Tischer 
et al., 1987). Once this has occurred, synthesis of a complementary DNA strand to 
generate the RF is the next step in the replication of the genome.  This is achieved 
utilising cellular enzymes (Tischer et al., 1987); RNA primers with cellular DNA 
primase are likely to be involved (Tischer et al., 1987; Gassmann et al., 1988). The 
priming reaction in PCV1 is not entirely random and DNA elongation can occur using 
the α and δ DNA polymerase (Tischer et al., 1987; Gassmann et al., 1988). DNA 
replication then proceeds using the RCR mechanism, a process of continuous 
elongation of the open positive-strand via endless copying around a closed circular 
negative strand template (Dressler, 1970). In bacteriophage ϕX174, one of the best 
studied of the ss DNA viruses, the virus DNA strand present in the RF is cleaved by 
a virus-coded (A) protein at a unique site to provide a 3’-OH terminus, which acts as 
a primer for extension by a cellular DNA polymerase (Todd et al., 2001a).  Upon 
elongation of the 3’-OH terminus by DNA polymerase, the original virus strand is 
displaced and then self-ligates to form a circular ss DNA.  In geminiviruses, the 
virus-coded Rep protein performs a similar function to that of the A protein (Hanley-
Bowdoin et al., 1999) and the Rep protein also forms this function in the 
circoviruses. Many copies of the circular virus strand can be produced following 
RCR and depending on the stage of the infection cycle, these can be used as 
templates for complementary strand synthesis to generate more RF molecules, or 
they can be encapsidated into virus particles.  
Comparative physical characteristics of circoviruses  
Similarities were observed between members of the genus Circovirus and viruses in 
the families Geminiviridae and Nanoviridae.  In the circoviruses, the genome 
consists of only one molecule, whereas the other viruses contain one or more small, 
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host factors, associated with the limited coding capacity of the genome.  In all, the 
origin of replication has a characteristic stem-loop structure with a conserved 
nanomer motif at the apex, and a Rep-binding site.  The Rep proteins are enzymes 
that initiate replication in the rolling circle mode (Ilyina and Koonin, 1992; Koonin 
and Ilyina, 1993) and contain 3 conserved aa motifs as well as a P-loop for dNTP 
binding.  These similarities have led to a hypothesis that circoviruses evolved by 
recombination between a plant nanovirus and an RNA virus such as a calicivirus 
(Gibbs and Weiller, 1999). Phylogenetic analyses have indicated that PCV may 
represent a link between mammalian and plant viruses (Mankertz et al., 1997; 
Meehan et al., 1997). 
While there are similarities within the circoviruses, there are also significant 
differences between the species.  Even though the clinical and pathological signs of 
a feathering disease in Senegal doves (Streptopelia senegalensis) were similar to 
PBFD (Pass et al., 1994), subsequent work demonstrated that the non-psittacine 
birds were infected with a circovirus antigenically different from BFDV (Raidal and 
Riddoch, 1997). The circovirus detected in pigeons is apparently also antigenically 
different from BFDV, even though there is considerable DNA homology in the two 
viruses (Woods et al., 1994). 
Although some variation has been reported in the size of the various circoviruses 
(Table 2.3) there is general consensus that they are within a limited size range of 
about 14-26.5 nm.  Different electron microscopic studies in a number of 
laboratories indicated that particle diameters of BFDV are 14-20.7 nm (Table 2.3).  
Todd et al. (1991) indicated PCV1 and BFDV were almost identical in size and some 
20% smaller than CAV.  The capsid morphology of the PCV and BFDV also appears 
to differ from that of CAV: PCV and BFDV have capsids with flat pentameric 
morphological units, whereas CAV has strikingly different protruding pentagonal 
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The buoyant density of the circoviruses and CAV in caesium chloride (CsCl) is within 
the range 1.33-1.38 g/mL, although some differences have been reported.  Allan 
et al. (1994) reported that the buoyant density of CAV (1.33-1.34 g/mL) was less 
than that of PCV1 (1.36-1.38 g/mL) and that similarly, CAV (91S) possessed a 
greater sedimentation coefficient than PCV1 (57S). 
 
Table 2.3.  Physical and biochemical characteristics of animal circoviruses (adapted from 
Todd et al., 2001a). 
 
Virus characteristic  CAV  PCV1  BFDV 
Particle size (nm)  19.1-26.5  17-20.7  14 - 20.7 
Buoyant density (g/mL in CsCl)  1.33-1.37 1.36-1.37  1.378 
Sedimentation coefficient (S)  91 57  Unknown 
Genome size (kb)  2.17-2.3 1.76  1.7-2.0 
Virion proteins (kDa)  50 36  26.3,23.7,15.9 
 
The circoviruses are very stable and resistant to many physicochemical treatments.  
For example, PCV1 was unaffected by treatment with ether or chloroform as would 
be expected for non-enveloped icosahedral viruses. PCV1 and CAV are also both 
highly stable at 70ºC for 15 min and after treatment at pH 3 (Yuasa et al., 1979; 
Allan et al., 1994). Equivalent data for BFDV has been difficult to determine due to 
the inability to culture these viruses in vitro but if it is similar as is likely then this 
could have significant implications for the transmission of BFDV and its survival in 
nesting sites and aviaries. 
Haemagglutination by circoviruses appears to occur only with BFDV, which unlike 
CAV or PCV, causes haemagglutination of erythrocytes from a variety of psittacine 
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1991b; Sexton et al., 1994; Sanada and Sanada, 2000) but not those of sheep or 
chickens (Ritchie et al., 1991b). The ability of BFDV to haemagglutinate was 
unaffected by incubation of the virus at 80ºC for 30 min (Raidal and Cross, 1994b) 
suggesting that the haemagglutinin receptor is heat stable.  
A high degree of resistance to chemical inactivation is also possessed by CAV.  For 
example, fumigation with formaldehyde or ethylene oxide for 24 h does not 
completely inactivate CAV, and comparatively high concentrations (10%) of iodine 
and hypochlorite are required to inactivate the virus following treatment at 37ºC for   
2 h (Yuasa, 1992). 
Strain variation of BFDV 
Ritchie et al. (1990b) had indicated that there is no ultrastructural or antigenic 
variation in strains from different genera of psittacine birds.  However, the most 
effective way of determining strain variation is genomic sequence analysis (Eckert 
and Kunkel, 1990) or DNA-DNA hybridisation (Baig et al., 1992).  
Phylogenetic analysis of
 isolates from New Zealand revealed a similar clustering 
pattern
 and apparent genotypes in specific psittacine
 species (Ritchie et al., 2003). 
Genetically unique strains defined by restriction length fragment polymorphism also 
seemed to be present in ring-neck parakeets (Psittacula krameri) and budgerigars 
(Melopsittacus undulatus) in South Africa (Albertyn et al., 2004).  
Cell culture and purification of the PBFD virus 
Efforts to cultivate BFDV in vitro have been largely unsuccessful.  Isolation of the 
virus from feather pulp of a salmon-crested cockatoo (Cacatua moluccensis) in 
primary chicken embryo fibroblasts has been reported (Lester and Gerlach, 1986) 
but other studies have been unable to repeat this (Lowenstine, 1984; Pass and 
Perry, 1985; Jacobson et al., 1986; Wylie, 1991; Raidal, 1994). No studies have 
  20successfully maintained the virus in in vitro systems such as embryonated chicken 
eggs (Lowenstine, 1984; Pass and Perry, 1985), galah (Eolophus roseicapillus) and 
budgerigar embryo cultures (Pass and Perry, 1985), various standard primary 
chicken cell cultures (Lowenstine, 1984; Jacobson et al., 1986), cockatiel embryo 
cultures (Pass and Perry, 1985; Jacobson et al., 1986), various continuous 
mammalian cell cultures (Pass and Perry, 1985), sulphur crested cockatoo (Cacatua 
galerita) monocyte-derived macrophage cell cultures (Wylie, 1991), lymphoblastoid  
MDCC-MSB1 cell cultures and a MSB1-cockatoo lymphoblastoid cell line (Raidal, 
1994).  
Infected birds are the only source of virus for genetic or immunological studies 
although obtaining considerable amounts of purified virus from these sources is 
difficult (Ritchie et al., 1989c). Ritchie et al. (1989c) purified the virus from feather 
follicle tracts using a combination of sucrose cushion ultracentrifugation and 2 CsCl 
gradient ultracentrifugation steps. Raidal et al. (1993a) and Raidal (1994) also 
purified the virus from dystrophic feathers by polyethylene glycol precipitation and 
ultracentrifugation through CsCl gradients. The purification of the virus from feather 
follicle tract needs a combination of ultracentrifugation through sucrose and 
isopycnic centrifugation in CsCl gradients (Raidal et al., 1993a).  
Clinical forms of PBFD in avian species 
There are acute and chronic clinical forms of PBFD. 
Acute form  
The clinical signs in the acute form of the PBFD have been described in neonatal 
cockatoos and African grey parrots (Psittacus erithacus), and consist of septicaemia, 
pneumonia, enteritis, rapid loss of weight followed by death (Clipsham, 1996; Pass 
and Perry, 1985). Bone marrow suppression in African grey parrots can lead to 
progressive, rapid non-regenerative anaemia during first week of infection 
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lethargy, inappetance and regurgitation of food following by necrosis of growing 
feathers and possibly death within 1-2 weeks (Wylie and Pass, 1987; Ritchie et al., 
1989a; Wylie, 1991; Gerlach, 1994; Raidal, 1994; Cross, 1996) although the 
depression, crop stasis, and diarrhoea may be the only changes detected prior to 
death (Latimer et al., 1991a; Gerlach, 1994). A mucoid to green diarrhoea has been 
observed in acutely affected birds (Cross, 1996) followed by green discoloration of 
the skin, faeces and urine (Raidal, 1994). Secondary bacterial and chlamydial 
infections (Smith, 1986; Perry, 1988; Marshall and Crowley, 1992; Raidal, 1994) as 
well as enteric cryptosporidiosis (Latimer et al., 1991a; Gerlach, 1994) may occur. 
In Australia and elsewhere, sulphur crested cockatoos (Cacatua galerita) and 
umbrella cockatoos (Cacatua alba) seem to be more susceptible to the acute form 
of PBFD than other psittacine species (Ritchie et al., 1989a; Raidal, 1994).  In the 
acute form of PBFD a range of feather abnormalities may be seen (Wylie and Pass, 
1987; Ritchie et al., 1989a; Wylie, 1991; Raidal, 1994) and touching the swollen and 
painful feather irritates the birds (Cross, 1996). A rapid loss of feathers occurs within 
one week in the development stage of feathering, and after maturation the body 
contour feather and flight feathers may grow very slowly (Pass and Perry, 1984b; 
Perry and Pass, 1985). Some common feather abnormalities seen in the growing 
feather are haemorrhage within the pulp, necrosis, bending and premature shedding 
of affected feathers, fractures from the necrotic points before exsheathing, 
hyperkeratosis and thickening of feather sheaths, lack of exsheathing, short or 
clubbed feathers, constrictions, and fault lines across the vanes (Pass and Perry, 
1984b; Perry and Pass, 1985; Wylie and Pass, 1987; Ritchie et al., 1989a; Wylie, 
1991; Gerlach, 1994; Raidal, 1994; Cross, 1996).  
In the acute form of disease, the presence of internal lesions seems to depend on 
secondary infections (Gerlach, 1994). Atrophy of the bursa of Fabricus in neonates 
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Wylie, 1991; Gerlach, 1994), hepatomegaly (Perry, 1981; Smith, 1986; Gough et al., 
1989), hepatonecrosis (Raidal, 1994; Raidal and Cross, 1995) and atrophy of the 
spleen in mature birds (Gerlach, 1994) have been described.  In PBFD-affected 
fledgling cockatoos, clinical signs can often be attributed to acute hepatic disease 
(Perry, 1981) and this has also been reported in experimentally affected birds 
(Raidal and Cross, 1995).  Hepatic disease may also occur after avian polyomavirus 
infection (Ramis et al., 1998). Other clinical signs of disease such as head tremor 
and ataxia have also been observed (Raidal, 1994). Acute PBFD in young 
cockatoos may cause death but in some species such as budgerigars 
(Melopsittacus undulatus), rainbow lorikeets (Trichoglossus haematodus), lovebirds 
(Agapornis sp.), king parrots (Alisterus scapularis) and eclectus parrots (Eclectus 
roratus), partial to complete recovery is observed (Cross, 1996). Most commonly, 
acute PBFD usually develops to a chronic form of disease (Cross, 1996). 
Chronic form  
The chronic form of PBFD usually occurs in birds 6 months to 3 years of age 
(Ritchie and Carter, 1995) but can be observed in birds up to 20 years of age 
(Graham, 1990). The most characteristic symptom of the chronic form of the disease 
is progressive development of abnormally growing feathers during successive 
moults (Pass and Perry, 1984b; Perry and Pass, 1985; Wylie and Pass, 1987; Wylie, 
1991; Gerlach, 1994). Pulviplumes (powder down feather) are often affected first 
and this is followed by damage to down and contour feathers (Figure 2.3).  A 
symmetrical pattern of involvement of the feather tracts is evident as the disease 
progresses (Pass and Perry, 1984b; Jacobson et al., 1986; Ritchie et al., 1989a).  
Down feathers and some contour feathers may remain in the final stages of the 
disease but the bird tends to become bald (McOrist et al., 1984; Pass and Perry, 
1984b; Perry and Pass, 1985; Wylie and Pass, 1987; Ritchie et al., 1989c; Wylie, 
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Other abnormalities of the feathers include involvement of the crest, tail and flight 
feathers without major changes to powder down feathers (Jacobson et al., 1986); 
general feather loss without other signs (Cross, 1996); thick dander lesion with 
minimal feather loss or periorbital lesions in lovebirds (Agapornis sp.) and some 
other psittacine birds (Schmidt, 1996a); discoloration of feathers, including yellowish 
feathers in birds with green plumage (Raidal, 1994) or red coloration in African grey 
parrots (Psittacus erithacus)  instead of grey contour feathers (Allen, 1990). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3.  A sulphur crested cockatoo (Cacatua galerita) infected with BFDV displaying 
gross clinical signs of feather loss. Provided by Shane Raidal, Murdoch University. 
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roseicapillus) and gang gang cockatoos (Callocephalon fimbriatum) (McOrist et al., 
1984; Pass and Perry, 1984b; Schmidt, 1996b; Jackson, 1991). It may be that 
cracks of distal parts of the corneum become the main reason for initial veterinary 
examination (Gerlach, 1994) and similar lesions may be detected in the nails 
(McOrist et al., 1984; Pass and Perry, 1984a; Pass and Perry, 1984b; Ritchie et al., 
1989a; Latimer et al., 1991a). The first abnormality in the beak of sulphur crested 
cockatoos (Cacatua galerita) is often a glossy black appearance, which is exposed 
following the lack of powder down (Pass and Perry, 1984b; Perry and Pass, 1985; 
Jacobson et al., 1986; Wylie, 1991; Gerlach, 1994).  In some cases, minor feather 
changes with severe beak damage have been reported (Pass and Perry, 1984b; 
Pass and Perry, 1985). 
Other important changes include beak softening and elongation, transverse and 
longitudinal fractures, delamination, necrosis of beak and palate, and oral ulcers 
(Pass and Perry, 1984b; Pass and Perry, 1985; Jacobson et al., 1986; Pass, 1989b). 
Oral necrosis may develop to involve the premaxilla (Gerlach, 1994) and 
osteomyelitis leads to sloughing (Cross, 1996) and separation of the plate from the 
beak (Pass and Perry, 1984b). Mycotic and secondary infectious in the clefts may 
exacerbate the severity of the lesions (Gerlach, 1994).   
The upper beak is more often involved than lower beak (Jacobson et al., 1986). 
After the lesions commence affected birds usually die in less than 18 months 
(Cross, 1996). Recovery of birds from the chronic form of the disease such as that 
shown in Figure 2.4 is not known.  
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Figure 2.4.  A galah (Eolophus roseicapillus) chronically infected with BFDV displaying 
gross clinical signs of beak fracture. From Shane Raidal, Murdoch University. 
 
 
Secondary disease problems occur including cryptosporidiosis, chlamydiosis, 
aspergillosis, candidiasis and polyomavirus infection (Latimer et al., 1991a; Raidal, 
1994; Gerlach, 1994). However, affected birds may live for many years in the 
absence of beak pathology with proper care (Latimer et al., 1991a; Raidal, 1994).  
Histopathological lesions of PBFD 
Histopathological lesions of PBFD can also be divided into acute and chronic forms.  
Acute form 
In the acute form, atrophy and necrosis of lymphoid follicles of the bursa of Fabricus 
and thymus, focal necrotic cellular debris and intracytoplasmic and intranuclear 
inclusion bodies in a range of organs are the most common internal 
histopathological lesions (McOrist et al., 1984; Pass and Perry, 1984b; Jacobson 
et al., 1986). Atrophy of the thymus without necrosis has been reported (Raidal, 
1994).  Hydropericardium and subcutaneous oedema have also been reported 
(Raidal, 1994). Following the acute form of PBFD in the feather shafts, ballooning 
degeneration and necrosis of epithelial cells in the epidermal and epidermal collar, 
  26basal and intermediate layers of the growing rachis was frequently observed 
(McOrist et al., 1984; Pass and Perry, 1984b; Jacobson et al., 1986; Latimer et al., 
1991b; Gerlach, 1994). Multifocal necrosis of the follicular epithelium may be 
present, but it is not common (Latimer et al., 1991b; Gerlach, 1994).  
Lesions in the feather pulp in the acute form of PBFD can occur but the lesions are 
variable with the characteristics of suppurative inflammation, including perivascular 
infiltration by heterophils, plasma cells, macrophages and occasionally lymphocytes 
(Gerlach, 1994); the absence of any lesions in the feather pulp and interfollicular 
dermis has been noted in some cases (Raidal, 1994).  In the epithelium of the 
feather sheath, mild to moderate hyperplasia and hyperkeratosis are common 
lesions (Pass and Perry, 1984b; Gerlach, 1994). In some instances, hyperplasia and 
hyperkeratosis of the feather tract are the only histopathological lesions (Latimer 
et al., 1991a; Latimer et al., 1991b).  
Chronic form 
In the chronic form of PBFD, lesions are similar to those in the acute form but are 
more diffuse and severe (Latimer et al., 1991b). Intracytoplasmic inclusions in 
macrophages of the dermis and epidermis predominate and this feature has been 
considered pathognomonic (McOrist et al., 1984; Pass and Perry, 1984b; Pass, 
1985; Pass, 1989b). It was noted that circoviruses such as PCV and BFDV do not 
accumulate in the nucleus but in large membrane-bound intracytoplasmic granules, 
in macrophages, lymphoid and epidermal cells (Raidal et al., 1993c; Tischer et al., 
1995; Timmusk et al., 2006). In feathers, intracytoplasmic inclusion bodies, necrosis 
varying from multifocal involvement of the petrologic (basal feather) epithelium to 
diffuse involvement of the pulp cavity have been detected (Latimer et al., 1991a).  
Infiltration of heterophils, macrophages, lymphocytes, plasma cells and giant cells 
was detected in 93.3%, 80%, 36.6% and 26% of cases of PBFD, respectively (Pass, 
1989b; Latimer et al., 1991a).  Specific interfollicular epidermal lesions are 
  27uncommon in the chronic form of PBFD (Pass, 1989b) but ulcers (Perry, 1981; 
Raidal, 1994), hyperkeratosis (Perry, 1981; Lowenstine, 1984; Raidal, 1994) and 
melanosis (McOrist et al., 1984; Pass and Perry, 1984b) have been reported.  In 
some affected peach-faced lovebirds (Agapornis roseicollis), chronic mononuclear 
cell perifollicular dermatitis was detected in the dermal layers, leading to nodule 
formation without any evidence of irritation or ulceration (Pass and Perry, 1985).  
Accumulation of dermal lymphocytes similar to that in Marek's disease may also be 
observed (Latimer et al., 1991a; Raidal, 1994). 
The most common histopathological lesion in the beak consists of necrosis and 
ballooning degeneration of epidermal cells in the inner layers especially in basal 
cells, hyperkeratosis more frequently in the tips, and macrophage infiltration of the 
epidermis (Pass and Perry, 1984b) and intracytoplasmic inclusion bodies within 
macrophages (Pass and Perry, 1984b).  Giant cells have been detected in the 
germinal layer of the beak (Schmidt, 1996b). In oral tissue, chronic inflammation is 
also present (Pass and Perry, 1984b) and in the digestive system, liver, epithelial 
cells of the oesophagus and endothelial cells, histopathological lesions may be 
observed (Pass, 1989; Schmidt, 1996b). Atrophy of the spleen with depletion of the 
lymphocytes and occasionally reticular cell necrosis may also be present (Gerlach, 
1994). 
The inclusion bodies occur not only in the cells of the feather and beak, but also in 
the alimentary system (Latimer et al., 1990).  In more than 97% of terminal cases, 
extracutaneous (non-skin and non-feather) viral inclusion bodies were found in a 
variety of tissues including the palate, tongue, crop, nail, oesophagus, intestine, 
thyroid and parathyroid glands, bone marrow, spleen and Küppfer cells of the liver 
(Latimer et al., 1990).  Inclusion bodies are also found in endothelial cells (Werther 
et al., 1998). Virus-induced apoptosis may facilitate the release and dissemination of 
viral particles from the inclusions (Trinkaus et al., 1998).  
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Latimer et al. (1991a) suggested that many factors can contribute to the variation in 
the fate of an infected bird, including age, dose of virus, mode of infection, strain 
variation in virus virulence, the immunocompetence of the host, the host species 
infected, whether there has been previous exposure to the virus, the simultaneous 
occurrence of other disease, the individual physiological or metabolic state of the 
host, and environmental conditions. Apparently, the infection of feather anlage cells 
can remain latent until the next moult (Cross, 1996) resulting in the appearance of 
lesions in association with moulting. 
The combination of dystrophy and hyperplasia in epidermal cells causes some 
lesions in the feather, beak and claws (Pass and Perry, 1984a). Due to hyperplasia, 
necrosis and disruption of the epidermal collar, basal membrane, intermediate 
epidermis and feather pulp, dystrophy occurs and leads to thrombosis and 
haemorrhage within the pulp (Pass and Perry, 1984a). The consequence of the 
hyperplasia is hyperkeratosis of the feather sheathes and external layers of the beak 
and claws (Pass and Perry, 1984a). Hyperkeratosis of feather sheaths leads to a 
condition where the sheaths break or partially break after emerging from the feather 
follicle. The haemorrhage, inflammation and necrosis in the pulp of the emerging 
feather lead to retention of the feathers and normally the necrotic tissue slough as 
the sheath breaks.  A painful distal swelling caused by a necrotic and inflamed pulp 
is exacerbated by vascular proliferation and oedema in the pulp, and the distal 
keratinising feathers curl up within the feather sheath and produce clubbed feathers.  
Bacterial infections exacerbate the lesions (Pass and Perry, 1984a). 
Circumferential indentations seen in affected feathers are the product of the rachis 
epidermis and might be due to a large amount of necrosis at the feather tip or a 
period of slow growth (Pass and Perry, 1984a). The feather follicles become 
increasingly atrophic and inactive and with successive moults the condition is 
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Wylie, 1991; Gerlach, 1994). It seems that hyperkeratosis and the inability of 
keratinised layer to slough can result in beak elongation (Pass and Perry, 1984a). 
Incubation period of PBFD 
In experimental transmissions, the minimum incubation period is 3-4 weeks but the 
situation in wild birds is unknown (Wylie and Pass, 1987; Ritchie et al., 1989a; 
Raidal, 1994).  However, there is anecdotal evidence suggesting that the incubation 
period of naturally occurring disease may be longer (Ritchie et al., 1989a; Raidal, 
1994) which is a serious problem during attempts to eradicate BFDV from aviaries 
by quarantine of clinically affected birds (Raidal, 1994). In the nestling or fledging 
bird, the incubation period may be as long as one year when horizontal transmission 
is the major route of transmission (Raidal, 1994). Factors that may contribute to and 
cause variation in the duration of the incubation period, include the infectious dose 
(Ritchie et al., 1992b; Clipsham, 1996; Cross, 1996), the age of the bird at the time 
of exposure (Cross, 1996), the stage of feather development (Cross, 1996) and that 
the manifestation of disease in most species requires moulting (Cross, 1996), which 
can take 6 months or more, and differences in host response (Ritchie et al., 1992b). 
Clinical pathological changes in PBFD 
There are contradictory reports describing haematological abnormalities in PBFD 
affected birds and significant and consistent haematological changes have not been 
reported.  Rosskopf and Woerpel (1981) reported abnormal haematological values 
while Jacobson et al. (1986) found no significant differences among affected birds.  It 
was reported that there were no differences in the level of serum corticosterone, 
thyroxine  (T4) and biochemical parameters in affected sulphur crested cockatoos 
(Cacatua galerita) and Moluccan cockatoos (Cacatua moluccensis), although 
affected birds had significantly lower serum gamma globulin and prealbumin 
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some affected birds but hypergammaglobulinemia was detected in others (Gerlach, 
1994). 
Evidence of virus within lesions 
Inclusion bodies containing virus-like particles are a consistent histopathological 
feature.  They have been observed in both the cytoplasm and nucleus of the cells 
but intranuclear inclusion bodies are less frequently observed than intracytoplasmic 
inclusion bodies (Latimer et al., 1991a).  Intracytoplasmic inclusion bodies in the 
macrophages and epithelial cells can be better observed using Feulgen and methyl-
pyronine green staining (McOrist et al., 1984; Pass and Perry, 1984b; Jacobson 
et al., 1986; Wylie and Pass, 1987; Wylie, 1991) suggesting the presence of DNA.  
The presence of DNA in intracytoplasmic inclusions has been confirmed by 
treatment of the inclusion bodies with DNase and post-staining with Feulgen stain 
(Wylie and Pass, 1987; Wylie, 1991). The ss DNA nature of the virus in inclusion 
bodies has been confirmed by acridine orange staining (Loupal et al., 1990; Desmidt 
et al., 1993).  
In early studies of BFDV replication, Feulgen techniques failed to demonstrate 
aggregated DNA staining within affected nuclei (Pass and Perry, 1985; Pass, 1989b) 
and paracrystalline arrays within the nucleus have never been identified (Jacobson 
et al., 1986; Wylie and Pass, 1987; Wylie, 1991). Nevertheless, Latimer et al. (1990, 
1991b) reported that it was possible to detect BFDV antigen in the epidermal cell 
nuclei using immuno-peroxidase and colloidal gold immuno-electron microscopic 
techniques.  A digoxigenin-labelled in situ DNA probe has also been used to 
demonstrate intranuclear virus DNA (Latimer et al., 1991b).  
The site of the replication of BFDV in affected birds 
There is no definitive information identifying the primary site of replication but the 
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gastrointestinal tract and liver suggest that virus uptake may be intracloacal (Latimer 
et al., 1990; Latimer et al., 1991b). The high concentrations of virus in the faeces, 
liver and crop washings support the theory that BFDV replicates principally in these 
organs (Raidal and Cross, 1995) and that the bursa of Fabricus may be the primary 
site of BFDV replication (Wylie and Pass, 1987; Wylie, 1991). The liver, however, 
seems to be an important site of BFDV replication in both the acute and chronic 
forms of disease (Raidal et al., 1993c; Raidal, 1994) and high titres of BFDV can be 
detected in the liver and bile of birds with the chronic form (Raidal and Cross, 
1994a). Cross (1996) suggested the primary replication site of virus is lymphoid 
tissue in the bursa of Fabricus and/or gastrointestinal tract, and secondary 
replication site occurs in the liver and thymus and probably other tissues (Cross, 
1996), but this is still to be substantiated. There is some evidence of haematological 
dissemination since viral antigens and viral DNA have been identified in peripheral 
blood mononuclear cells (PBMC) and bone marrow macrophages shortly after 
infection (Niagro et al., 1990; Latimer et al., 1991a).  
BFDV appears to be epitheliotropic in the feathers and follicles particularly targeting 
the actively dividing cells of basal layers of epithelium virus (Pass and Perry, 1984b; 
Latimer et al., 1991b; Raidal, 1994) with viral antigen detectable in a variety of 
tissues such as thymus, bursa of Fabricus, crop, oesophagus, plate, intestine, skin, 
beak and feather (Latimer et al., 1990).  
Immunosuppression associated with PBFD  
While there is no definitive evidence of immunosuppression in affected birds, virus 
replication and necrosis in the lymphoid tissues such as the bursa of Fabricus, 
thymus and other lymphoid tissues (Pass and Perry, 1984b; Perry and Pass, 1985; 
Jacobson et al., 1986; Smith, 1986; Latimer et al., 1990; Schmidt, 1990; Latimer 
et al., 1991a) are suggestive that immunosuppression may occur (Latimer et al., 
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 most 
pronounced in the bursa of Fabricus and the thymus (Latimer et al., 1991a).
  Death 
could be a consequence of secondary and multiple infections as a consequence of 
immunosuppression (Latimer et al., 1990; Latimer et al., 1991a; Raidal, 1994) and 
affected birds frequently succumb to secondary infections, such
 as peritonitis, 
chlamydiosis, and mycotic ventriculitis (Todd et al., 2000). 
Damage to lymphoid tissues and suppression of the immune system is typical of 
circovirus infections.  These viruses are thought to target precursor T cells depleting 
populations of both helper (CD4
+) and cytotoxic (CD8
+) T cells (Adair, 2000) and 
mortality is usually the result of a secondary bacterial or fungal infection (Latimer 
et al., 1992b; Schoemaker et al., 2000). Wylie and Pass (1987) found occasional 
infiltration of heterophils and lymphocytes into the pulp to feathers during 
experimental reproduction of PBFD using budgerigars (Melopsittacus undulatus), a 
finding supported by Jacobson et al. (1986), suggesting that feather lesions are 
immunologically-mediated. 
Immunological response to virus infection 
Antibody against BFDV has been detected in affected birds, and a serological 
survey in wild and aviary flocks in Australia indicated a high degree of antibody-
positive birds, especially in wild populations of sulphur crested cockatoos (Cacatua 
galerita) and galahs (Eolophus roseicapillus) (Raidal, 1994). It was suggested that 
the complete or partial recovery from the acute form of PBFD that has been reported 
in budgerigars (Melopsittacus  undulatus), lorikeets (Trichoglossus sp.), lovebirds 
(Agapornis sp.), a Pionus parrot (Pionus sp.) and some macaw (Ara sp.) neonates 
(Perry, 1981; Pass and Perry, 1984a; Gerlach, 1994) was due to seroconversion 
(Cross, 1996).  Haemagglutination-inhibition (HI) antibodies, however, were not 
detected in affected cockatoos even though high levels of HA antigens were 
detected in tissues such as liver, kidney and serum.  A number of possibilities were 
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presence of bound antibody in circulating immuno-complexes, possible 
immunosuppression or immuno-tolerance of the diseased birds (Raidal, 1994).  
Range of BFDV-susceptible species 
PBFD, as the name suggests, is detected only in the order Psittaciformes (Pass, 
1985; Jacobson et al., 1986; Huff et al., 1988; Ritchie et al., 1990a; Greenacre et al., 
1992; Gerlach, 1994) but similar diseases exist in other avian orders (Pass et al., 
1994; Raidal and Riddoch, 1997; Twentyman et al., 1999). It has been detected in 
more than 61 wild and captive psittacine species in both Old and New World 
psittacine species (Lowenstine, 1984; Jacobson et al., 1986; Huff et al., 1988; Allen, 
1990; Latimer et al., 1990; Greenacre et al., 1992; Cross, 1996) and although the 
complete host range of BFDV has not been defined (Gerlach, 1994) it is probably 
capable of infecting all psittacine species (Clipsham, 1996).  
Studies have indicated varying susceptibility of psittacine species to the virus 
(Schmidt, 1996a).  Cockatoos (McOrist et al., 1984; Pass and Perry, 1984b; Smith, 
1986),
 eclectus parrots (Eclectus roratus) (Speer, 1990; Dalhausen and Radabaugh, 
1993), lovebirds (Agapornis sp.) (McOrist et al., 1984; Ritchie et al., 1990b; 
Dalhausen and Radabaugh, 1993), budgerigars (Melopsittacus  undulatus) (Wylie 
and Pass, 1987; Ritchie et al., 1989c), African grey parrots (Psittacus erithacus) 
(Speer, 1990), lorikeets (Trichoglossus sp.) and cockatiels (Nymphicus hollandicus) 
(Raidal, 1994) may be less susceptible.  
Age-related susceptibility to BFDV 
The age of infected birds is the most important parameter determining the severity 
of clinical signs that develop (Gerlach, 1994). Clinical and anecdotal evidence 
suggests birds at all ages are susceptible but that disease is more common in 
juvenile and young adults less than 2 years of age (Cross, 1996; Raidal and Cross, 
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age, demonstrated clear differences in susceptibility and severity (Raidal, 1994).  
Prognosis in birds with PBFD 
In the acute and chronic form of PBFD the main outcome of disease is mortality 
within 1-2 weeks for the acute form, and within 6-12 months for chronic forms 
(Latimer et al., 1991a; Wylie, 1991; Ritchie et al., 1992b; Gerlach, 1994; Raidal, 
1994). Complete and partial recovery and the development of a carrier state have 
been reported (Raidal, 1994; Clipsham, 1996) but this is unusual.  There are reports 
indicating that recovery from acute form of PBFD in budgerigars (Melopsittacus  
undulatus), lorikeets (Trichoglossus sp.), lovebirds (Agapornis sp.), a Pionus parrot 
(Pionus sp.) and some macaw (Ara sp.) neonates was associated with 
seroconversion (Perry, 1981; Pass and Perry, 1984a; Pass and Perry, 1984b; 
Gerlach, 1994). 
Death usually occurs either because of the primary lesions or because of multiple 
secondary infections. Secondary infections reported include Gram-positive and 
Gram-negative bacteria in association with septicaemia, other localised bacterial 
infections, mycobacterial infections, chlamydiosis, severe enteric cryptosporidiosis, 
pulmonary aspergillosis, polyomavirus infection, herpesvirus infection, septicaemia 
and hepatitis due to E. coli, and necrotic enteritis (Latimer et al., 1990; Latimer et al., 
1991b; Raidal, 1994). Difficulty in eating and the resulting malnutrition often leads to 
death but with good management some completely defeathered birds have lived for 
more than 10 years, particularly in the absence of beak abnormalities (Gerlach, 
1994; Raidal, 1994). 
Transmission of PBFD 
It has been claimed that PBFD is a highly contagious disease in which the flocking 
behaviour of birds promotes its transmission in the wild (Marshall and Crowley, 
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BFDV into susceptible birds by using several different routes of inoculation, 
including per os (Wylie and Pass, 1987; Ritchie et al., 1991a; Wylie, 1991; Ritchie 
et al., 1992b), intracloacal (Wylie and Pass, 1987; Ritchie et al., 1991a; Wylie, 1991; 
Ritchie et al., 1992b), intranasal (Ritchie et al., 1992b; Clipsham, 1996), 
intraconjunctival (Wylie and Pass, 1987; Ritchie et al., 1991a; Wylie, 1991; Ritchie 
et al., 1992b), subcutaneous (Wylie and Pass, 1987; Wylie, 1991; Ritchie et al., 
1992b), intramuscular (Raidal, 1994) and respiratory (Clipsham, 1996) routes. The 
presence of viral antigen in the renal collecting tubular epithelium (Raidal, 1994; 
Schmidt, 1996b) suggested that transmission through urine might be possible 
(Gerlach, 1994). 
Faeces can contain high concentrations of virus and are probably one of the most 
important sources of virus infection (Ritchie et al., 1991a; Wylie, 1991; Raidal et al., 
1993c). The detection of virus in inclusion bodies in the gastrointestinal tract of 
affected birds and associated tissues (bursa of Fabricus and liver) (Ritchie et al., 
1991a; Wylie, 1991; Raidal et al. 1993c) suggests that these tissues are potential 
sources of virus present in the faeces.  It is assumed that the virus may also be 
transferred to offspring via the regurgitation of food contaminated with exfoliated 
crop epithelial cells (Ritchie et al., 1991a) but transmission by this means is not 
considered a major route of infection as BFDV is less concentrated in the crop of 
affected birds (Ritchie et al., 1991a).  Nestling psittacine birds might also be 
contaminated directly by infection of the bursa of Fabricus; birds of this age have 
weak legs and sit in a tripodal fashion that exposes the cloaca to potential virus-
containing material such as faeces and feather dust (Wylie, 1991; Raidal et al., 
1993c).  
Another major source of BFDV infection is feather dust (Perry, 1981; McOrist et al., 
1984; Pass and Perry, 1984b; Perry and Pass, 1985; Jacobson et al., 1986; Huff 
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inclusion bodies in the necrotic feather sheaths (Pass and Perry, 1984b) and the 
consistent spread of high concentration virus in the dust of bird-rooms (Ritchie et al., 
1991b) suggests this source could be important.  
The role of vertical transmission in the natural transmission of disease is uncertain 
(Raidal, 1994) although the presence of DNA of BFDV in the ovary of infected birds 
has been reported (Werther et al., 1998).  
Epidemiology of PBFD 
PBFD has been documented in more than 61 wild and captive psittacine species 
(Lowenstine, 1984; Jacobson et al., 1986) and virus infection is common in wild 
psittacine species in Australia (McOrist et al., 1984; Pass and Perry, 1985) with the 
prevalence of antibody varying from 41% to 94% in different wild psittacine 
populations (Raidal et al., 1993b). Another report estimated the prevalence rate to 
be 50% in a small flock of free ranging crimson rosellas (Platycercus elegans) 
(McOrist et al., 1984; McOrist, 1989).  Clinical signs have been seen in young wild 
birds of both sexes during their first feather formation and after replacement of 
neonatal down, but also in older birds (Pass, 1985; Ritchie et al., 1989b; Raidal and 
Cross, 1995). 
The disease is also widespread in captive birds, for which there is a considerable 
international trade, legal and illegal.  PBFD was estimated to affect 8.05% of 
psittacines kept in captivity in Italy, based on the detection by PCR of virus in 122 of 
1516 feather samples (Bert et al., 2005). In the USA, a 0.5% prevalence was 
estimated in imported psittacine birds, due to infection contracted in the country from 
which they originated (Jacobson et al., 1986; Gerlach, 1994). 
Diagnosis of PBFD 
There are a range of diagnostic techniques available for the detection of clinical or 
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histological lesions, tests for the detection of virus genetic material in tissues, tests 
for the detection of virus antigen in tissues, serological tests for the detection of 
BFDV antibody and electron microscopy for the detection of virus in tissues. 
Histopathological lesions  
PBFD can be confirmed by the presence of characteristic histological lesions (Pass 
and Perry, 1984b; Latimer et al., 1991a; Wylie, 1991; Raidal, 1994) in association 
with the detection of inclusion bodies in the affected feather, beak, bursa of 
Fabricus, thymus and other tissues, which are considered pathognomonic of PBFD 
(Pass and Perry, 1984b; Latimer et al., 1991a; Wylie, 1991; Clipsham, 1996; Cross, 
1996). Histopathological methods of diagnosis are advantageous in terms of time 
and cost when screening large numbers of samples (Latimer et al., 1989; Marshall 
and Crowley, 1992; Raidal, 1994; Cross, 1996) but reliance on histopathological 
findings is not possible in some cases as lesions may be absent if birds are recently 
infected (Ritchie et al., 1989a) . 
Tests for the detection of virus genetic material in tissues 
PCR assays including reverse transcription PCR assays are a potentially sensitive 
and specific tool for the detection of viral genetic material and a commercial PCR 
test has been developed (Niagro et al., 1990; Dalhausen and Radabaugh, 1993; 
Heath et al., 2004; Kondiah et al., 2005). DNA extracted from peripheral blood 
mononuclear cells (PBMC) present in heparinised blood (Raidal and Cross, 1994b)  
or formaldehyde-fixed feathers (Gerlach, 1994) can be used for PCR detection of 
the virus, although care should be taken when using heparinised blood as high 
levels of heparin may inhibit the PCR assay. Hess et al. (2004) reported that the 
sensitivity of PCR appeared to be higher for feather samples than for blood 
samples. 
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would allow for an increase in sensitivity of the amplification process.  Budgerigar 
fledging disease (BFD) caused by an avian polyomavirus can be confused with 
PBFD as both produce similar feather disorders (Ogawa et al., 2005) and a duplex 
shuttle PCR technique was developed for the differential diagnosis of the 2 viruses. 
A DNA Dot-Blot assay has also been developed for the detection of both clinical and 
subclinical cases of PBFD in the USA (Niagro et al., 1990; Dalhausen and 
Radabaugh, 1993).   
In situ hybridisation (ISH) could also be a useful technique for the identification of 
genetically-related circoviruses.  ISH has proven to be a useful tool in studies of 
many infectious diseases and has been used to detect PBFD viral nucleic acid in the 
nuclear inclusions of the feather epithelial cells, and in the cytoplasmic inclusions of 
pulp macrophages (Latimer et al., 1992a; Ramis et al., 1994). Examination of 
infected pigeons by ISH has revealed circovirus DNA in many tissues, sometimes in 
large quantities, without its presence having been suspected previously (Smyth 
et al., 2001).  
Tests for the detection of virus antigen in tissues 
HA can be used for the detection of virus in a variety of tissues, including dystrophic 
powder down feathers, actively growing contour feathers, faeces, and in 
homogenates of different tissues such as kidney, liver and serum (Ritchie et al., 
1991a; Raidal, 1994). If the results of HA tests using faecal or feather samples show 
titres of 640 to >40,960 HA units/50 µL, the bird is considered to be infected with 
BFDV (Raidal et al., 1993c; Raidal, 1994).  The specificity seems to be high and 
there are no reports of non-specific reactions occurring when using feather samples 
from clinically normal birds (Raidal, 1994). The HA result can be confirmed by 
inhibition of the HA activity with specific BFDV antibody (Raidal et al., 1993c; Raidal, 
1994).  
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tissue (Graham, 1985; Ritchie et al., 1989a; Raidal, 1994).  Polyclonal antisera 
(Latimer et al., 1990; Latimer et al., 1991b) and monoclonal antibody (Ritchie et al., 
1992b) have been used in PFDV-specific immunoperoxidase techniques. 
Detection of BFDV antigen in feathers with an enzyme immunoassay was described 
by Raidal (1994).  This immunoassay (EIA) utilised polyclonal chicken anti-PBFD as 
the primary antibody with rabbit anti-chicken horseradish peroxidase conjugated 
serum as the secondary antibody (Raidal, 1994).  The immunoassay developed 
could detect BFDV antigen in affected feather tips, but non-specific background 
staining and dried blood adherent to and within feather shafts made the 
interpretation difficult (Raidal, 1994).  Modifications of the EIA technique were 
suggested by Raidal (1994)  to overcome some of these problems but with the 
availability of other simple, sensitive, quantitative and specific diagnostic assays 
such as PCR and HA, the future for the application of this non-quantitative technique 
is doubtful. 
Serological tests 
Serological methods have been used for the detection of BFDV-infected flocks and 
for the demonstration of seroconversion in individual cases (Ritchie et al., 1991b; 
Raidal, 1994).  However, serological detection can be difficult when seropositive 
birds are not actively shedding the virus, or when infected birds have not yet 
developed antibodies (Ritchie et al., 1991a). The HI test is the most commonly used 
and standard serological test used for the detection of BFDV antibody, although 
ELISA, immunoprecipitation and other tests are also possible (see below).   
Most susceptible birds affected by PBFD develop HI antibody to BFDV (Ritchie 
et al., 1991b) and the levels of HI antibody increase following recovery from natural 
infections or after whole virus immunisation (Ritchie et al., 1991b; Raidal et al., 
1993c).  A high HI seroprevalence rate was demonstrated in populations of free 
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had HI titres of 1:20 to 1:10,240 HI units/50 μL (Raidal et al., 1993b).  Although 
generally sensitive and specific, there are problems associated with the test. Non-
specific inhibitors of HA are present in serum samples, although these can be 
removed (Raidal et al., 1993c).  Birds with active PBFD virus infections and 
chronically infected birds have low-to-undetectable levels of HI antibodies that can 
result in them being considered false negatives (Ritchie et al., 1991b; Raidal et al., 
1993c). 
An ELISA can also be used for detection of circulating antibodies and is a valuable 
tool in disease diagnosis (Roitt et al., 2001). Preparation of whole virus antigen can 
be a problem and alternative recombinant protein antigens need to be considered.  
Recently, Johne et al. (2004) developed an indirect ELISA and an immunoblotting 
technique for the detection of antibodies to BFDV in psittacine sera, using a 
truncated recombinant BFDV capsid protein expressed in E. coli. However, because 
of the frequent problems associated with solubilisation of proteins expressed in 
bacterial systems, alternative methods of producing the recombinant proteins need 
also to be considered and techniques such as baculovirus vectors in insect cells 
should be investigated: an ELISA antigen prepared from baculovirus-expressed 
PCV-2 capsid protein has been described by Liu et al. (2004).  
An agar gel immunodiffusion (AGID) test has been used to detect precipitating 
antibody in vaccinated birds (Ritchie et al., 1992b).  This test is not a preferred 
assay method because while it is relatively rapid it is less sensitive than other 
serological tests (Raidal, 1994).  
Electron microscopic detection of virus 
The presence of BFDV in tissues through the detection of intranuclear and 
intracytoplasmic inclusion bodies in macrophages and epithelial cells can be 
achieved using transmission electron microscopy (Gough et al., 1989; Ritchie et al., 
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bodies are membrane-bound, and spherical non-enveloped particles 14-20 nm in 
diameter are present in dense paracrystalline arrays (McOrist et al., 1984; Pass and 
Perry, 1984b; Wylie and Pass, 1987; Ritchie et al., 1989c; Latimer et al., 1991b; 
Wylie, 1991; Sanada et al., 1999; Sanada and Sanada, 2000).  Direct electron 
microscopic examination of negatively stained virus in faecal suspension and 
feather pulp homogenates (Wylie, 1991) has been achieved.  Immune electron 
microscopy is also a useful diagnostic technique (Raidal, 1994). 
Treatment and control of PBFD 
Chemotherapeutic trials using a variety of anti-viral drugs, immune system 
stimulants and herbal extracts have been administered to PBFD virus -infected birds 
and although some therapies can improve the conditions of the host, none of the 
treatment regimes were capable of eliminating the virus (Latimer et al., 1990).  
Recently, it was postulated that the application of gamma interferon of poultry origin 
has the potential to resolve circovirus infections in African grey parrots; no side 
effects were observed from the repeated interferon injections in any bird in the study 
(Stanford, 2004). 
It has been assumed that PBFD virus is resistant to physical and chemical agents 
but this is difficult to confirm due to the lack of an in vitro culture system.  It is 
assumed that the resistance will be similar to CAV, which is highly resistant and can 
remain stable when treated with some detergent such as sodium hypochlorite (1% 
bleach), methyl alcohol, ethyl alcohol and heating to 80ºC for 1 h (Yuasa et al., 
1979).  
Methods suggested to reduce levels of infection have included the boiling of feed 
and water cups utensils to inactivate virus (Raidal, 1994).  The use of disinfectants is 
frequently recommended but their disinfection abilities are unknown: sodium 
hypochlorite (bleach), phenolic compounds or stabilised chlorine dioxide have been 
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PBFD vaccination  
Vaccination is a potential method for controlling PBFD in captive birds, and could 
also be considered in breeding programs for endangered species.  In lovebirds 
(Agapornis sp.) and cockatoos vaccinated with whole virus preparations emulsified 
with an oil adjuvant, seroconversion was detected and the disease was not 
observed for 1-2 years post-vaccination (Raidal and Cross, 1994a).  Serum antibody 
titres as high as 1:160 HI units/50 μL were found to persist in some vaccinated birds 
for more than 6 months and it was suggested that HI antibody titres as low as 1:80 
HI units/50 μL were probably protective (Raidal and Cross, 1994a). However, as 
attempts to isolate and maintain the virus in vitro have not been successful, 
production of whole virus for preparation of vaccines would be problematic.  A future 
approach to the development of a vaccine would be the use of recombinant subunit 
vaccines, which could be produced by one of several expression systems including 
bacterial, yeast, mammalian cell, insect cell and cell-free systems. Recombinant 
proteins have been used as vaccines for the control of several viral, bacterial and 
parasitic diseases (Almeida et al., 2003; Law et al., 2003). 
Bacterial expression systems have many advantages for the production of 
recombinant proteins.  They can express foreign proteins at a high level and low 
cost (Sambrook and Russel, 2001).  They do, however, have disadvantages 
including the absence of post-translational modifications and the frequent production 
of proteins that are in inclusion bodies and insoluble (Sambrook and Russel, 2001; 
Coligan et al., 2002).  Post-translational modifications may not be critical as there is 
no evidence that circovirus capsid proteins undergo essential post-translational 
modifications such as glycosylation. To overcome frequent solubility problems 
associated with the expression of recombinant proteins in bacterial systems, the use 
of eukaryotic systems including mammalian, yeast and insect cell systems have 
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soluble and post-translational modifications such as glycosylation are possible 
(Coligan et al., 2002).  In baculovirus expression systems, large amounts of 
recombinant protein can be produced by using a helper virus that can be 
propagated to high titres in insect cells adapted for growth in suspension culture 
(Coligan et al., 2002).  Yeast expression systems also enable similar post-
translational modifications but frequently result in only low recombinant protein 
yields (Sambrook et al., 1989; Sambrook and Russel, 2001). 
Recombinant proteins could also be used for the production of diagnostic antigens.  
In the case of BFDV, recombinant virion proteins might have HA activity and could 
provide an antigen for HI tests, which are particularly valuable for the detection of 
BFDV infection (Raidal and Cross, 1994a).  They could also be used for the 
development of ELISA antigens, which are potentially useful for the detection of 
circulating antibodies and a valuable tool in disease diagnosis (Roitt et al., 2001).  
Detection of BFDV antibodies in psittacine sera by ELISA test have been performed 
using truncated recombinant BFDV Capsid proteins expressed in E. coli (Johne 
et al., 2004) and the development of ELISA antigens utilising baculovirus expressed 
PCV-2 capsid proteins has been described (Liu et al., 2004) suggesting the 
approach should also be possible for BFDV.  Truncated recombinant BFDV Capsid 
proteins developed by Johne et al. (2004) induced an antibody response in 
chickens.  
 
  44Chapter 3. Comparison of haemagglutination, 
haemagglutination-inhibition and polymerase chain 
reaction assays for detection of Beak and feather 
disease virus infection 
 
Summary 
Several diagnostic methods for the detection of Beak and feather disease virus 
(BFDV) infection have been developed but there are few studies comparing the 
relative merits or sensitivity and specificity of each diagnostic test. In this Chapter, 
the results of PCR, haemagglutination (HA) and haemagglutination inhibition (HI) 
tests conducted with 679 samples from a range of psittacine bird species suspected 
of being infected with BFDV were analysed. There was a strong agreement (kappa 
= 0.757 P <0.000) between PCR and HA testing of feather samples, and PCR-
negative birds were 12.7 times more likely to have HI antibody than PCR-positive 
birds. False positive HA results with titres up to 1:320 HA units/50 μL were identified 
in 6 feather samples that were PCR negative because the haemagglutination 
detected in these samples was not inhibited by anti-BFDV sera and was removed by 
filtration through a 0.22 µm filter. Of 143 birds that were PCR feather-positive only 2 
had detectable HI antibody and these birds were also HA feather-negative 
suggesting that they were developing immunity to recent infection. All birds with HI 
antibody were negative on feather HA testing.  Although cockatiels (Nymphicus 
hollandicus) are normally considered resistant to infection, there was evidence of 
BFDV infection in 2 cockatiels. 
  45Introduction 
Psittacine beak and feather disease (PBFD) is the most common viral disease of 
wild Psittaciformes in Australasia and it has a world wide distribution in captive birds.  
It is recognised as a threat for endangered psittacine birds in Australia, New Zealand 
and South Africa. In Africa, PBFD has been identified in captive Agapornis sp. 
(lovebirds) (Kock, 1990) as well as wild Cape parrots (Poicephalus robustus) (Heath 
et al., 2004), although these outbreaks may be due to the release of aviary birds. 
The disease is also widespread in captive collections of psittacine species in Europe 
(Desmidt et al., 1993; Baker, 1996) and North America (Ritchie et al., 1989c; Latimer 
et al., 1991a).  
The causative virus, BFDV, has a circular ss DNA ambisense genome (Bassami 
et al., 1998; Niagro et al., 1998) with 2 major open reading frames (ORF). ORF V1 
encodes for the replication-associated protein (Rep) and ORF C1 encodes for the 
capsid protein. BFDV is a haemagglutinating circovirus which has permitted the 
development of haemagglutination (HA) and haemagglutination inhibition (HI) 
assays for the virus and antibody responses to infection, respectively (Raidal and 
Cross, 1994b). These assays, as well as PCR testing based on the relatively 
conserved ORF V1 (Ypelaar et al., 1999; Ritchie et al., 2003; Kondiah et al., 2006), 
are in wide use throughout Australia and the world for diagnosing infection (Raidal 
et al., 1993b; Sanada and Sanada, 2000) but there have been no studies comparing 
the value of HA and HI testing relative to PCR. In this Chapter, an evaluation of the 3 
tests for the detection of virus infection using feather and blood samples submitted 
to Murdoch University for routine diagnostic testing is reported.  
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Tissue samples 
Feather and blood samples were submitted by referring veterinarians throughout 
Australia from 623 psittacine birds either tentatively diagnosed with PBFD, with a 
history of being in contact with PBFD-affected birds, or to confirm absence of 
disease in quarantined birds (Table 3.1). Blood samples were either collected onto 
filter paper as described by Riddoch et al. (1996) when long distance transportation 
was required, or collected into heparinised collection tubes for processing as 
described by Raidal et al. (1993b).  Feathers were transported without preservation. 
To compare assays on feathers and blood, a flock of 56 peach faced lovebirds 
(Agapornis roseicollis) recently imported into a pet shop was sampled by feather HA 
assay, feather PCR, blood PCR and HI tests (Table 3.4).  
The presence of BFDV in 13 cockatiels (Nymphicus hollandicus) was studied to 
investigate resistance to PBFD (Table 3. 5). One of the birds (NH-AUS) was 
subsequently donated to Murdoch University by the owner and housed in the animal 
house. Physical examination revealed that the bird was in good body condition but 
with loss of feathers from the body, head, wings and tail. Remaining feathers were 
stunted and many had retained feather shafts and these feathers were easily 
removed. 
Haemagglutination (HA) and haemagglutination inhibition (HI) assays 
HA assays were performed on feather samples using galah (Eolophus roseicapillus) 
erythrocytes as described by Raidal et al. (1993c). HI assays on blood samples 
collected onto filter paper were performed as described by Riddoch et al. (1996) or 
when submitted as plasma or serum as described by Raidal et al. (1993b). 
Confirmation of HA results was by inhibition of HA activity with BFDV-specific antibody  
and by filtration of samples through 0.22 µm filters as described by Raidal et al. 
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erythrocytes was carried out as necessary whenever there was a discrepancy between 
HA and PCR test results. A kappa statistical analysis was calculated to measure the 
level of agreement between 2 diagnostic procedures (Motulsky, 1995). 
Extraction of antigen from feathers 
A single feather shaft from PBFD-affected or healthy birds was weighed and made 
into a 10% (w/v) suspension in PBS by agitation and vortexing.  This suspension 
was incubated at 60°C for 1 h, and clarified by centrifugation at 11,000 x g for 3-5 
min. One hundred μL of the clarified supernatant was mixed with an equal volume of 
chloroform as previously described by Raidal (1994), vortexed and centrifuged at 
11,000 x g for 3-5 min. The supernatant was assayed by HA. 
Erythrocyte preparation for HA and HI assays 
Normal galahs (Eolophus roseicapillus) with type A (BFDV-sensitive) erythrocytes 
(Raidal, 1994) were used to supply blood for HA and HI tests.  Usually 2 mL of blood 
was collected by jugular venipuncture from galahs (Eolophus roseicapillus), directly 
into a syringe containing 2 mL of Alsever's solution (glucose 20.5 g, NaCl 4.2 g, tri-
sodium citrate 8 g, citric acid 0.55 g, made up to 1 L with distilled H2O). The blood 
was washed 3 times with PBS and resuspended to a 10% (v/v) suspension in 
Alsever's solution and used as the erythrocyte stock; this was stored at 4°C for up to 
14 days when signs of haemolysis usually became evident.  A 0.75% (w/v) red 
blood cell (RBC) suspension in PBS was prepared as required for HA or HI assays 
(Raidal, 1994). 
Haemagglutination (HA) assay  
Microtitre methods using round-bottomed, polystyrene, 96-well plates (Disposable 
Products) were used for HA assays as recommended by Raidal (1994). Fifty μL of 
PBS were added to each well of the plates, and then 50 μL of a 1:10 dilution of the 
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fold dilutions from 1:20 to 1:40,960 were prepared. A positive virus control row for 
titration of purified BFDV and a negative virus row containing PBS to check for 
spontaneous HA were conducted each time HA assays were performed. To each 
well, 50 μL of 0.75% (w/v in PBS) galah (Eolophus roseicapillus) RBC suspension 
was added. The plates were then incubated at 37°C for 1 h. The highest dilution of 
the tissue preparations causing complete haemagglutination of the galah RBC was 
considered the HA titre of the suspension, and the results were recorded as HA 
units per 50 μL of tissue suspension. 
Inhibition of HA as a confirmatory test for the specificity of HA 
To confirm that the HA activity was virus-specific, chicken anti-BFDV sera (kindly 
supplied by Associate Professor Shane Raidal) was used to inhibit the HA activity; 
the specificity of this sera for BFDV was reported by Raidal (1994). In round-
bottomed polystyrene, 96-well plates (Disposable Products), 2 series of serial 
dilutions of the antigen were prepared (as described above), and to each well in one 
row of dilutions was added 50 μL of phosphate buffered saline (PBS), and to the 
duplicate row 50 μL of BFDV antiserum in PBS diluted to contain the equivalent of 4 
HI units/50μL). After 1 h at 37°C or overnight at 4°C, 50 μL of 0.75% galah 
(Eolophus roseicapillus) erythrocyte suspension were added to each well, and the 
plates incubated at 37°C for 60 min. The HA titres of the rows were compared, and if 
an 8-fold or greater decrease in HA titre occurred in the row containing antiserum, 
the sample was considered positive for BFDV. 
HI assays for the detection of BFDV-specific antibody in serum or plasma 
A microtitre HI method (Raidal, 1994) was performed using round-bottomed, 
polystyrene, 96-well plates (Disposable Products). Serial dilutions of 
haemadsorbed serum or plasma, commencing with an initial 1:20 dilution, were 
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HA units per 50 μL were added to each well. The plates were incubated at 37°C for 
1 h, and 0.75% galah (Eolophus roseicapillus) RBC suspension was added. Wells 
containing 1:20 dilutions of serum without antigen, wells containing diluted antigen 
without antiserum, and the RBC suspension without antigen or serum, were 
included as controls. The plates were incubated at 37°C for 60 min and the highest 
dilution of serum causing inhibition of haemagglutination was considered to 
represent the HI titre of the antiserum, which was recorded as HI units per 50 μL of 
serum or plasma (HI units/50 μL). 
Preparation of feather samples for DNA extraction 
DNA was extracted from feathers using a method modified from Taberlet and Bouvet 
(1991) and Morin et al. (1994). Approximately 5-10 mM of a feather tip was cut using 
a sterile surgical blade on a sterile glass plate, and this was washed first in 70% 
ethanol and secondly in sterile water. Washed feather tips were transferred into 500 
µL of proteinase K in lysing buffer (250 µg/mL proteinase K, 50 mM KCl, 10 mM Tris-
HCl pH 8.0, 2.5 mM MgCl2, 0.5% Tween 20, 0.5% Nonidet P40) and incubated at 
37
oC for 1-2 h with gentle shaking (200-230 rpm). Following proteinase K digestion, 
keratinous sheath material appeared opaque. The solution was then heated at 95
oC 
for 10 min to inactivate the proteinase K.  Undigested material was brought to the 
bottom of the tube by a short centrifugation step or removed using sterile forceps. 
The resulting supernatant was then used for viral DNA extraction via the QIAamp 
Blood kit (QIAGEN). 
Viral DNA extraction from blood samples  
The use of the QIAamp blood kit (QIAGEN) allowed rapid purification of DNA from 
various sources using spin columns containing a silica membrane that adsorbs 
DNA. The blood and body fluid protocol described by the manufacturer was used to 
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or blood sample was digested with proteinase K (QIAGEN) and buffer AL 
(composition not supplied) and incubated at 70
oC for 10 min. The supernatant from 
digested solution was loaded into a QIAamp spin column and centrifuged at 6,000 x 
g for 1 min. The column was washed twice with 500 µL of buffer AW (composition 
not supplied). DNA was then eluted by adding 200 µL of buffer AE (composition not 
given) pre-heated to 70
oC and centrifuged for 1 min.  To increase the DNA yield the 
spin column containing buffer AE was incubated at 70
oC for 5 min prior to 
centrifugation. The eluted DNA was then stored at -20
oC until used. DNA extracted 
from blood samples, evaluated by spectrophotometer, and had an average OD of 
1.2 μg/μL with an OD 260/280 ratio of 1.7. 
PCR for detection of viral DNA extracted from feathers and blood  
The PCR assays were performed in a total volume of 25 µL comprising 5 units of Tth 
Plus DNA polymerase, 1X polymerisation buffer (Biotech), 2.5 mM MgCl2, 2 µL DNA 
template (40-50 ng DNA) and 12.8 pmol of primer.  Reaction mix was made up to 25 
µL with pure distilled water. PCR primers were also employed as described by 
Ypelaar et al. (1999), the sequence of which is as follows: forward primer  
5΄-AACCCTACAGACGGCGAG-3΄ (genome position 182-199) and reverse primer: 
5΄-GTCACAGTCCTCCTTGTACC-3΄ (genome position 879-898). Reactions were 
thermocycled on a PerkinElmer Cetrius 2400 Thermocycler. PCR was performed to 
amplify a fragment of ORF1 of 717 bp in length which is used by Ypelaar et al., 
(1991) with denaturation 96° C for 30 s (5 min was used for the first cycle), 
annealing at 60° C for 30 s, extension at 72° C for 90 s, for 32 cycle, final extension 
at 72° C for 10 min. The amplification conditions are shown in Figure 3.1. 
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Figure 3.1. Thermal cycling condition used for the amplification of 717 bp product of the 
BFDV genome.  
 
Agarose gel electrophoresis 
Agarose gel electrophoresis was employed to examine virus DNA extractions, PCR 
products generated, and to determine the size of DNA fractions. Agarose gel 
electrophoresis was carried out as described by Sambrook et al. (1989). The 
equipment used was a BioRad Mini Sub™ DNA cell or BioRad Wide Mini Sub™ 
DNA cell apparatus. Depending on the application, either agarose LE (Analytical 
Grade; Promega) or agarose LMP (low melting point agarose; Promega) was used.  
Agarose gels consisted of 1-2% agarose and 10 μg/mL ethidium bromide.  The DNA 
samples were mixed with gel tracking dye and loaded into the sample wells.  
Molecular markers used in this study were 100 bp ladder (Pharmacia or Promega), 
a 1 kb ladder (Promega) or lambda (λ) Hind III EcoRI digests (Gibco BRL) for 
displaying bands of known sizes. Agarose gel electrophoresis was performed in 1X 
TAE buffer (0.2 M Tris-acetate, 5 mM EDTA, pH 8.0) as described by Sambrook 
et al. (1989).  Gels were electrophoresed at a constant voltage of 70-110 V for 30-60 
min and gels were viewed under ultraviolet light with a UVP transilluminator 
(BioRad). Photographs of gels were taken using the Gel-Doc 1000 (BioRad) and 
Molecular Analyst Software version 1.4 (BioRad) or a Polaroid MP.4 Land Camera 
(Polaroid). On some occasions, gels were not pre-stained as described above but 
were post-stained in a 1 μg/mL solution of ethidium bromide in 1X TAE solution for 
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Transilluminator [UVP]). 
 
Results 
Comparison of HA, HI and feather PCR assay for the detection of BFDV 
A total of 623 diagnostic accessions were received but not all accessions provided 
appropriate samples for all 3 tests, and the results of these assays are shown in 
Table 3.1 and summarised in Table 3.2. Of 621 feather samples received, 143 
(23%) were PCR-positive (Table 3.2). There was a strong agreement between the 
PCR and HA tests (kappa = 0.757 P<0.000). Of the 143 PCR-positive feather 
samples, 132 were also tested by HA and 88 (66.7%) were positive with HA titres 
ranging from 1:80 to 1:40,960 (mean log2 10.4 ± HA units/50 µL) and 44 were HA-
negative. Of the remaining feather samples that were PCR-negative, 6 were initially 
positive by HA with titres up to 1:320 HA units/50 µL but the HA activity in these 
samples was not inhibited by anti-BFDV anti-sera and was removed by filtration 
through a 0.22 µm filter, which indicated that BFDV was not the cause of the HA in 
the sample. The prevalence of BFDV in feather samples according to the major 
Psittaciforme groups is shown in Table 3.3. 
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from 623 birds either tentatively diagnosed with PBFD, with a history of being in contact with 
PBFD-affected birds, or to confirm absence of disease in quarantined birds. 
 
Animal ID  Family  Species  PCR  HA titre  HI titre 
03-1014 A  Loriidae  Red lory  -  -  20 
03-1014 B  Loriidae  Red lory  -  -  20 
03-698  Loriidae  Lorikeet -  -  20 
03-708   Cacatuidae  Cockatoo -  -  160 
03-719   A  Loriidae  Red lory  -  -  80 
03-719   B  Loriidae  Red lory  -  -  320 
03-719   C  Loriidae  Red lory  -  -  - 
03-767 Unknown  Unknown  + -  - 
03-821  Loriidae  Red collared lorikeet   -  -  640 
03-855  Loriidae  Rainbow lorikeet  +  1,280 - 
03-871  Cacatuidae  Sulphur crested cockatoo  -  -  320 
03-875  Cacatuidae  Sulphur crested cockatoo  +  80 - 
03-886  Cacatuidae  Cockatoo  +  40,960 - 
03-913  Psittacidae  Scarlet chested parrot  +  40,960  NA 
03-914  Psittacidae  Lovebird  + -  NA 
03-915  Cacatuidae  Cockatoo  +  40,960 - 
03-976  Loriidae  Scaly breasted lorikeet  -  -  20 
03-977  Psittacidae  Red wing parrot  -  False +  NA 
03-997  Cacatuidae  Sulphur crested cockatoo  -  False + 1:160  NA 
04-011  Cacatuidae  Sulphur crested cockatoo  -  -  80 
04-014  Cacatuidae  Corella -  -  20 
04-037  Cacatuidae  Cockatoo -  -  40 
04-040  Cacatuidae  Corella LB  + -  - 
04-065  Cacatuidae  Galah  +  40,960 - 
04-066  Cacatuidae  Cockatoo  +  40,960 - 
04-070  Cacatuidae  Galah -  -  20 
04-074  Cacatuidae  Sulphur crested cockatoo  +  40,960 - 
04-075   Unknown  Unknown  +  NA  - 
04-089   Unknown  Unknown  + -  NA 
04-092  Cacatuidae  Cockatoo  +  5,120 - 
04-093A  Cacatuidae  Galah  + -  NA 
04-093B  Cacatuidae  Galah  +  40,960  NA 
04-1007  Psittacidae  Eclectus  +  NA  - 
04-1021  Psittacidae  Eclectus  + -  - 
04-1025  Cacatuidae  Galah  +  40,960 - 
04-1027  Psittacidae  Lovebird  +  40,960 - 
04-1031  Psittacidae  Eclectus  +  2,560 - 
04-1047  Cacatuidae  Galah/Corella  +  40,960 - 
04-1052  Cacatuidae  Sulphur crested cockatoo  + -  NA 
04-1060  Psittacidae  Indian ringneck   -  -  160 
04-1083  Psittacidae  Sun conure  + -  - 
04-1084  Psittacidae  Sun conure  + -  - 
04-1085  Psittacidae  Eclectus  + -  - 
04-1094  Loriidae  Rainbow lorikeet  +  40,960 - 
04-1095  Cacatuidae  Cockatoo  + -  - 
04-1096  Cacatuidae  Galah  + -  - 
04-1101  Cacatuidae  Sulphur crested cockatoo  +  320  NA 
  5404-1102  Cacatuidae  Cockatoo  + -  - 
04-1120  Cacatuidae  Cockatoo  +  40,960 - 
04-1121  Loriidae  Lorikeet  + -  - 
04-1129  Loriidae  Rainbow lorikeet  -  -  5,120 
04-115  Cacatuidae  Cockatoo  +  1,280 - 
04-1162  Cacatuidae  Cockatoo  +  160  NA 
04-119  Psittacidae  Eclectus -  -  20 
04-122  Psittacidae  Scarlet chested parrot   -  -  5,120 
04-123  Psittacidae  Scarlet chested parrot   -  -  5,120 
04-125  Psittacidae  Neophema parrot  +  40,960 - 
04-126  Cacatuidae  Major Mitchell cockatoo  + -  - 
04-142  Cacatuidae  Corella -  -  40 
04-145   Unknown  Unknown  +  40,960 - 
04-146  Loriidae  Lorikeet  +  40,960 - 
04-173   Unknown  Unknown  -  -  20 
04-174  Psittacidae  Ringneck   + -  - 
04-186  Cacatuidae  Cockatoo  +  40,960 - 
04-190 Unknown  Unknown  False +  -  - 
04-191 Unknown  Unknown  False +  - - 
04-192 Unknown  Unknown  False +  - - 
04-195  Cacatuidae  Cockatoo  +  20,480 - 
04-196   Unknown  Unknown  +  20,480 - 
04-197   Unknown  Unknown  -  -  40 
04-204   Unknown  Unknown  False +  -  - 
04-216  Psittacidae  Indian ringneck  +  40,960 - 
04-218  Psittacidae  Rosella -  -  20 
04-220  Cacatuidae  Cockatoo  False -  40,960  - 
04-223 A   Psittacidae  Swift parrot  +  40,960 - 
04-223 B  Psittacidae  Swift parrot  +  40,960 - 
04-227  Cacatuidae  Cockatoo  +  40,960 - 
04-231  Psittacidae  Jardine’s parrot  +  40,960 - 
04-234  Loriidae  Rainbow lorikeet  +  40,960  NA 
04-241  Cacatuidae  Cockatoo  +  40,960 - 
04-255  Cacatuidae  Corella -  -  80 
04-284  Cacatuidae  Sulphur crested cockatoo  +  NA NA 
04-291  Psittacidae  Rosella  +  40,960 - 
04-297  Psittacidae  Eclectus -  -  20 
04-298  Cacatuidae  Galah  +  1,280 - 
04-303  Cacatuidae  Galah/Corella  + -  - 
04-339  Cacatuidae  Cockatoo  +  40,960  NA 
04-343  Psittacidae  Amazon parrot  + -  - 
04-344  Cacatuidae  Cockatoo  +  10,240 - 
04-346 B  Psittacidae  Hahn’s macaw   -  -  2,560 
04-346 C  Psittacidae  Hahn’s macaw   -  -  1,280 
04-346 E  Psittacidae  Jardine’s parrot  -  -  40 
04-355  Cacatuidae  Galah -  False +  - 
04-370  Psittacidae  Budgie  +  40,960 - 
04-386  Psittacidae  Eclectus -  False +  - 
04-391  Psittacidae  Princess parrot  +  40,960 - 
04-398  Psittacidae  Eastern rosella  -  -  20 
04-410  Cacatuidae  Galah  +  2,560  NA 
04-433 A  Psittacidae  King parrot  +  40,960  NA 
  5504-441  Loriidae  Musk lorikeet  +  20,480 - 
04-447  Cacatuidae  Galah/Corella  +  40,960  NA 
04-491  Cacatuidae  Gang gang cockatoo  +  NA  - 
04-507  Loriidae  Rainbow lorikeet  +  5,120 - 
04-509  Cacatuidae  Sulphur crested cockatoo  +  40,960 - 
04-566  Loriidae  Dusky lory  -  -  20 
04-575  Psittacidae  Eclectus -  -  40 
04-576  Loriidae  Red collared lorikeet   -  -  80 
04-580  Loriidae  Scaly breasted lorikeet  -  -  20 
04-581  Loriidae  Scaly breasted lorikeet  -  -  20 
04-593  Cacatuidae  Major Mitchell cockatoo  +  40,960 - 
04-594  Loriidae  Rainbow lorikeet  + -  - 
04-595  Psittacidae  Lovebird -  -  20 
04-604  Cacatuidae  Gang gang cockatoo  +  10,240 - 
04-618  Cacatuidae  Galah lutino  +  1,280  NA 
04-619  Cacatuidae  Galah lutino  +  640  NA 
04-626  Loriidae  Rainbow lorikeet  +  20,480 - 
04-627  Psittacidae  Kakariki parrot  -  -  40 
04-657  Cacatuidae  Sulphur crested cockatoo  + -  - 
04-666  Loriidae  Lorikeet  + -  - 
04-721  Cacatuidae  Major Mitchell cockatoo  +  2,560 - 
04-723  Cacatuidae  Major Mitchell cockatoo  +  40,960  NA 
04-745  Loriidae  Rainbow lorikeet  + -  - 
04-760  Cacatuidae  Sulphur crested cockatoo  +  40,960 - 
04-761  Cacatuidae  Sulphur crested cockatoo  -  -  40 
04-826   Unknown  Unknown  +  40,960 - 
04-858  Loriidae  Red collared lorikeet   -  -  20 
04-859  Cacatuidae  Sulphur crested cockatoo  + -  - 
04-860  Loriidae  Rainbow lorikeet  -  -  640 
04-861  Psittacidae  Macaw -  -  - 
04-862  Psittacidae  Budgerigar  +  10,240 - 
04-898  Cacatuidae  Galah -  -  20 
04-899  Cacatuidae  Corella -  -  160 
04-900  Cacatuidae  Galah -  -  20 
04-902  Psittacidae  Eclectus   +  NA  - 
04-906  Psittacidae  Eclectus -  -  20 
04-955  Psittacidae  Budgie  +  2,560 - 
04-977  Cacatuidae  Cockatoo  +  20,480 - 
04-994  Psittacidae  Eclectus   + -  - 
05-037  Cacatuidae  Cockatoo  +  40,960 - 
05-069  Psittacidae  Macaw -  -  20 
05-070  Psittacidae  Macaw -  -  40 
05-072   Unknown  Unknown  -  -  640 
05-081  Loriidae  Lory  +  1,280 - 
05-098  Cacatuidae  Sulphur crested cockatoo  +  40,960 - 
05-106  Cacatuidae  Cockatiel  +  40,960  NA 
05-114  Loriidae  Rainbow lorikeet  + -  NA 
05-115  Psittacidae  Conure green cheeked parrot  + -  NA 
05-149  Cacatuidae  Cockatoo  + -  - 
05-150  Psittacidae  Parrot Jardine’s   +  40,960 - 
05-151  Cacatuidae  Major Mitchell cockatoo  + -  - 
05-174  Cacatuidae  Cockatoo  +  40,960 - 
  5605-180  Cacatuidae  Sulphur crested cockatoo  +  40,960 - 
05-181  Cacatuidae  Cockatoo  +  5,120 - 
05-199  Cacatuidae  Cockatoo  +  40,960 - 
05-214  Cacatuidae  Sulphur crested cockatoo  -  -  20 
05-220  Cacatuidae  Cockatoo  +  1,280  NA 
05-227  Cacatuidae  Galah  +  80 - 
05-229  Loriidae  Rainbow lorikeet  + -  - 
05-232  Cacatuidae  Sulphur crested cockatoo  +  40,960 - 
05-236  Psittacidae  Alexandrine parrot  + -  NA 
05-273  Psittacidae  Eclectus  +  160 - 
05-285  Cacatuidae  Major Mitchell cockatoo  +  40,960 - 
05-311  Psittacidae  Lovebird  +  1,280 - 
05-341  Cacatuidae  Corella  + -  - 
05-342  Cacatuidae  Corella -  -  320 
05-346  Loriidae  Lorikeet Dusky   -  -  80 
05-363  Cacatuidae  Sulphur crested cockatoo  +  40,960 - 
05-364  Psittacidae  Indian ringneck  +  40,960 - 
05-375   Unknown  Unknown  -  -  - 
05-376  Loriidae  Lory  +  40,960 - 
05-377R  Cacatuidae  Cockatoo  +  NA NA 
05-378   Unknown  Unknown  +  40,960 - 
05-380  Cacatuidae  Galah/Corella  +  40,960 - 
05-397  Cacatuidae  Black yellow tailed cockatoo  + -  - 
05-397R  Cacatuidae  Black yellow tailed cockatoo  +  NA NA 
05-398  Cacatuidae  Sulphur crested cockatoo  -  NA  640 
05-400  Cacatuidae  Cockatoo  + -  - 
05-400R  Cacatuidae  Cockatoo  +  NA NA 
05-401  Cacatuidae  Cockatoo  + -  - 
05-401R  Cacatuidae  Cockatoo  +  NA NA 
05-402  Cacatuidae  Cockatoo  +  40,960 - 
05-437  Cacatuidae  Galah  +  20,580 - 
05-438   Unknown  Unknown  -  -  - 
05-439  Psittacidae  Lovebird  + -  NA 
05-440  Cacatuidae  Galah  +  5,120 - 
05-441  Cacatuidae  Cockatoo  +  40,960 - 
05-457  Cacatuidae  Corella -  -  80 
05-458  Psittacidae  Eclectus   -  -  160 
05-484  Psittacidae  Eclectus   +  NA  - 
05-493  Psittacidae  Eclectus   -  -  - 
05-494  Loriidae  Lorikeet  +  160 - 
63  (1)  Cacatuidae  Sulphur crested cockatoo  -  -  40 
66  (4)  Loriidae  Rainbow lorikeet  -  -  80 
67  (5)  Cacatuidae  Short billed corella  -  -  40 
68  (6)  Cacatuidae  Galah -  -  80 
69  (7)  Cacatuidae  Short billed corella  -  -  160 
70  (8)  Cacatuidae  Corella ELBC   -  -  160 
72  (10)  Cacatuidae  Galah/Corella -  -  20 
75  (13)  Cacatuidae  Galah -  -  20 
78  (16)  Cacatuidae  Galah -  -  20 
79  (17)  Cacatuidae  Galah -  -  40 
80  (18)  Cacatuidae  Black red- tailed cockatoo  -  -  20 
81  (19)  Cacatuidae  Corella -  -  320 
  5791 (10)  Cacatuidae  Corella -  -  40 
Beak 1  Cacatuidae  Galah -  -  20 
Beak 2  Cacatuidae  Galah -  -  20 
Cage 113 rtI  Cacatuidae  Galah  + -  NA 
Cage 113 rtu  Cacatuidae  Galah  +  5,120  NA 
Cage 113 unm  Cacatuidae  Galah  +  40,960  NA 
Cage 137 Itu  Cacatuidae  Galah  + -  NA 
F 2  Cacatuidae  Galah  +  NA NA 
Mad SBC  Cacatuidae  Corella -  -  160 
Mad Sulpher/Corella  Cacatuidae  Sulphur crested cockatoo  -  -  20 
Muvh Cage bt  Cacatuidae  Galah  + -  NA 
Not Tame  Cacatuidae  Black red tailed cockatoo   -  -  80 
No Tag  Cacatuidae  Galah/Corella  + -  320 
No Tag  Cacatuidae  Corella  + -  20 
Orange No 2 Left Leg  Loriidae  Red collared lorikeet   +  160 - 
Orange No 4 Left Leg  Loriidae  Rainbow lorikeet  -  -  40 
Quiet  /Corella  Cacatuidae  Sulphur crested cockatoo  -  -  40 
Red Leg Band  1     Cacatuidae  Major Mitchell cockatoo  +  40,960 - 
Red Leg Band  3  Cacatuidae  Major Mitchell cockatoo  +  40,960  NA 
Red Leg Band  4  Cacatuidae  Major Mitchell cockatoo  +  40,960 - 
Red Leg Band  8  Cacatuidae  Galah -  -  640 
Red Leg Band  9  Cacatuidae  Galah -  -  20 
Red Leg Band 6 (9)  Cacatuidae  Galah  + -  - 
Repeat of No 19  Cacatuidae  Corella -  -  40 
S/S Sun Corella  No Ring  Psittacidae  Sun conure  -  False +  - 
S/S Sun Corella Ring  Psittacidae  Sun conure  -  False +  - 
Tame Green Kakariki  Psittacidae  Kakariki parrot  -  -  160 
White Leg Band   Cacatuidae  Black red tailed Samueil  -  -  20 
 
Samples listed as false-positives by HA or by PCR were so designated as there was no concurrence between the 
HA and PCR assays. It is, however, also possible that in some cases the other test that was conducted and found 
negative, may have been a false-negative. The designation is primarily for differentiation of the result from other 
results where there was concurrence between PCR and HA assays. 
NA=Not applicable
  58Table 3.2. Summary of test results obtained from diagnostic samples submitted from 623 
psittacine birds showing the numbers of birds in each group and false negative and false 
positive results detected (italics). 
 
No. birds  HI (blood)  HA (feathers)  PCR (feathers) 
6* <1:20  1:20 – 1:320  - 
88  <1:20  1:80 – 1:40,960  + 
44 <1:20  <1:20  + 
9 NA  NA  + 
2  1:20 – 1:320  <1:20  + 
78 1:20  –1:5,120  <1:20  - 
396
§
  <1:20 <1:20 - 
 
*  False positive HA titres (italicised and bold) present in feathers from 5 samples that were PCR negative. These 
were designated false-positives as accompanying PCR assays on the same samples were negative. 
§   In some of these cases not all 3 tests were done due to inappropriate or insufficient sample. 
NA: denotes examination not attempted. 
 
 
Table 3.3. Prevalence of BFDV shedding in feathers based on haemagglutination and or 
PCR testing of samples collected from 623 birds in various families and genera of birds.  
 
Taxonomic group  Total tested  Positive (percent positive 
Cacatuidae (total)  282 87(30.9  %) 
Cacatua and Eolophus   239 82  (34.3%) 
Cockatiel (Nymphicus hollandicus)  14  2 (14.3 %) 
Calyptorhynchus and Callocephalon   31  4 (12.9%) 
Loriidae (total)  71  17 (23.9 %) 
Lorikeets  58  15 (25.9 %) 
Lories  13  2 (15.4 %) 
Psittacidae (total)  241 32  (13.3%) 
Eclectus   87 8  (9.2%) 
African species.*  24  6 (25%) 
South American species
 †
 
 
59 4  (6.8%) 
Asiatic species
‡ 28 4  (16.7%) 
Australasian species  43  10 (23%) 
Others (Unknown)  29  7 (24.2%) 
 
* Jardine’s parrot (Poicephalus gulielmi), African grey (Psittacus erithacus) and Agapornis species. 
†  Macaws (Ara sp.), Amazons, Conures (Aratinga species.) and Quaker parrots (Myiopsitta monachus).  
‡   Indian ringneck (Psittacula krameri), Alexandrine (P. eupatria), Derbyan (P. derbiana) and moustached (P. 
alexandri) parrots. 
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tested and HI titres ranged from 20 to 5,120 HI units/50 µL. There was a poor 
agreement between PCR and HI test results (kappa = -0.193 P<0.000) with PCR-
negative birds 12.7 times more likely to be HI positive than PCR-positive birds (95% 
confidence interval = 3.1 to 52.6). Of the 143 birds that were feather PCR-positive, 
only 2 had detectable HI antibody and these birds were also feather HA-negative 
suggesting that they were developing immunity to recent infection. All birds with HI 
antibody were feather HA-negative (kappa = -0.178 P<0.000).   
Detection of virus in peach faced lovebirds (Agapornis roseicollis) 
In a group of 56 peach faced lovebirds examined, 47 of the 56 (83.9%) birds had 
PCR-positive blood samples but only 10 (17.9%) of these 47 birds had PCR-positive 
feather samples (Table 3.4). No bird was PCR feather-positive without being PCR 
blood-positive. Of the 10 PCR blood-positive birds, 5 had detectable feather HA 
titres ranging from 20 to 40,960 HA units/50 µL. Five birds that were PCR blood-
positive and feather-positive had no detectable feather HA activity. The 56 peach 
face lovebirds had a low seroprevalence rate (16%) and of the 9 birds that had 
detectable HI antibody titres (ranging from 20 to 320 HI units/50 µL) none were 
feather HA or PCR-positive but 6 were PCR blood-positive. 
Detection of virus in cockatiels (Nymphicus hollandicus) 
Two of 13 samples were both PCR-positive samples and had feather HA titres of 
1:40,960 HA units/50 µL and 1; 20,480 HA units/50 µL, respectively (Table 3.5).  
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(A. roseicollis) at a pet shop in Western Australia.  Five of the birds had lesions consistent 
with PBFD. 
 
No. birds   HI (blood)  HA (feathers)  PCR (blood)  PCR (feathers) 
5*  < 1:20  1:20 – 1:40,960  +  + 
5  < 1:20  < 1:20  +  + 
31  < 1:20  < 1:20  +  - 
6  1:20 – 1:320  < 1:20  +  - 
3  1:40 – 1:320  < 1:20  -  - 
6  < 1:20  < 1:20  -  - 
* Clinical signs and lesions in these 5 birds were consistent with PBFD. 
 
 
Table 3.5. Results of PCR, HA and HI assays conducted with cockatiel (Nymphicus 
hollandicus) samples.  
 
Animal ID  Origin  PCR  HA  HI 
03-636 WA  -  -  NA 
03-744 NSW  -  -  - 
03-799 A  WA  -  -  - 
03-799 B  WA  -  -  NA 
03-922 WA  -  -  NA 
04-041 NSW  -  -  - 
04-098 NSW  -  -  - 
04-924 QId  -  -  - 
05-006 NSW  -  -  NA 
05-106 (NH-AUS)  WA  +  40,960  NA 
05-107 WA  -  -  NA 
05-340 QId  -  -  - 
05-726 SA  +  20,480  NA 
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The results indicated that PCR assays were more sensitive than HA for detecting 
BFDV in feathers and detected viral DNA in some feather suspensions that were HA 
negative (< 20 HA units/50 µL). This discrepancy is possibly due to the presence of 
viral DNA in infected feather material but the absence of virus in sufficient quantities 
to detect by HA. However, HA assays provided a quantifiable indication of virus 
excretion not available with conventional PCR assays (but would also be available 
with newer PCR technologies such as RT-PCR).  When HA assays are used in 
conjunction with PCR this would provide a valuable control for the interpretation of 
results. From a diagnostic viewpoint, the use of both assays adds a degree of 
assurance not available with one assay but this does of course add to diagnostic 
costs.  
The presence of HI antibody in blood samples was inversely related to the presence 
of HA activity in feathers and except for one result, was also highly correlated with a 
negative feather PCR result. When used together, all 3 tests can provide useful 
information about the BFDV-infection and immune status of a bird. Feather HA titres 
in excess of 640 HA units/50 μL, particularly in cockatoos, are highly correlated with 
the presence of chronic disease and have been used to confirm a clinical diagnosis 
of PBFD (Raidal et al. 1993b). Problems with non-specific HA reactions have not 
previously been reported in feather samples but are relatively common in faecal 
samples (Raidal et al., 1993b). Confirmation of results by inhibition of the HA activity 
with BFDV-specific antibody is therefore recommended and should form part of a 
standard operating procedure.  Parallel tests using BFDV-sensitive and BFDV-
insensitive erythrocytes can also be used to ensure that the observed 
haemagglutination is specific and not due to other antigens (Raidal and Cross, 
1994b).  
The HI test has been used for sero-epidemiological studies of BFDV infection in wild 
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of HI antibody titres is a strong negative predictive indicator for PBFD (Ritchie et al., 
1991a; Raidal et al., 1993c) but birds with active or latent BFDV infection may have 
low anti-BFDV HI titres that wax and wane. The non-detectable and low HI titres that 
occur in PBFD-affected birds may be explained by the severe damage that occurs to 
the bursa of Fabricus and thymus and/or by the apparently persistent infections that 
occur in macrophages (Latimer et al., 1991a).  
Interpretation of any BFDV diagnostic testing regime must consider the signalment, 
clinical signs and history of the bird and its environment. The HA and HI assays are 
quantitative and provide valuable laboratory information that can influence clinical 
decisions but sources of suitable erythrocytes can be limited and differences in the 
agglutinating ability of erythrocytes obtained from different individuals of the same 
species have been reported (Sanada and Sanada, 2000). However, this is 
insufficient reason alone to discount HA as a diagnostic assay. As in any diagnostic 
assay, standardised procedures and appropriate internal controls should be used to 
provide reliable and valid results. Nevertheless, there is a need to develop other 
methods for quantifying BFDV excretion in feathers and faeces because such 
information can be very important for guiding diagnostic judgements. Real time PCR 
assays for BFDV infection may provide this information (Raue et al., 2004) but such 
techniques do so by detecting viral DNA and not antigen and their interpretation, 
from a clinical perspective, may not necessarily be any better than conventional 
non-quantitative PCR methods.  
There has been only one report of the development of a direct ELISA for detecting 
BFDV antibodies in psittacine bird sera (Johne et al., 2004) but this method of 
testing has yet to be validated with a large number of samples from birds with known 
health status. The HI assay is likely to remain the gold standard for anti-BFDV 
antibody detection for several reasons. Anti-psittacine IgG is not readily available 
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antibody directed against psittacine IgG is not required as in a direct ELISA.  Johne 
et al. (2004) used a truncated recombinant capsid protein as the antigen in their 
ELISA and only 11 serum samples from 7 psittacine bird species were tested and 
the secondary antibody was raised against immunoglobulin from an African grey 
parrot (Psittacus erithacus).  There have been only limited studies of the cross-
reactivity of anti-psittacine antibody preparations so it is not possible to be certain if 
serum from a rare species that tested negative is truly negative or if the secondary 
antibody has failed to recognise immunoglobulin from that particular species. Within 
the Cacatuidae, there are 6 genera including 21 species and within the Psittacidae 
there are 78 genera including 332 species. This present report and others (Ritchie 
et al., 1991b; Raidal et al., 1993c) have shown that HI testing is suitable for 
detecting anti-BFDV antibodies in sera from a large proportion of these 353 species. 
The use of a truncated recombinant protein in an ELISA might also limit the assay’s 
specificity. Until these issues are resolved HI will probably continue to be the most 
reliable test for detecting BFDV antibodies. 
The high prevalence of PCR-positive blood samples (83.9%) and low 
seroprevalence (16%) detected in the flock of peach faced lovebirds (Agapornis 
roseicollis) (Table 3.4) could be explained by the flock being recently infected 
following mixing of birds from different sources at the pet shop. Seroprevalence 
rates have been shown to be much higher in endemically infected flocks of 
Agapornis sp. (62%) and cockatoos (41-94%) (Raidal and Cross, 1994a).  
Alternatively, there may be a high prevalence of latent or chronic carrier BFDV 
infections in Agapornis sp. Nevertheless, the observations made in this current 
study that PCR can be more sensitive with blood than feather samples is in contrast 
to that of Hess et al. (2004) who found a much higher prevalence of BFDV DNA in 
feather samples collected from budgerigars (Melopsittacus undulatus) even though 
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feather lesions. Perhaps the reason for the higher prevalence of BFDV DNA in 
lovebirds compared to budgerigars (Melopsittacus undulatus) could be explained by 
biological or immunological factors of the host species.  
An interesting observation was PCR and HA positive results indicative of BFDV 
infection in 2 captive cockatiels (Nymphicus hollandicus).  There are no published 
reports of PBFD in cockatiels (Nymphicus hollandicus) even though this species is 
one of the more commonly kept companion and aviary birds worldwide. One of the 
birds had lesions typical of BFDV.  To determine the significance of the virus 
detected in the cockatiels, whether it represented a cockatiel-specific genotype of 
BFDV or infection by another genotype of BFDV, further phylogenetic analysis of 
one of these strains was undertaken and this is reported in Chapter 4. 
It is important to note that PCR tests may vary in sensitivity and specificity between 
laboratories even when the same primers and optimisation methods are employed 
(East et al., 2004). Samples used in different surveys may also vary and in the 
current study not all birds had lesions of BFDV, some only had a history of exposure 
to affected birds.  However, the PCR prevalence rates detected in this current study 
are similar to those reported by Bert et al. (2005) although they are much lower than 
those reported by Rahaus and Wolff (2003) who reported a much higher prevalence 
(39%) of BFDV DNA in feather samples collected from 146 clinically normal 
psittacine birds and even non-psittacine birds in Germany. Non-specific amplification 
of other avian circovirus amplicons was mooted as one possible reason for the latter 
observation but the primers designed by Ypelaar et al. (1999) do not amplify product 
from samples known to contain non-psittacine avian circoviruses (Shane Raidal, 
personal communication). PCR assays for infectious agents have a theoretical high 
sensitivity and specificity but in practice they are rarely 100% sensitive or specific 
(Muller-Doblies et al., 1998; Peter et al., 2000; East et al., 2004) and may even be 
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et al., 1993). Nested PCR assays can increase the sensitivity of an assay but the 
extra level of complexity can undo any gains in sensitivity or interfere with test 
specificity.  
Errors in PCR assays can occur for a variety of reasons. False-negative PCR results 
may occur when inhibitors such as heparin (Holodniy et al., 1991) or biological 
materials in samples interfere with the assay (Konet et al., 2000).  Operator error is 
always possible and the quality of reagents can be monitored by the inclusion of 
adequate positive and negative controls.  False-positive results can occur as a 
consequence of cross-contamination during sample collection or during laboratory 
handling; in the current study every effort was made to minimise this, including use 
of laminar flow hoods for assay preparation, and re-extraction of DNA from the 
sample or alternative samples from the same bird when results did not seem to 
correspond with other assays conducted on the same animal.  Non-replicating DNA 
may take up to 3 months to clear from blood (Lazizi and Pillot, 1993) and it is for this 
reason that PCR-positive birds without clinical signs should be recommended for 
retesting after 3 months (Dalhausen and Radabaugh, 1993). 
PCR technology should be used together with, and not replace, conventional 
diagnostic testing for PBFD (Cross, 1996). The data presented in this Chapter 
indicates there is merit in having a 2-stage method for BFDV sample testing. HA 
testing seems to provide a valuable alternative method for identifying those birds 
that may be chronically affected and excreting large amounts of virus in feather 
dander versus those birds that may only be recently infected, and not shedding virus 
but mounting an effective immune reaction.  
Ypelaar et al. (1999) found that consistent PCR results could only be achieved with 
primers designed to amplify ORF V1, which codes for the Rep protein and is 
therefore more likely to be genetically conserved than the gene encoding the capsid 
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technologies may not detect all isolates even when conserved primers are used 
(Bassami et al., 2001; Ritchie et al., 2003; Heath et al., 2004; Johne et al., 2004).  
This is another reason for having a 2-stage testing regime to capture isolates that 
may be genetically unique but still capable of causing haemagglutination. However, 
in this current study there was no evidence of this possibility in the samples 
examined and the 5 false positive HA reactions that were obtained were cleared by 
filtering the sample through 0.22 µM filters and were not inhibited by anti-BFDV 
antibody.  
  67Chapter 4. Genotypic analysis of BFDV strains from a 
cockatiel (Nymphicus hollandicus), loriids 
(Trichoglossus sp.) and swift parrots (Lathamus 
discolor)  
 
Summary 
This Chapter describes a study undertaken to further our understanding of BFDV 
detected in a grey cockatiel (Nymphicus hollandicus), a species normally considered 
resistant to infection with BFDV, of viruses present in lorikeets (Trichoglossus sp.) in 
Australia, and virus detected in 2 swift parrots (Lathamus discolor).  There are no 
previous reports of PBFD in cockatiels, and the detection of virus in captive birds of 
this species enabled the nucleotide (nt) sequence of the genome of this cockatiel 
isolate to be examined to determine if it was a cockatiel-specific biotype.  Analysis of 
the sequence of the entire genome revealed that the cockatiel virus clustered 
phylogenetically with 2 other viruses, one from a sulphur crested cockatoo (SCC1-
AUS) and one from a Major Mitchell cockatoo (MMC-Australia), suggesting that the 
virus in the grey cockatiel was not a cockatiel-specific biotype. Phylogenetic analysis 
of the ORF V1 of BFDV detected in 7 lorikeets demonstrated all 7 isolates clustered 
phylogenetically with all other isolates obtained from Loriidae species elsewhere in 
the world.  Phylogenetic analysis of the ORF V1 of BFDV in 2 endangered swift 
parrots indicated they were BFDV genotypes derived from other species of birds, 
one isolate clustering with viruses from a Loriidae genotype and the other with 
isolates derived from species of Cacatuidae and Psittacidae.  
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The geographic distribution of BFDV in the wild is potentially equivalent to the 
distribution of psittacines but there appears to be considerable variation in the 
susceptibility of different psittacine species to infection.  For example, most of the 6 
genera of the Cacatuidae seem to be highly susceptible to the effects of BFDV 
infection.  Many probably die before the classic, chronic advanced feather lesions 
have had time to develop, which is known to occur in Cacatua species such as the 
sulphur crested cockatoo (Cacatua galerita) (Pass and Perry, 1984b). Captive birds 
like galahs (Eolophus roseicapillus) and budgerigars (Melopsittacus  undulatus) are 
thought to have a lower disease incidence than sulphur crested cockatoos (Cacatua 
galerita) with as many as 20% of wild sulphur crested cockatoos having clinical 
signs of PBFD in Australia in any one year (Maramorosch et al., 2001). Birds such 
as galahs and budgerigars are New World psittacines and it has been suggested 
that these are less likely to be infected by BFDV than Old World psittacines (Ritchie 
and Carter, 1995). There are no published reports of PBFD in cockatiels (Nymphicus 
hollandicus) even though this species is one of the more commonly kept companion 
and aviary birds worldwide. The detection of BFDV infection in tissues of cockatiels 
with lesions typical of PBFDV infection (Chapter 3) was therefore of interest to 
determine the genetic relationship of the BFDV present in the cockatiels with other 
BFDV isolates.  
There has been debate in the literature over the existence of species-specific BFDV 
biotypes adapted to lorikeets (Trichoglossus sp.) and parrots (Ritchie et al., 2003; de 
Kloet and de Kloet, 2004; Heath et al., 2004; Raue et al., 2004) and the evolution of 
species-specific BFDV-genotypes in cockatoo (Cacatua sp.), budgerigar 
(Melopsittacus  undulatus), lorikeet (Trichoglossus sp.) and lovebird (Agapornis 
species) lineages. There seem to be genetically distinguishable biotypes of BFDV 
which infect and are maintained in different psittacine species, some of which may 
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manner (de Kloet and de Kloet, 2004).  
In this Chapter, PCR products from isolates obtained from 7 lorikeets were 
sequenced to further investigate the possible presence of a particular genotype 
adapted to lorikeets (Trichoglossus sp.) in Australia. Concurrent with this 
investigation, the genotype of virus detected in a cockatiel (Nymphicus hollandicus) 
in Australia (reported in Chapter 3) and in 2 swift parrots (Lathamus discolor) with 
evidence of BFDV infection in Australia was also investigated.  Genotype analysis of 
isolates from cockatiels and swift parrots has not been previously reported. 
 
Materials and methods 
Samples 
Samples were taken from birds diagnosed with PBFD or from samples submitted to 
the Murdoch University veterinary clinic showing signs of psittacine beak and feather 
disease or with a history of PBFD (as reported in Chapter 3). The cockatiel 
(Nymphicus hollandicus) strain sequenced was designated NH-AUS and was 
previously described in Chapter 3. The 2 isolates from swift parrots (Lathamus 
discolor) were from young wild birds that died with acute PBFD shortly after being 
taken by National Park rangers from a nest on Bruny Island (near Tasmania).  
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To amplify the entire genome of BFDV from a grey cockatiel (Nymphicus 
hollandicus), 2 sets of primers, Iprm3.F and Iprm2.R in one direction, and Prm2.F 
and Iprm3.R primers in the reverse direction (Table 4.1), were used to amplify the 
entire genome of the cockatiel (Nymphicus hollandicus) strain (Table 3.5; sample 
05-106); the predicted size of the products were 717 and 1298 bp. The primers were 
designed using the sequence of the single BFDV reported previously by Bassami 
et al. (1998) and PCR reactions were conducted as described in Chapter 3. 
 
Table 4.1. Primers used to amplify the complete nucleotide sequence of a grey cockatiel 
(Nymphicus hollandicus) BFDV isolate.  
 
Primer* Sequence:  (5
َ –3َ  )  Size  Position in 
virion strand 
Position in 
complementary 
strand 
Prm2.F   TGGTACAAGGAGGACTGTGAC 21  878–898 
 
 
Iprm2.R GTCACAGTCCTCCTTGTACC  20    1814–1834 
 
Iprm3.F AACCCTACAGACGGCGAG 18  182–199 
 
 
Iprm3.R GTTAAGGGTGAAACACCAACG  21    1097–1116 
 
 
* Primer pairs Prm2.F and Iprm3.R were used in one reaction, and Iprm3.F and Iprm2.R in 
the reverse direction 
 
 
To amplify a segment of the ORF V1 of DNA from isolates in 7 lorikeets and 2 swift 
parrots, a PCR assay was performed as described by Ypelaar et al. (1999)
 with 
forward primer 5'-AACCCTACAGACGGCGAG-3 and reverse primer
  
5'-GTCACAGTCCTCCTTGTACC-3.  
All PCR products generated were visualised by agarose
 gel electrophoresis and a 
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Purification of DNA from agarose gels 
DNA fragments were purified from 1.0% agarose gels. For DNA gel extraction the 
Wizard
® PCR Prep DNA Purification System (Promega) or a BRESA-CLEAN™ 
Purification Kit (GeneWorks) was used following the manufacturer’s instructions.  
Cloning of PCR products into plasmid vectors 
The formula below was used to define the amount of insert needed to obtain desired 
molar ratios of insert to vector which usually were 1:3 or 1:5 for efficient ligation into 
plasmid vectors:  
 
(bp size of insert) x (ng vector) x (molar ratio of insert to vector)  
________________________________________________                         
bp size of vector 
= ng insert DNA 
 
Ligation reactions were performed in a total 10 μl volume containing 10X ligation 
buffer, the determined amount of vector, appropriate amount of insert, and 4 Weiss 
units of T4 DNA ligase in sterile distilled H2O. The ligation was performed overnight 
at 14°C. The reaction was terminated by heat inactivation of the enzyme for 10 min 
at 70°C, and then the mixture was cooled to room temperature. Ligation mixtures 
were stored at -20°C until used for later transformation procedures. 
The concentration of DNA was normally determined by fluorometric analysis in a 
DyNA Quant 200 Fluorometer (Hoefer Pharmacia Biotech Inc) by standard methods 
using a calf thymus DNA standard (Promega).  However, in some cases, DNA 
concentrations were determined by quantification of the DNA in agar gels. To do 
this, serial dilutions of DNA were electrophoresed in parallel with serial dilutions of 
known molecular weight standards. The amount of DNA present in each sample 
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of a similar sized fragment in the standard marker.  DNA in each sample was then 
calculated using the following formula: 
Size of DNA standard  X  amount of standard used     
________________________________________  
Total molecular weight of marker 
 
Transformation of plasmids into competent E. coli 
Competent E. coli were prepared as described by Inoue et al. (1990) and stored at -
80°C for up to 3 months.  Transformation was conducted by either the heat-shock 
method described by Inoue et al. (1990) or by electroporation.  
For the heat shock method, competent cells were thawed on ice and 1-5 μL of the 
ligation mixture was immediately added to the cells which were then allowed to 
equilibrate on ice for 20-30 min, followed by heat-shock at 42°C for 45 sec. The 
mixture was then immediately chilled by placing it on ice for 2 min.  A 500 μl volume 
of SOC medium (2.0% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 
mM MgCl2.6H2O , 20.0 mM glucose pH 7.0) or LB medium (1.0% tryptone, 0.5% 
yeast extract, 1.0% NaCl pH 7.0) was then added to the transformation mixture and 
incubated for 1 h at 37°C.  Volumes of 50 and 200 μl of the cell suspensions were 
then spread on LB agar plates containing the appropriate antibiotics, or 1.6 mg of X-
Gal in dimethylformamide and 40 μl of 100 mM isopropyl-ß-D-thiogalactopyranoside 
(IPTG) in the case of blue and white screening, and incubated for approximately 15-
18 h at 37°C. Appropriate (white) colonies were screened by PCR or by restriction 
enzyme digestion. 
For the electroporation method, frozen competent E. coli cells were thawed on ice.  
Electroporation cuvettes (BioRad) and SOC medium were pre-chilled on ice. Two μl 
of ligation mixture was added to the competent cell suspension, mixed by gentle 
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carried out at 1.2 kV, 200Ω resistance and 25 μF capacitance for approximately 3 
sec in a Gene Pulser™ electroporation apparatus (BioRad). Treated cells were then 
diluted in 1 mL SOC medium and retrieved from the cuvette. Cell suspensions were 
incubated for 1 h at 37°C and an aliquot plated on medium containing 50 μg/mL 
ampicillin. Plates were incubated overnight at 37°C and colonies analysed by PCR 
screening or crude plasmid mini-preps as described above.  
Screening of recombinant plasmids by PCR  
Ten to 20 μl of liquid culture or one half a colony was resuspended in 100 μl 1% 
Triton X-100 in TE, pH 8.0, vortexed, then heated at 95-98°C for 5-10 min. The 
reaction mix was centrifuged at 12,000 x g, and 5 μL of supernatant used as a 
template for PCR amplification. All PCR reactions were prepared in 0.2 mL 
microcentrifuge tubes (Treff) containing 10X buffer (67 mM Tris-HCl, pH 8.8 at 25
oC; 
16 mM [NH4]2SO4; 0.45% Triton X-100; 0.2 mg/mL gelatin), Tth Plus DNA 
Polymerase (1.1 U) (Biotech) and varying amounts of dNTPs, MgCl2 (2-2.5 mM), 
M13 forward and reverse primers (3.2 pmoles/μL) and 5 μL template as shown in 
Table 4.2.  Amplification of DNA was carried out using a thermocycler (Gene-Amp 
model 2400; PerkinElmer) using the following temperature conditions: initial 
denaturing at 94-95
oC for 2-5 min, 35 cycles of a denaturing step at 94-95
oC for 1 
min, an annealing step at 55°C for 0.5-1.0 min, and extension at 72
oC for 2 min. A 
final extension at 72
oC was carried out for 5-10 min. The reactions were 
electrophoresed on agarose gels as described above. 
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Ingredient Volume 
10X buffer   2.5 μl 
2.5 mM MgCl2
  2 -2.5 μl 
M13 forward primer (3.2 pmoles/μl) 4  μl 
M13 reverse primer  (3.2 pmoles/μl) 4  μl 
Template  5 μl 
Tth Plus diluted in enzyme buffer  2 μl 
Ultrapure H2O  To a total volume of 25 μl 
 
 
Plasmid purification 
For cloning and sequencing purposes, 2 commercial kits, the Wizard
® Plus 
Minipreps DNA Purification System and a QIA Prep Spin Plasmid kit, were 
employed for plasmid purification as recommended by the manufacturers.  
Sequencing reactions 
Complete DNA sequences of cloned inserts were obtained by sequencing double-
stranded templates. Sequencing was done with the Taq DyeDeoxy™ Terminator 
Cycle sequencing kit (ABI) using either Rhodamine or BigDye™ Terminator Cycle 
Sequencing chemistry.  Sequencing reactions were conducted using half the 
volumes recommended by ABI, consisting of 300-800 ng of plasmid DNA added to 
4 µL of Terminator Ready Reaction Mix, 1.6/3.2 pmoles of primers, made to a final 
volume of 10 µL with sterile distilled water in a 0.2 mL microfuge tube. The 
reactions were incubated in a PerkinElmer Cetus Thermal Cycler 2400 at 96°C for 
2 min followed by 25 cycles of denaturation at 96°C for 15 sec, annealing at 50°C 
for 5 sec and extension at 60°C for 4 min (Figure 4.1). 
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Figure  4.1. Schematic representation of PCR thermocycling conditions used for 
sequencing. 
 
Purification of PCR products for sequencing  
PCR products were cooled, briefly centrifuged and then transferred into a 0.5 mL 
centrifuge tube containing 2.5 volumes of 100% ice cold ethanol and 0.1 volumes 
of 3 M NaOAc, pH 5.2. The mixture was vortexed briefly and kept at -20°C for 20 
min after which the DNA was centrifuged at 20,200 x g for a further 30 min, washed 
with 125 µL of 70% ice cold ethanol and centrifuged again at 20,200 x g for 5 min, 
and the pellet dried in a Speedvac. Sequencing reactions were conducted by the 
State Agricultural Biotechnology Centre at Murdoch University on an ABI 373 or 377 
DNA Sequencer.  
Data analysis  
For multiple sequence alignment and phylogenetic analysis of sequences the 
programs PileUp, Distances, and Grow tree of the Wisconsin Package, Genetics 
Computer Group (GCG), Madison, Wisconsin, provided by the Australian National 
Genomic Information Service (ANGIS), were used. The data were edited and 
aligned by the PileUp program (ANGIS) and used for phylogenetic analysis using 
the ClusTree program with 1000 bootstrap cycles. ClusTree computes a 
phylogenetic tree according to the neighbour-joining method of Saitou and Nei 
(1987). Sequence databases used included EMBL and GenBank, created by the 
National Centre for Biotechnology Information (NCBI) and ANGIS using BLAST 
(Altschul et al., 1990) and FASTA (Pearson and Lipman, 1988). The abbreviations 
  76used to denote the isolates and their origins are as described in Tables 4.3, 4.4. 
BFDV-AUS refers to the isolate described previously by Bassami et al. (1998) and 
BFDV-USA to the isolate described by Niagro et al. (1998). 
 
Table 4.3.  GenBank accession numbers for ORF V1 DNA sequence data generated from 7 
BFDV-infected lorikeets (Trichoglossus sp.) and 2 swift parrots (Lathamus discolor).  Feather 
HA (HA units/50 µL) and blood HI titres (HI units/50 µL) derived as described and reported in 
Chapter 3 are shown. 
 
Isolate  Species  HA HI 
GenBank 
accession No. 
1-RL-NSW Rainbow  lorikeet 
Trichoglossus haematodus 
1,280 <20 
DQ016388 
2-RL-NSW  Rainbow lorikeet  40,960 <20  DQ016389 
5-RL-VIC  Rainbow lorikeet  40,960 <20  DQ016392 
7-RL-WA  Rainbow lorikeet  5,120 <20  DQ016394 
9-RL-NSW  Rainbow lorikeet  <20 <20  DQ016396 
6-ML-WA Musk  lorikeet 
Glossopsitta  concinna 
20,480 <20  DQ016393 
8-RCL-WA  Red collared lorikeet 
T. haematodus rubritorquis 
80 <20  DQ016395 
3-SP-TAS  Swift parrot  
Lathamus discolor 
40,960 <20  DQ016390 
4-SP-TAS  Swift parrot   40,960 <20  DQ016391 
 
Results 
Phylogenetic analysis of the complete sequence of BFDV from a grey 
cockatiel (Nymphicus hollandicus) 
The genome of the one grey cockatiel (Nymphicus hollandicus) isolate (NH-AUS) 
was 1996 bp, 3 bp longer than the SSC3-AUS described by Bassami et al. (1998) 
  77(Figure 4.2). Phylogenetic analysis of the genome sequence of this virus with other 
BFDV strains listed in Tables 4.3 and 4.4 revealed a number of phylogenetic clusters 
with strong bootstrap support and that the cockatiel isolate was not unique and was 
closely related to the strains MMC-AUS and SCC1-AUS (Figure 4.6).  
Phylogenetic analysis of ORF V1 of BFDV isolates from 7 lorikeets 
(Trichoglossus sp.) and 2 swift parrots (Lathamus discolor) 
The sequences of ORF V1 of 7 lorikeets (Trichoglossus sp.) and 2 swift parrots 
(Lathamus discolor) was determined and compared to the sequence of other strains 
of BFDV obtained from GenBank and the results are shown in Figures 4.3 and 4.4.  
Pairwise analysis of the sequences demonstrated that the isolates were 88-99% 
identical at the nucleotide (Figure 4.3) and 87-98% similar at the amino acid (aa) 
level (Figure 4.4) and that there was conservation of the nucleotide binding site and 
the second motif involved in rolling circle replication (Figure 4.4). In the first motif 
involved in rolling circle replication, 2 strains (3-SP-TAS and 6-ML-WA) had one 
amino acid difference only (Figure 4.4). Phylogenetic analysis demonstrated a 
clustering of all the lorikeet (Trichoglossus sp.) isolates with all other isolates 
obtained from Loriidae species.  One of the swift parrot (Lathamus discolor) isolates 
clustered with the isolates from the Loriidae species and the other did not (Figure 
4.5). The sequence of the 2 swift parrot (Lathamus discolor) isolates was confirmed 
by repeated DNA extraction from the tissues, recloning and resequencing. 
  78 
 
Table 4.4. Circovirus reference sequences from psittacine and non-psittacine hosts obtained from 
GenBank and used in this study. 
Code GenBank  Accession  No.  Host species (common name) 
BB-AUS   AF311295  Psephotus haematogaster  (Blue bonnet parrot) 
LB-AUS   AF311296  Agapornis roseicollis (Peach faced lovebird) 
ELBC-AUS AF311297  Cacatua tenuirostris (Long billed corella) 
ER-AUS   AF311298  Eolophus roseicapillus (Galah) 
TH-AUS AF311299  Trichoglossus haematodus (Rainbow lorikeet) 
MMC-AUS   AF311300  C. leadbeateri (Major Mitchell cockatoo) 
SCC1-AUS   AF311301  C. galerita (sulphur crested cockatoo) 
SCC2-AUS   AF311302  C. galerita 
SCC3-AUS AF080560  C. galerita 
BFDV-USA   AF071878  Pooled virus 
PK1-USA   AY521234  Psittacula krameri  (Indian ringneck) 
LB-UK   AY521235  A. roseicollis 
AGP-UK AY521238  Psittacus erithacus (African grey parrot) 
AGP-SAF AY450443  Psittacus erithacus (African grey parrot) 
AGP-GER AY521237  P. erithacus 
LB-SAF AY450442  A. nigrigenis (Black-cheeked love bird) 
PG-SAF AY450441  Poicephalus gulielmi  (Jardine’s parrot) 
WBC-SAF AY450434  Pionites leucogaster (White-bellied caique)  
PE-SAF AY450435  P. erithacus 
WC-SAF AY450436  C. alba (Umbrella cockatoo) 
PR1-SAF AY450437  Poicephalus robustus (Cape parrot) 
PR2-SAF AY450438  P. robustus 
PR3-SAF AY450439  Poicephalus rueppellii (Rüppell's parrot) 
AGP-POR AY521236  P. erithacus 
SCC1-NZ AY148285  C. galerita 
SCC2-NZ AY148286  C. galerita 
SCC3-NZ AY148287  C. galerita 
LC1-NZ AY148289  C. tenuirostris 
RCL-NZ AY148291  T. haematodus rubritorquis (Red-collared lorikeet) 
YBL-NZ AY148292  Lorius chlorocercus (Yellow-bibbed lory) 
RL1-NZ AY148293  T. haematodus 
BSL1-NZ AY148296  Eos reticulata (Blue-streaked lory) 
BSL2-NZ AY148297  E. reticulata 
GL-NZ AY148298  Psitteuteles goldiei (Goldie’s lorikeet) 
RL2-NZ AY148300  T. haematodus 
BG1-NZ AY148301  Melopsittacus undulatus (budgerigar) 
BG2-AA AJ605577  M. undulatus 
CaCV   AJ301633  Serinus canaria (Canary) 
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ACCCGCCGCCTGGGGCACCGGGGCACCGCAACCATTGGCTGCTCTGCCCCAGGTCCCCGC 
CCCTACTCAGGAGGATGAAATGGCGCCGGAGGCGTCCTAAGCTCCGAAGGATGACACTCA 
CCCGGTGACCATGCCGTCCAACGAGGGCTCTGGTTGTCGCCGTTGGTGTTTCACCCTTAA 
CAACCCTACAGACGGCGAGATCGAATTAGTCCGTACTCTCGGGCCTGACGAATTCCACTA 
TGCCATCGTTGGACAGGAAAAGGGCGAGCAAGGTACCCCCCATCTACAAGGCTACTTTCA 
TTTTAAAAATAAGAAGCGCCTGAGCGCTCTTAAGAAACTGCTGCCCCGAGCTCATTTTGA 
GCGCGCTAAAGGGAGCGATGCGGACAATGAAAAGTATTGCAGTAAAGAGGGGGACGTGAT 
ACTTACCCTGGGCATTGTGGCGAGAGATGGTCACCGCGCTTTCGACGGAGCTGTTGCTGC 
CGTGATGTCCGGACGCAAAATGAAGGAAGTCGCGCGAGAGTTCCCGAATATCTACGTCAG 
GCATGGGCGGGGCTTACATAACCTCTCGCTATTGGTTGGATCCCGCCCACGTGATTTCAA 
GACTGAGGTTGACGTCATCTACGGGCCACCCGGGTGTGGCAAGAGTAGATGGGCCAATGA 
GCAGTCTGGGACTAAATATTATAAAATGCGCGGTGAATGGTGGGATGGATATGATGGGGA 
AGATATCGTCATCTTGGACGACTATTATGGGTGGCTACCTTATTGCGAGATGCTCCGCCT 
CTGCGACCGTTACCCACATAAAGTGCCAGTTAAGGGCGCTTTTGTGGAGTTTACGAGCAA 
GAGGATCATTATCACGAGCAATAAGGCCCCCGAGGCCTGGTACAAGGAGGACTGTGACCC 
TAAGCCACTGTTCCGGAGATTCACACGTGTTTGGTGGTACAACGTGGACAAGTTGGAACA 
AGTCCGGCCTGACTTCCTCGCCCACCCCATCAATTATTGATAGTCTCGGTGATGTTTTCA 
TAAAGCTAGGCGTCGGGCCGAAGGCCCGATGCCGCAGGGCGGGACCCCCTGCCGGAGGGC 
TGGCAGGGCCGTCAGGCCCGAAAGACCGACCAGCCCGGAGGGCGTTTTCAGTGTCGGGGG 
GGGGCCCCCGGGGGGTCCCCCCGACACGACGAGCACGGTCAGCGCCAAAGGCGCCAATAA 
ACACTCTAAAACGTATTTGCTGTCTGAGTCTTTATTAGGTGCTGGGATTGTTCGGGGAAA 
ACTGGCGGAATTGAACATAGATAGTGAGAATGCATTCATAAGTGATCTTTGTTTGTGGCT 
GTGGGAAGCTGAATGCAAGGCCGTAGTGCCTGACCTTCGATCCTGCTGTGTTGGGTCTTC 
CTTGTAGTGGGATCCAGCCGGTTCTGGTGCTGTTCAGCCACAATGCCGCAGACTGGTTTA 
CCGTGGTCAGGTCTTTTATTGTGATTTGTGGTTTACGTCTGAGGAGGCGTTTGAATCCCT 
TGTTAAGATACCACTTTCTGGCACCGTCGAAAGGTGCTAGCGGGTCTTGTGTTTGGTCTG 
CAGTAGTCTTAAATTTACTTATTCTGGAATCTTGAATTACGGCCGTGTGGCCGAATCCTT 
CTGAATTAGTGTATGAGTGGCCCCATGTGGGCTTCATTTCCATTTTAGCTAACTTAATAC 
GGTAATCTTCGAAGGGCCAACTTGTTGGGTTCGGTGCTGTTAGGAAGTCTGACAGTGCAA 
AGGTTACGTAGTCAGAATTACAAATAATTTGGCCAGTATGGGTGGTTTGTTTGTTAATAT 
CGAATTTGAATTCGCGCTTGAGTCTAATAGTGTAAAGTCTATTGGTTGTGAAACGGCGTC 
TGCGGAAGTGCCTACGTCGCGGACGGTATCGGTATCGCCTGATGTGACGTCTGCGGTATG 
GGCGGGCATATCTTCGTCTAATCTGAAATGTGGCGCATGGGCAGTTAGAGGTGCCCCACA 
GGCGGCGGTTAGTATT
 
 
 
Figure 4.2. Nucleotide sequence of the encapsidated BFDV genome of the cockatiel 
(Nymphicus hollandicus) strain NH-AUS containing a potential stem-loop sequence 
(underlined) encompassing a nonanucleotide sequence (bold face).  This sequence has not 
been lodged in the GenBank database. 
 
  80SCC3-AUS        AACCCTACAGACGGCGAGATCGAATTCGTCCGTTCTCTGGGGCCTGACGAATTCTACTAT 191 
1-RL-NSW        AACCCTACAGACGGCGAGATCGAATTCGTCCGTTCTCTGGGGCCTGACGAATTCTACTAT 191 
2-RL-NSW        AACCCTACAGACGGCGAGATCGAATTCGTCCGTTCTCTGGGGCCTGACGAATTCTACTAT 191 
3-SP-TAS        AACCCTACAGACGGCGAGATCGAATACGTCCGTGCTCTTTCGGCTGACGAATTCCACTAT 191 
6-ML-WA         AACCCTACAGACGGCGAGATCGAATACGTCCGTGCTCTTTCGGCTGACGAATTCCACTAT 191 
5-RL-VIC        AACCCTACAGACGGCGAGATCGAATACGTCTGTGCTCTTTCGGCTGACGAATTCCACTAT 191 
9-RL-NSW        AACCCTACAGACGGCGAGATCGAATACGTCTGTGCTCTTTCGGCTGACGAATTCCACTAT 191 
7-RL-WA         AACCCTACAGACGGCGAGATCGAATACGTCCGTGCTCTTTCGCCTGACGAATTCCACTAT 191 
8-RCL-WA        AACCCTACAGACGGCGAGATCGAATACGTCCGTGCTCTTTCGACTGACGAATTCCACTAT 191 
4-SP-TAS        AACCCTACAGACGGCGAGATCGAATTCGTCCGTGCTCTGGGACTTGACGAATTCCACTAT 191 
 
 
               ************************* **** ** ****      ********** ***** 
SCC3-AUS        GCCATCGTTGGACGCGAAAAGGGTGAGCAAGGCACCCCCCATTTGCAAGGCTACTTTCAT 251 
1-RL-NSW        GCCATCGTTGGACGGGAGAAGGGCGAGCAAGGTACCCCCCATTTGCAAGGCTACTTTCAT 251 
2-RL-NSW        GCCATCGTTGGACGGGAGAAGGGCGAGCAAGGTACCCCCCATTTGCAAGGCTACTTTCAT 251 
3-SP-TAS        GCCATCGTTGGACGGGAGAAGGGCGAGCAAGGTACCCCCCATTTGCAAGGCTTCTTTCAT 251 
6-ML-WA         GCCATCGTTGGACGGGAGAAGGGCGAGCAAGGTACCCCCCATTTGCAAGGCTTCTTTCAT 251 
5-RL-VIC        GCCATCGTTGGACGGGAAAAGGGCGAGCAAGGTACCCCCCATTTGCAAGGCTACTTTCAT 251 
9-RL-NSW        GCCATCGTTGGACGGGAAAAGGGCGAGCAAGGTACCCCCCATTTGCAAGGCTACTTTCAT 251 
7-RL-WA         GCCATCGTTGGACGGGAAAAGGGCGAGAAAGGTACCCCCCATTTGCAAGGCTACTTTCAT 251 
8-RCL-WA        GCCATCGTTGGACGGGAAAAGGGCGAGCAAGGTACCCCCCATTTGCAAGGCTACTTTCAT 251 
4-SP-TAS        GCCATCGTTGGACGTGAAAAGGGCGAGCAAGGTACCCCCCATTTGCAAGGCTACTTCCAT 251 
                ************** ** ***** *** **** ******************* *** *** 
 
SCC3-AUS        TTTAAAAATAAGAAGCGACTGAGCGCGCTTAAGAAACTGCTGCCGCGAGCCCATTTTGAG 311 
1-RL-NSW        TTTAAAAATAAGAAGCGTCTGAGTGCGCTTAAGAAAATGCTGCCGCGAGCTCATTTCGAG 311 
2-RL-NSW        TTTAAAAATAAGAAGCGTCTGAGTGCGCTTAAGAAAATGCTGCCGCGAGCTCATTTCGAG 311 
3-SP-TAS        TTTAAAAATAAGAAGCGCCTGAGTGCGCTTAAGAAAATGCTGCCGCGAGCTCATTTTGAG 311 
6-ML-WA         TTTAAAAATAAGAAGCGCCTGAGTGCGCTTAAGAAAATGCTGCCGCGAGCTCATTTTGAG 311 
5-RL-VIC        TTTAAAAATAAGAAGCGCCTTAGCGCGCTTAAGAAAATGCTGCCGCGAGCTCATTTCGAG 311 
9-RL-NSW        TTTAAAAATAAGAAGCGCCTTAGCGCGCTTAAGAAAATGCTGCCGCGAGCTCATTTCGAG 311 
7-RL-WA         TTTAAAAATAAGAAGCGCCTTAGCGCGCTTAAGAAAATGCTGCCACGAGCTCATTTTGAG 311 
8-RCL-WA        TTTAAAAATAAGAAGCGCCTTAGCGCGCTTAAGAAAATGCTGCCGCGAGCTCATTTTGAG 311 
4-SP-TAS        TTTAAAAATAAGAAGCGACTAAGCGCTCTTAAGAAAATGCTGCCCCGAGCTCATTTTGAG 311 
                ***************** ** ** ** ***************** *********** *** 
 
SCC3-AUS        CGCGCTAAAGGTAGCGATGCTGATAATGAGAAGTATTGCAGTAAAGAGGGGGACGTTATA 371 
1-RL-NSW        CGTGCTGTGGGGAGCGATTTGGATAATGAGAAGTATTGCAGTAAAGAGGGGGACGTTATA 371 
2-RL-NSW        CGTGCTGTGGGGAGCGATTTGGATAATGAGAAGTATTGCAGTAAAGAGGGGGACGTTATA 371 
3-SP-TAS        CGTGCTATGGGGAGCGATTTGGATAATGAGAAGTATTGCAGTAAAGAGGGGGACGTTATA 371 
6-ML-WA         CGTGCTATGGGGAGCGATTTGGATAATGAGAAGTATTGCAGTAAAGAGGGGGACGTTATA 371 
5-RL-VIC        CGTGCTATGGGGAGCGATTTGGATAATGAGAAGTATTGCAGTAAAGAGGGGGACGTAATA 371 
9-RL-NSW        CGTGCTATGGGGAGCGATTTGGATAATGAGAAGTATTGCAGTAAAGAGGGGGACGTAATA 371 
7-RL-WA         CGTGCTGTGGGGAGTGATGCGGATAATGAGAAGTATTGCAGTAAAGAGGGGGACGTTATA 371 
8-RCL-WA        CGTGCTGTGGGGAGTGATGCGGATAATGAGAAGTATTGCAGTAAAGAGGGGGACGTTATA 371 
4-SP-TAS        CGCGCTAAAGGGAGTGATGCGGATAATGAGAAGTATTGCAGTAAAGAGGGTGATGTGATA 371 
 
 
               ** ***   ***** ***  ****************************** ** ** *** 
SCC3-AUS        CTCACCCTGGGCATTGTGGCGAGAGACGGTCACCGCGCGTTCGACGGAGCTGTTGCTGCC 431 
1-RL-NSW        CTTACCCTGGGCATTGTGGCGAGAGACAGTCACCGCGGATTCGACCGAGCTGTTGCTGCC 431 
2-RL-NSW        CTTACCCTGGGCATTGTGGCGAGAGACAGTCACCGCGGATTCGACCGAGCTGTTGCTGCC 431 
3-SP-TAS        CTTACCCTGGGCATTGTGGCGAGAGGCGGTCACCGCGCGTTCAATCGAGCTGTTGCTGCC 431 
6-ML-WA         CTTACCCTGGGCATTGTGGCGAGAGGCGGTCACCGCGCGTTCAATCGAGCTGTTGCTGCC 431 
5-RL-VIC        CTTACCCTGGGCATTGTGGCGAGAGACGGTCACCGCGCTTTCGATCGAGCTGTTGCTGCC 431 
9-RL-NSW        CTTACCCTGGGCATTGTGGCGAGAGACGGTCACCGCGCTTTCGATCGAGCTGTTGCTGCC 431 
7-RL-WA         CTTACCCTGGGCATTGTGGCGAGAGACGGTCACCGCGCTTTCGATCGAGCTGTTGCTGCC 431 
8-RCL-WA        CTTACCCTGGGCATTGTGGCGAGAGACGGTCACCGCGCTTTCGATCGAGCTGTTGCTGCC 431 
4-SP-TAS        CTTACCCTGGGCATTGTGGCGAGAGACGGTCACCGCGCTTTCGACGGAGCTGTTGCTGCC 431 
 
 
               ************************* * *********  *** *  ************** 
SCC3-AUS        GTGATGTCCGGACGCAAAATGAAGGAAGTCGCGCGAGAGTTCCCAGAAGTCTACGTAAGG 491 
1-RL-NSW        GTGGTGGCCGGAAGTAAAATGAAGGACGTCGCGCGAGAGTTCCCTGATATCTACGTCAGA 491 
2-RL-NSW        GTGGTGGCCGGAAGTAAAATGAAGGACGTCGCGCGAGAGTTCCCTGATATCTACGTCAGA 491 
3-SP-TAS        GTGATGGCCGGAAGTAAAATGAAGGACGTCGCGCGAGAGTTCCCTGATATCTACGTCAGA 491 
6-ML-WA         GTGATGGCCGGAAGTAAAATGAAGGACGTCGCGCGAGAGTTCCCTGATATCTACGTCAGA 491 
5-RL-VIC        GTGATGGCCGGAAGTAAAATGAAGGACGTCGCGCGAGAGTTCCCTGATATCTACGTCAGA 491 
9-RL-NSW        GTGATGGCCGGAAGTAAAATGAAGGACGTCGCGCGAGAGTTCCCTGATATCTACGTCAGA 491 
7-RL-WA         GTGATGGCCGGAAGTAAAATGAAGGACGTCGCGCGAGAGTTCCCTGACATCTACGTCAGA 491 
8-RCL-WA        GTGATGGCCGGAAGTAAAATGAAGGACGTCGCGCGAGAGTTCCCTGATATCTACGTCAGA 491 
4-SP-TAS        GTGATGTCCGGACGCAAAATGAAGGAAGTCGCGCGAGAGTTCCCTGAGATCTACGTCAGG 491 
                *** ** ***** * *********** ******************** *********** 
 
Figure 4.3 (continued over page) 
 
  81SCC3-AUS        CATGGGCGGGGCTTACATAACCTCTCGCTATTGGTTGGTTCCAGCCCACGTGACTTCAAG 551 
1-RL-NSW        CATGGGCGGGGCTTGCACAACCTTTCACTATTGGTTGGTTCCCACCCACGTGACTTCAAG 551 
2-RL-NSW        CATGGGCGGGGCTTGCACAACCTTTCACTATTGGTTGGTTCCCACCCACGTGACTTCAAG 551 
3-SP-TAS        CATGGGCGGGGCTTGCACAACCTTTCACTATTGGTTGGTTCCCACCCACGTGATTTCAAG 551 
6-ML-WA         CATGGGCGGGGCTTGCACAACCTTTCACTATTGGTTGGTTCCCACCCACGTGATTTCAAG 551 
5-RL-VIC        CATGGGCGGGGCTTGCACAACCTTTCACTATTGGTTGGTTCCCACCCACGTGATTTCAAG 551 
9-RL-NSW        CATGGGCGGGGCCTGCACAACCTTTCACTATTGGTTGGTTCCCACCCGCGTGACTTCAAG 551 
7-RL-WA         CATGGGCGGGGCTTGCACAACCTTTCACTATTGGTTGGTTCCCACCCACGTGACTTCAAG 551 
8-RCL-WA        CATGGGCGGGGCTTGCACAACCTTTCACTATTGGTTGGTTCCCACCCACGTGACTTCAAG 551 
4-SP-TAS        CATGGGCGGGGCCTGCATAATCTCTCGCTATTGGTTGGTTCCCGCCCACGTGACTTCAAG 551 
 
 
               ************ **** ** ** ** **************** *** ***** ****** 
SCC3-AUS        ACTGAGGTTGACGTCATTTACGGGCCACCGGGGTGTGGCAAGAGTAGATGGGCCAATGAG 611 
1-RL-NSW        ACGGAAGTCGACGTTGTGTACGGCCCCCCGGGGTGTGGCAAGAGCAGATGGGCCAATGAA 611 
2-RL-NSW        ACGGAAGTCGACGTTGTGTACGGCCCCCCGGGGTGTGGCAAGAGCAGATGGGCCAATGAA 611 
3-SP-TAS        ACGGAAGTCGACGTTGTGTACGGCCCCCCGGGGTGTGGCAAGAGCAGATGGGCCAATGAA 611 
6-ML-WA         ACGGAAGTCGACGTTGTGTACGGCCCCCCGGGGTGTGGCAAGAGCAGATGGGCCAATGAA 611 
5-RL-VIC        ACGGAAGTCGACGTTGTGTACGGCCCCCCGGGGTGTGGCAAGAGCAGATGGGCCAATGAA 611 
9-RL-NSW        ACGGAAGTCGACGTTGTGTACGGCCCCCCGGGGTGTGGCAAGAGCAGATGGGCCAATGAA 611 
7-RL-WA         ACGGAAGTCGACGTTGTGTACGGCCCCCCTGGGTGTGGCAAGAGCAGATGGGCCAATGAA 611 
8-RCL-WA        ACGGAAGTCGACGTTGTGTACGGCCCCCCTGGGTGTGGCAAGAGCAGATGGGCCAATGAA 611 
4-SP-TAS        ACTGAAGTCGACGTCATCTATGGCCCACCGGGGTGTGGCAAGAGCAGATGGGCCAATGAG 611 
                ** ***********  * ** ***** ** *****************************  
 
SCC3-AUS        CAGCCTGGGACTAAATATTATAAAATGCGCGGTGAATGGTGGGATGGATATGACGGGGAA 671 
1-RL-NSW        CAGCCGGGGACTAAATATTATAAAATGCGCGGTGAATGGTGGGATGGATATGATGGGGAG 671 
2-RL-NSW        CAGCCGGGGACTAAATATTATAAAATGCGCGGTGAATGGTGGGATGGATATGATGGGGAG 671 
3-SP-TAS        CAGCCTGGGACTAAATTTTATAAAATGCGCGGTGAGTGGTGGGATGGATATGATGGGGAA 671 
6-ML-WA         CAGCCTGGGACTAAATTTTATAAAATGCGCGGTGAGTGGTGGGATGGATATGATGGGGAA 671 
5-RL-VIC        CAGCCTGGGACTAAATTTTATAAAATGCGCGGTGAGTGGTGGGATGGATATGATGGGGAA 671 
9-RL-NSW        CAGCCGGGGACTAAATTTTATAAAATGCGCGGTGAGTGGTGGGATGGATACGATGGGGAA 671 
7-RL-WA         CAGCCTGGGACTAAATTTTATAAGATGCGCGGTGAATGGTGGGATGGATATGATGGGGAA 671 
8-RCL-WA        CAGCCTGGGACTAAATTTTATAAGATGCGCGGTGAATGGTGGGATGGATATGATGGGGAA 671 
4-SP-TAS        CAGCCTGGGACTAAATATTATAAAATGCGCGGCGAATGGTGGGATGGATATGATGGGGAA 671 
                ***** ********** ****** ******** ** ************** ********  
 
SCC3-AUS        GATGTCGTCGTCTTGGACGATTTTTATGGGTGGCTACCTTATTGCGAGATGCTCCGCCTC 731 
1-RL-NSW        GAGAACGTCATCATTGATGACTTCTATGGGTGGCTCCCTTATTGCGAGATGCTCCGCCTT 731 
2-RL-NSW        GAGAACGTCATCATTGATGACTTCTATGGGTGGCTCCCTTATTGCGAGATGCTCCGCCTT 731 
3-SP-TAS        GATATCGTCATCATTGACGACTTCTATGGGTGGCTCCCTTATTGCGAGATGCTCCGCCTT 731 
6-ML-WA         GATATCGTCATCATTGACGACTTCTATGGGTGGCTCCCTTATTGCGAGATGCTCCGCCTT 731 
5-RL-VIC        GATATCGTCATCATTGACGACTTCTATGGGTGGCTCCCTTATTGCGAGATGCTCCGCCTT 731 
9-RL-NSW        GATATCGTCATCATTGACGACTTCTATGGGTGGCTCCCTTATTGCGAGATGCTCCGCCTT 731 
7-RL-WA         GATATCGTCATCATTGACGACTTCTATGGGTGGCTCCCTTATTGCGAGATGCTCCGCCTT 731 
8-RCL-WA        GATATCGTCATCATTGACGACTTCTATGGGTGGCTCCCTTATTGCGAGATGCTCCGCCTT 731 
4-SP-TAS        GATGTCGTCGTATTGGACGACTTCTATGGGTGGCTACCGTATTGCGAGATGCTCCGCCTC 731 
 
 
               **   **** *  * ** ***************** ** ********************  
SCC3-AUS        TGCGACCGTTATCCACATAAAGTGCCAGTCAAGGGCGCTTTTGTGGAGTTTACCAGCAAG 791 
1-RL-NSW        TTGGACCGTTACCCACATAAGGTGCCTGTTAAGGGCGCCTTTGTGGAGTTTACCAGCAAG 791 
2-RL-NSW        TTGGACCGTTACCCACATAAGGTGCCTGTTAAGGGCGCCTTTGTGGAGTTTACCAGCAAG 791 
3-SP-TAS        ATGGACCGTTACCCACATAAGGTGCCAGTTAAGGGCGCCTTTGTGGAGTTTACCAGCAAG 791 
6-ML-WA         ATGGACCGTTACCCACATAAGGTGCCAGTTAAGGGCGCCTTTGTGGAGTTTACCAGCAAG 791 
5-RL-VIC        ATGGACCGTTACCCACATAAGGTGCCAGTTAAGGGCGCCTTTGTGGAGTTTACCAGCAAG 791 
9-RL-NSW        ATGGACCGTTACCCACATAAGGTGCCTGTTAAGGGCGCCTTTGTGGAGTTTACCAGCAAG 791 
7-RL-WA         ATGGACCGTTACCCACATAAGGTGCCTGTTAAGGGCGCCTTTGTGGAGTTTACCAGTAAG 791 
8-RCL-WA        ATGGACCGTTACCCACATAAGGTGCCTGTTAAGGGCGCCTTTGTGGAGTTTACCAGTAAG 791 
4-SP-TAS        TGCGACCGTTACCCACATAAGGTGCCAGTTAAGGGCGCCTTTGTGGAGTTTACCGGCAAG 791 
 
 
                  *********************** *************************** * *** 
SCC3-AUS        AGGATAATTATCACGAGCAATAAGCCCCCCGAGACCTGGTACAAGGAGGACTGTGAC 848 
1-RL-NSW        AGGATCATTATAACGAGCAATAAGCCACCCCAGGAGTGGTACAACCAGGACTGTGAC 848 
2-RL-NSW        AGGATCATTATAACGAGCAATAAGCCACCCCAGGAGTGGTACAACCAGGACTGTGAC 848 
3-SP-TAS        AGGATCATTATAACGAGCAACAAGGCACCCCAGGATTGGTACAACCAGGACTGTGAC 848 
6-ML-WA         AGGATCATTATAACGAGCAACAAGCCACCCCAGGATTGGTACAACCAGGACTGTGAC 848 
5-RL-VIC        AGGATCATTATAACGAGCAACAAGCCACCCCAGGATTGGTACAACCAGGACTGTGAC 848 
9-RL-NSW        AGGATCATTATAACGAGCAATAAGCCACCCCAGGAGTGGTACAACCAGGACTGTGAC 848 
7-RL-WA         AGGATCATTATAACGAGCAATAAGCCACCCCAGGAGTGGTACAACCAGGACTGTGAC 848 
8-RCL-WA        AGGATCATTATAACGAGCAATAAGCCACCCCAGGAGTGGTACAACCAGGACTGTGAC 848 
4-SP-TAS        AGGATCATTATCACGAGCAATAAGCCCCCCGAGACCTGGTACAACCAGGACTGTGAC 848 
                                  *********** ******** ***** *** **   *********************    
Figure 4.3. Multiple nucleotide sequence alignment of the ORF V1 of BFDV from 7 lorikeets and 2 swift 
parrots (as shown in Table 4.3).  They are shown by comparison to the original SCC1-AUS isolate (bold 
type) sequenced by Bassami et al. (1998).  The alignments were generated and displayed by PileUp 
and Pretty programs respectively.  Asterisks indicate identical nt in all strains.   
  821-RL-NSW        NPTDGEIEFVRSLGPDEFYYAIVGREKGEQGTPHLQGYFHFKNKKRLSALKKMLPRAHFE 60 
2-RL-NSW        NPTDGEIEFVRSLGPDEFYYAIVGREKGEQGTPHLQGYFHFKNKKRLSALKKMLPRAHFE 60 
5-RL-VIC        NPTDGEIEYVCALSADEFHYAIVGREKGEQGTPHLQGYFHFKNKKRLSALKKMLPRAHFE 60 
9-RL-NSW        NPTDGEIEYVCALSADEFHYAIVGREKGEQGTPHLQGYFHFKNKKRLSALKKMLPRAHFE 60 
3-SP-TAS        NPTDGEIEYVRALSADEFHYAIVGREKGEQGTPHLQGFFHFKNKKRLSALKKMLPRAHFE 60 
6-ML-WA         NPTDGEIEYVRALSADEFHYAIVGREKGEQGTPHLQGFFHFKNKKRLSALKKMLPRAHFE 60 
7-RL-WA         NPTDGEIEYVRALSPDEFHYAIVGREKGEKGTPHLQGYFHFKNKKRLSALKKMLPRAHFE 60 
8-RCL-WA        NPTDGEIEYVRALSTDEFHYAIVGREKGEQGTPHLQGYFHFKNKKRLSALKKMLPRAHFE 60 
4-SP-TAS        NPTDGEIEFVRALGLDEFHYAIVGREKGEQGTPHLQGYFHFKNKKRLSALKKMLPRAHFE 60 
                ********:* :*. ***:**********:*******:********************** 
 
1-RL-NSW        RAVGSDLDNEKYCSKEGDVILTLGIVARDSHRGFDRAVAAVVAGSKMKDVAREFPDIYVR 120 
2-RL-NSW        RAVGSDLDNEKYCSKEGDVILTLGIVARDSHRGFDRAVAAVVAGSKMKDVAREFPDIYVR 120 
5-RL-VIC        RAMGSDLDNEKYCSKEGDVILTLGIVARDGHRAFDRAVAAVMAGSKMKDVAREFPDIYVR 120 
9-RL-NSW        RAMGSDLDNEKYCSKEGDVILTLGIVARDGHRAFDRAVAAVMAGSKMKDVAREFPDIYVR 120 
3-SP-TAS        RAMGSDLDNEKYCSKEGDVILTLGIVARGGHRAFNRAVAAVMAGSKMKDVAREFPDIYVR 120 
6-ML-WA         RAMGSDLDNEKYCSKEGDVILTLGIVARGGHRAFNRAVAAVMAGSKMKDVAREFPDIYVR 120 
7-RL-WA         RAVGSDADNEKYCSKEGDVILTLGIVARDGHRAFDRAVAAVMAGSKMKDVAREFPDIYVR 120 
8-RCL-WA        RAVGSDADNEKYCSKEGDVILTLGIVARDGHRAFDRAVAAVMAGSKMKDVAREFPDIYVR 120 
4-SP-TAS        RAKGSDADNEKYCSKEGDVILTLGIVARDGHRAFDGAVAAVMSGRKMKEVAREFPEIYVR 120 
                ** *** *********************..**.*: *****::* ***:******:**** 
 
1-RL-NSW        HGRGLHNLSLLVGSHPRDFKTEVDVVYGPPGCGKSRWANEQPGTKYYKMRGEWWDGYDGE 180 
2-RL-NSW        HGRGLHNLSLLVGSHPRDFKTEVDVVYGPPGCGKSRWANEQPGTKYYKMRGEWWDGYDGE 180 
5-RL-VIC        HGRGLHNLSLLVGSHPRDFKTEVDVVYGPPGCGKSRWANEQPGTKFYKMRGEWWDGYDGE 180 
9-RL-NSW        HGRGLHNLSLLVGSHPRDFKTEVDVVYGPPGCGKSRWANEQPGTKFYKMRGEWWDGYDGE 180 
3-SP-TAS        HGRGLHNLSLLVGSHPRDFKTEVDVVYGPPGCGKSRWANEQPGTKFYKMRGEWWDGYDGE 180 
6-ML-WA         HGRGLHNLSLLVGSHPRDFKTEVDVVYGPPGCGKSRWANEQPGTKFYKMRGEWWDGYDGE 180 
7-RL-WA         HGRGLHNLSLLVGSHPRDFKTEVDVVYGPPGCGKSRWANEQPGTKFYKMRGEWWDGYDGE 180 
8-RCL-WA        HGRGLHNLSLLVGSHPRDFKTEVDVVYGPPGCGKSRWANEQPGTKFYKMRGEWWDGYDGE 180 
4-SP-TAS        HGRGLHNLSLLVGSRPRDFKTEVDVIYGPPGCGKSRWANEQPGTKYYKMRGEWWDGYDGE 180 
                **************:**********:*******************:************** 
 
1-RL-NSW        ENVIIDDFYGWLPYCEMLRLLDRYPHKVPVKGAFVEFTSKRIIITSNKPPQEWYNQDCD 239 
2-RL-NSW        ENVIIDDFYGWLPYCEMLRLLDRYPHKVPVKGAFVEFTSKRIIITSNKPPQEWYNQDCD 239 
5-RL-VIC        DIVIIDDFYGWLPYCEMLRLMDRYPHKVPVKGAFVEFTSKRIIITSNKPPQDWYNQDCD 239 
9-RL-NSW        DIVIIDDFYGWLPYCEMLRLMDRYPHKVPVKGAFVEFTSKRIIITSNKPPQEWYNQDCD 239 
3-SP-TAS        DIVIIDDFYGWLPYCEMLRLMDRYPHKVPVKGAFVEFTSKRIIITSNKAPQDWYNQDCD 239 
6-ML-WA         DIVIIDDFYGWLPYCEMLRLMDRYPHKVPVKGAFVEFTSKRIIITSNKPPQDWYNQDCD 239 
7-RL-WA         DIVIIDDFYGWLPYCEMLRLMDRYPHKVPVKGAFVEFTSKRIIITSNKPPQEWYNQDCD 239 
8-RCL-WA        DIVIIDDFYGWLPYCEMLRLMDRYPHKVPVKGAFVEFTSKRIIITSNKPPQEWYNQDCD 239 
4-SP-TAS        DVVVLDDFYGWLPYCEMLRLCDRYPHKVPVKGAFVEFTGKRIIITSNKPPETWYNQDCD 239 
                : *::*************** *****************.*********.*: ******* 
 
Figure 4.4. Derived amino acid sequence alignment for BFDV ORF1 fragments from 7 
lorikeets and 2 swift parrots (nt sequence data shown in Figure 4.3) demonstrating 2 
replication motifs (red font) and the nucleotide binding site (green font). Asterisks indicate 
identical amino acids in all strains. 
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Figure 4.5. Neighbour joining tree of 45 BFDV ORF V1 nucleotide sequences rooted to the 
Rep gene of canary circovirus. Numbers at the nodes indicates percentage bootstrap 
support. Putative loriid and cockatoo clusters are shown with outlying cockatoo* and swift 
parrot (Lathamus discolor) 
† isolates highlighted. 
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Figure 4.6. Neighbour joining tree of the complete sequences of the BFDV strains used in 
this study. Numbers at the nodes indicate bootstrap support. The phylograms were 
generated from aligned, edited sequence data using the ClusTree program (ANGIS). The 
percentage divergence from 1000 bootstrap replicates (analysed by the neighbour-joining 
method) is indicated at the left of the supported node. The identity and accession numbers of 
the strains is shown in Table 4.4. 
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There are strong indications that there are species-specific BFDV biotypes adapted 
to lorikeets (Trichoglossus sp.) and parrots, and maybe also cockatoo (Cacatua sp.), 
budgerigar (Melopsittacus undulatus), lorikeet (Trichoglossus sp.) and lovebird 
(Agapornis sp.) lineages (Ritchie et al., 2003; de Kloet and de Kloet, 2004; Heath 
et al., 2004; Raue et al., 2004). There may be genetically distinguishable biotypes of 
BFDV which infect and are maintained in different psittacine species (de Kloet and 
de Kloet, 2004). The 7 Australian lorikeet isolates sequenced in this study all 
grouped with other lorikeet isolates in a Loriidae-specific genotype, providing further 
support for the existence of a Loriidae-specific BFDV genotype as proposed by 
Heath et al. (2004).  
The virus from a captive grey cockatiel in which there were lesions typical of PBFD 
was not a cockatiel-specific genotype and the BFDV infection was probably not due 
to a cockatiel-adapted strain but more likely a chance infection derived from other 
psittacine species; the cockatiel virus was similar to strains MMC-AUS infecting a 
Major Mitchell cockatoo (Cacatua leadbeateri) and SCC1-AUS infecting a sulphur 
crested cockatoo (Cacatua galerita).The lack of reports of PBFD in cockatiels 
(Nymphicus hollandicus), the second most popular bird kept as a caged pet, 
suggest they only rarely develop signs of PBFD and may have a natural immunity to 
PBFD.  Why the cockatiels in this instance developed PBFD is unknown.  Whether a 
bird is resistant to virus infection and the response to virus infection has been 
associated with the age of the bird at the time of infection, the presence and 
concentrations of maternal antibodies, the route of viral exposure and/or the titre of 
the infecting virus (Ritchie et al., 1992b) but these would appear to be unlikely 
factors associated with the resistance of cockatiels to BFDV as infection is 
uncommon in all age groups.  More likely there are innate factors that contribute to 
the immunity of cockatiels (Nymphicus hollandicus) to BFDV. The innate defence, 
  86formed by natural killer cells, granulocytes and macrophages and their secreted 
products, such as nitric oxide and various cytokines, is of crucial importance early in 
viral infections (Jeurissen et al., 2000).  Differences in genetic susceptibility to many 
of the major viral pathogens of poultry has been demonstrated and specific 
resistance genes have been identified in some cases, such as avian leukosis and 
Marek's disease (Lamont et al., 1987; Bumstead, 1998).  
Swift parrots (Lathamus discolor) are an endangered species of the Psittacidae 
family (Christidis et al., 1991; Christidis and Boles, 1995) but they are behaviourally 
and anatomically similar to lorikeets (Trichoglossus sp.). They are a monotypic 
genus that probably evolved in the south east of Australia from a granivorous 
psittacid into a specialist nectarivorous bird before the more recent introduction of 
trichoglossid lorikeets (Trichoglossus sp.) (Christidis et al., 1991). They compete 
closely for nectar and pollen as well as nesting sites with several lorikeet and parrot 
species including, at Bruny Island, musk lorikeets (Glossopsitta  concinna), eastern 
rosellas (Platycercus eximius) and green rosellas (Platycercus caledonicus). Swift 
parrots (Lathamus discolor) use different nest holes each year according to the 
proximity of flowering trees. The wild swift parrot (Lathamus discolor) population 
currently consists of fewer than 1300 breeding pairs and is thought to be decreasing 
by more than 1% every year (Gartrell and Jones, 2001). 
The generated DNA sequence data of 2 isolates from swift parrots was compared to 
36 previously described BFDV ORF V1 sequences from psittacine birds from 
Australia, USA, UK, Germany, South Africa, Portugal, Austria and New Zealand and 
demonstrated that the swift parrot isolates were genetically different to each other.  
One isolate (isolate 3-SP-TS) grouped phylogenetically, based on the ORF V1, into 
a loriid genotype similar to that proposed by Ritchie et al. (2003). The other isolate 
from swift parrots grouped separately, together with BFDV isolates from other 
psittacine species.  The difference in the 2 swift parrot sequences, even though they 
  87were from siblings within the same nest hollow, suggests that this species is 
naturally susceptible to both loriid and psittacid genotypes, that there is cross 
infection of BFDV between lorikeets (Trichoglossus sp.) and swift parrots (Lathamus 
discolor) and that BFDV might survive in nesting sites from one breeding season to 
another and be transmitted from one species to another in this manner.  
  88Chapter 5.  Expression of an antigenic Beak and 
feather disease virus capsid protein using a 
baculovirus expression system 
 
Summary  
This chapter describes the production of a recombinant BFDV Capsid protein in 
insect cells using a baculovirus expression system. The entire coding region of 
BFDV ORF C1, encoding the putative capsid protein of the virus, was expressed in 
Sf9 insect cells using a baculovirus expression system. Electron microscopic 
examination of negatively stained material demonstrated that the recombinant 
protein self-assembled to produce virus-like particles (VLPs) thus confirming that 
ORF C1 was likely to be the sole determinant for capsid construction in vivo. BFDV 
VLPs also possessed HA activity which provides further evidence that self-
assembled BFDV VLPs retain receptor mediated biological activity. The recombinant 
protein reacted with anti-BFDV sera from naturally immune parrots and cockatoos 
and from chickens experimentally inoculated with native BFDV in both Western 
immunoblot and HI assays. Immunisation of chickens with the recombinant BFDV 
Capsid protein induced BFDV HI antibodies in 2 of 4 chickens. The BFDV VLPs 
were a suitable replacement antigen for serological detection of BFDV antibody by 
HI and would provide an alternative to the production of BFDV antigens for 
diagnostic purposes from whole virus present in tissues of infected birds. 
 
Introduction 
Expression of proteins from foreign genes in diverse host organisms has become a 
  89common procedure in basic research, with many applications for the expressed 
proteins. Apart from classic approaches with bacteria, the expression of protein in 
eukaryotic host cells has become popular since these have several advantages over 
bacterial systems.  These advantages include their ability to build disulphide-bonds 
and to perform essential modifications like glycosylation, phosphorylation, 
carboxylation, and acylation which are very crucial when it comes to correct folding 
and maintaining authentic functionality of the foreign protein. Eukaryotic cells are 
also capable of translocating proteins to the nucleus and the outer membranes, as 
well as secreting them to the extracellular matrix, providing the basis for diverse 
sophisticated applications in modern biotechnology (Marchal et al., 2001). 
Insect cells lines derived from members of the Lepidoptera as hosts for recombinant 
protein expression possess several advantages over mammalian cell culture 
techniques. Apart from their high expression rates they are very easy to propagate 
and they possess specific transferases like glucosidases, mannosidases and N-
acetylglucosamine-transferases which are essential for authentic post-translational 
modification of many proteins. Although it is not clear whether they are capable of 
performing sufficient and genuine sialyl- and galactosyl-transferase activity (Marchal 
et al., 2001), diverse functionally active proteins of animal and human origin have 
been expressed with the aid of lepidopteran cell lines.  
In the baculovirus expression system, the heterologous genes are placed under the 
transcriptional control of the strong polyhedrin promoter of the Autographa 
californica nuclear polyhedrosis virus (AcNPV) and are often abundantly expressed 
during the late stages of the recombinant virus infection of insect cells.  In most 
cases, the recombinant proteins are processed, modified, and targeted to their 
appropriate cellular locations, where they are functionally similar to their authentic 
counterparts (Luckow, 1991; King and Possee, 1992; O'Reilly et al., 1992; Luckow, 
1993; Luckow et al., 1993; Davies, 1994; Luckow, 1995a; Luckow, 1995b). 
  90AcNPV has a large (130 kb) circular double-stranded DNA genome with multiple 
recognition sites for many restriction endonucleases. As a result, recombinant 
baculoviruses are traditionally constructed in 2 steps.  The gene to be expressed is 
first cloned into a plasmid transfer vector downstream from a baculovirus promoter 
that is flanked by baculovirus DNA derived from a nonessential locus, usually the 
polyhedrin gene. This plasmid is then introduced into insect cells along with circular 
wild-type genomic viral DNA. Typically, 0.1-1% of the resulting progeny are 
recombinant, with the heterologous gene inserted into the genome of the parent 
virus by homologous recombination in vivo (Luckow, 1991). 
Recently, a rapid and efficient method to generate recombinant baculoviruses was 
developed by researchers at Monsanto (Luckow, 1993) and such a recombinant 
baculovirus was used in the experiments reported in this Chapter. The methods are 
based on site-specific transposition of an expression cassette into a baculovirus 
shuttle vector (bacmid) propagated in E. coli. The bacmid contains the low-copy-
number mini-F replicon, a kanamycin resistance marker, and a segment of DNA 
encoding the lacZα peptide from a pUC-based cloning vector.  Inserted into the N-
terminus of the lacZα gene is a short segment containing the attachment site for 
the bacterial transposon Tn7 (mini-attTn7) that does not disrupt the reading frame 
of the lacZα peptide. The bacmid propagates in E. coli DH10Bac
™ as a large 
plasmid that confers resistance to kanamycin and can complement a lacZ deletion 
present on the chromosome to form colonies that are blue in the presence of a 
chromogenic substrate such as Bluo-gal or 5-bromo-4-chloro-3-indolyl-ß-D-
galactopyranoside (X-Gal) and the inducer isopropyl-ß-D-thiogalactopyranoside 
(IPTG).  
Recombinant bacmids are constructed by transposing a mini-Tn7 element from a 
pFastBac
™ donor plasmid to the mini-attTn7 attachment site on the bacmid when 
the Tn7 transposition functions are provided in trans by a helper plasmid 
  91(pMON7124). The helper plasmid confers resistance to tetracycline and encodes 
the transposase. A series of pFastBac
™ donor plasmids are available which share 
common features. Each vector has a baculovirus-specific promoter (the polyhedrin 
or p10 promoter from Autographa californica multiple nuclear polyhedrosis virus or 
AcMNPV) for expression of proteins in insect cells. The mini-Tn7 in a pFastBac
™ 
donor plasmid contains an expression cassette consisting of a gentamycin 
resistance (Gm
r) gene, a baculovirus-specific promoter, a multiple cloning site, and 
an SV40 poly (A) signal inserted between the left and right arms of Tn7. The 
pFastBac
™ HT (Polayes et al., 1996) series of vectors are used to express 
polyhistidine-tagged proteins which can be rapidly purified on metal affinity resins. 
Genes to be expressed are inserted into the multiple cloning site of a pFastBac
™ 
donor plasmid downstream from the baculovirus-specific promoter. Insertions of the 
mini-Tn7 into the mini-attTn7 attachment site on the bacmid disrupts expression of 
the lacZα peptide, so colonies containing the recombinant bacmid are white in a 
background of blue colonies that harbour the unaltered bacmid.  
Recombinant bacmid DNA can be rapidly isolated from small scale cultures and 
then used to transfect insect cells. Viral stocks (>10
7 pfu/mL) harvested from the 
transfected cells can then be used to infect fresh insect cells for subsequent protein 
expression, purification and analysis. Using site-specific transposition to insert 
foreign genes into a bacmid propagated in E. coli has a number of advantages over 
the generation of recombinant baculoviruses in insect cells by homologous 
recombination.  Recombinant virus DNA isolated from selected colonies is not 
mixed with parental, non-recombinant virus, eliminating the need for multiple 
rounds of plaque purification.  As a result, this greatly reduces the time it takes to 
identify and purify a recombinant virus from 4-6 weeks (typical for conventional 
methods) to within 7-10 days (Figure 5.1).  Perhaps the greatest advantage of this 
method is that it permits the rapid and simultaneous isolation of multiple 
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Figure 5. 1. The diagram depicts the generation of recombinant baculovirus and expression 
of gene of interest using the Bac-to-Bac (Invitrogen) baculovirus expression system 
including cloning, transformation, transposition, transfection, amplification, expression and 
titration of recombinant baculovirus. From www.invitrogen.com/content/ 
sfs/vectors/pfastbacht_map. 
 
recombinant viruses, and is particularly suited for the expression of protein variants 
for structure/function studies. 
Attempts at culturing BFDV in numerous culture systems have been unsuccessful 
so the current BFDV antigen is extracted from the feathers of affected birds. This 
process is expensive, ethically questionable, time consuming and results in low 
yields and the extracted product can be contaminated with host proteins that can 
interfere with many types of serological assays. Specificity of the antigen produced 
from a recombinant BFDV capsid should not present a problem, as while BFDV 
exhibits some genetic diversity in the gene encoding the capsid protein it is 
antigenically conserved and there is no evidence of different BFDV serotypes at 
  93least using HI assay techniques (Khalesi et al., 2005; Raidal et al., 1993c; Ritchie 
et al., 1991b).  
It is well-known that virus structural proteins, especially those produced using the 
baculovirus system, can self-assemble and produce virus-like particles (VLP) that 
imitate native virus morphology and immunological properties (Wong et al., 1994; 
Nawagitgul et al., 2000; Noad and Roy, 2003). Therefore, the aim of the studies 
reported in this chapter was to express recombinant histidine (HIS) tagged BFDV 
Capsid protein encoded by the ORF C1 of BFDV, demonstrate that the protein self-
assemble to produce VLPs, verify that the determinant for HA are located within the 
capsid and assess its ability to react with BFDV specific antibodies and ability to 
induce an antibody response.  
 
Materials and methods  
Amplification of BFDV ORF C1 
The BFDV-AUS isolate (Genbank accession number, AF080560) described by 
Bassami et al. (1998) was used as a template in construction of recombinant 
plasmids. 
Oligonucleotide primers (Table 5.1) were designed to amplify a 740 nt fragment of 
the entire coding sequence of the ORF C1 (encoding the capsid protein) from the 
BFDV DNA; the 5’ end of each primer contained the recognition site for the 
restriction enzyme EcoRI and SalI. This facilitated construction of the recombinant 
pFastBac
™ plasmid. The primer pair BFDV ORF C1 forward and BFDV ORF C1 
reverse was used to amplify the subfragment. 
 
  94Table 5.1. Primers used for the amplification of genes of interest from BFDV ORF C1 
template DNA.  All primers contained the coding sequence for the restriction enzyme 
EcoRI and SalI at the 5’ end. 
 
Name 
 
Sequence (5’ - 3’)  Nucleotide target 
in genome 
Annealing 
temperature (°C) 
Forward 
primer  T 5′-gaattcatgtggggcacctgcgtctaacgcg-3′  1-22 60 
Reverse 
primer  5′-gtcgactaagtgctgggattgattagg-3′  725-745 60 
 
 
PCR reactions were performed in 25 µL volumes containing 2 mM MgCl2, 2 mM of 
each dNTP and 0.5 U of AmpliTaq
® DNA polymerase (PerkinElmer) made up to 
volume with PCR buffer (PerkinElmer). The reaction was carried out in a Cetrius 
2400 Thermocycler (PerkinElmer) using an initial denaturing step at 96
oC for 5 min, 
32 cycles of denaturing 96
oC for 0.5 min, annealing at 60°C for 0.5 min and 
extension at 72
oC for 1.5 min, with a final extension at 72
oC for 10 min. This was 
followed by a final extension step at 72°C for 10 min to provide better efficiency of 
3’ deoxyadenosine triphosphate addition to PCR products, useful in TA cloning.  
PCR products were visualised by agarose gel electrophoresis using either BioRad 
Mini Sub™ DNA cells or BioRad Wide Sub™ DNA cells (BioRad). Tank and gel 
buffers consisted of TAE (50X TAE: 2 M Tris-Acetate, 0.05 M EDTA, pH 8.0) as 
described by Sambrook et al. (1989). Agarose gels consisted of 0.8% (w/v) 
electrophoresis-grade agarose (Progen) and 10 µg/mL ethidium bromide.  
Electrophoresis was performed at 90 V for approximately 45 min and the gels 
viewed under ultraviolet light with a transilluminator. Gels were photographed using 
the GelDoc system (BioRad).  
PCR products were purified from the agarose using the QIAquick Gel Extraction Kit 
(QIAGEN) and ligated into pCR
® 2.1-TOPO
® vector (Invitrogen) according to 
manufacturer's protocols. For sequence analysis, the ABI Prism™ Dye Terminator 
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protocols except reaction volumes were halved to 10 μL and the annealing 
temperature was raised to 58°C. Sequence data were generated in duplicate in both 
directions from distinct regions of the cloned products. 
Molecular cloning and expression of BFDV Capsid protein 
The Bac-to-Bac
® (Invitrogen) baculovirus expression system (Anderson et al., 1995) 
was used to express the BFDV Capsid. The PCR amplified BFDV ORF C1 was 
excised from the pCR2.1/BFDV ORF C1 construct using an EcoR1/Sal1 double 
digest.  Restriction digests were performed in a total volume of 20 µL containing 2 
µL 10X reaction buffer, 5 µL DNA template (approximately 800 ng plasmid DNA), 1 
µL restriction endonuclease (10 U) and 12 µL dH2O. The digest reactions were 
normally incubated for at least 2 h at 37°C and where incubations exceeded this 
time, 0.5 µL (5 U) of enzyme was used and the residual volume was replaced by an 
appropriate amount of dH2O.    
The restriction digests were ligated into the EcoR1/Sal1 site of the pFastBAC HTa 
(Invitrogen) baculovirus transfer vector.  The formula below was used to accurately 
define the amount of insert needed to obtain desired molar ratios of insert to vector for 
efficient ligation:  
(ng of vector) x (bp size of insert) x (molar ratio of insert to vector) 
--------------------------------------------------------------------------------------- = µg insert needed  
                                (bp size of vector)  
Ligation reactions were typically performed in a total volume of 10 µL containing 
ligation buffer (New England Biolabs), a determined amount of linearised plasmid 
(typically 25 µg), an appropriate amount of insert and 4 Weiss units of T4 DNA 
ligase (New England Biolabs) in sterile dH2O. Ligation was performed using a 5:1 
insert:vector molar ratio. The ligation reaction was incubated overnight (~15 h) at 
14°C. The reaction was stopped by heat inactivation of the enzyme at 70°C for 10 
  96min and then the mixture was cooled to room temperature. Ligation mixtures were 
stored at -20°C until used later for transformation.    
The ligated plasmids were then transformed into TOP10F’ chemically competent 
E. coli (Invitrogen). The orientation of the gene in pFASTBAC was verified by 
restriction digest with BamH1 and sequence analysis. The recombinant bacmid was 
generated according to the manufacturer's protocol (Bac-to-Bac
® Baculovirus 
Expression System; Invitrogen) (Figure 5.2). The pFASTBAC HTa BFDV ORF C1 
construct was transformed into the chemically competent E. coli DH10Bac 
(Invitrogen) containing the bacmid and helper vector, where the BFDV ORF C1 gene 
was transposed into the bacmid. The recombinant bacmid containing the BFDV 
ORF C1 was purified using a plasmid DNA mini-prep procedure modified from 
Morelle (1991).  
 
                                
 
Figure 5.2. Vector map of pFastBac™ HT A. The polyhedrin promoter (PPH) allows 
efficient high level expression of recombinant protein in insect cells. The SV40 
polyadenylation signal permits efficient transcription termination and polyadenylation of 
mRNA. From www.invitrogen.com/content/ sfs/vectors/pfastbacht_map. Accessed 27 
July 2006).    
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baculovirus. In wells of a 6-well multiplate or an individual 35 mM tissue culture dish 
(Nunc), Sf9 insect cells (9 x 10
5 cells per well of a 6-well plate) were seeded in 2 
mL of Sf-900 II SFM (Invitrogen) containing antibiotics (50 units/mL penicillin and 
50 µg/mL streptomycin). Cells were allowed to attach at 27°C for at least 1 h. For 
each transfection, 1 µg of purified bacmid DNA was mixed with 100 µL of Sf-900 II 
SFM and 6 µL of Cellfectin (GibcoBRL). The mixture was incubated for 45 min at 
room temperature. While the DNA:lipid complexes were incubated, medium was 
removed from the cells and they were washed once with 2 mL of Sf-900 II SFM. To 
each tube containing the DNA:lipid complexes, 0.8 mL of Sf-900 II SFM was added, 
mixed gently and added to one well of cells.  Cells were incubated at 28°C for 5 h 
before the DNA: lipid complexes were removed and 2 mL Sf-900 II SFM containing 
antibiotics was added. Cells were incubated again at 28°C but this time in a 
humidified environment for 72 h or until a cytopathic effect (CPE) developed. Once 
the transfected cells showed an advanced CPE, the medium (containing virus) from 
each well was collected and transferred to a sterile 15 mL tube. The tubes were 
centrifuged (500 x g for 5 min) to remove cells and large debris, and the clarified 
supernatant was transferred to fresh 15 mL tubes.  
The recombinant baculovirus was amplified by cell-to-cell passage until the titre was 
sufficient for high-level expression of the protein. After each passage, the titre of 
infectious virus in the baculovirus stocks was determined by plaque assay.  
Approximately 1 x 10
6 Sf9 cells were seeded into each well of a 6-well plate, then 
incubated at room temperature for at least 1 h to ensure cell attachment, then the 
medium was aspirated. Ten-fold serial dilutions of the virus preparation were 
prepared and 1 mL of each dilution added to wells and the monolayers incubated at 
room temperature for an additional 1 h. The virus inoculum was then aspirated and 
replaced with 2 mL of a plaquing overlay consisting of Sf-900 II SFM 1.3X 
  98(GibcoBRL) and sterile 4% (w/v) agarose at a ratio of 3:1.  Plates were incubated at 
28°C in a humidified incubator for 4 days, and then the cells were stained by the 
addition of 2 mL of 0.03% (w/v) neutral red and incubation for 1 h at room 
temperature. Excess stain was aspirated and the plates were inverted and placed 
in the dark at room temperature until the number of visible plaques did not change 
for 2 consecutive days. To determine the titre as pfu (plaque forming units/mL) of 
the viral inoculum, the plaques were counted in wells containing 3-20 plaques 
(Figure 5.3).  
 
         
  
Figure 5.3. Baculovirus plaques generated by infection of Sf9 cells with baculovirus. 
Uninfected Sf9 cells surrounding plaques stained pink with neutral red. 
 
Once a pFastBac™ baculovirus stock was generated with a titre of 1 x 10
8 
pfu/mL or greater, insect cells were infected for expression of recombinant 
protein.  Suspension cultures of Sf9 cells were grown in serum-free conditions in 
Sf-900 II SFM, and growth was monitored by counting viable cells in a 
haemocytometer using trypan blue exclusion. Once cultures reached a density of 
2 x 10
6 - 3 x 10
6 viable cells/mL they were infected with the recombinant 
baculovirus at an MOI of 5 pfu/cell. Infected cells were monitored at regular 
intervals and harvested 72 h post-infection by centrifugation (500 x g for 10 min). 
The diameter of the insect cells and the size of nuclei increased over 24 h when 
the cells ceased to grow and appeared granular (Figure 5.4). 
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Figure 5.4. Comparison of uninfected Sf9 insect cell (right) with recombinant bacmid 
transfected infected Sf9 cells (left) under phase contrast light microscope.  
 
Purification of baculovirus proteins  
Two methods were developed to purify recombinant BFDV Capsid from the Sf9 
insect cell lysates: Ni-NTA affinity and caesium chloride (CsCl) ultracentrifugation. In 
the Ni-NTA affinity method, all steps of the protein purification were carried out at 
4°C. The volume of the transfected Sf9 cells harvested by centrifugation was 
estimated and the cells then lysed by the addition of 5 volumes of Sf9 cell lysis 
buffer (50 mM Tris-HCl [pH 8.5]; 5 mM ß-mercaptoethanol; 100 mM KCl; 1 mM 
PMSF; 1% (v/v) Nonidet P-40) and gently mixed end-over-end for 5 min.  
Suspensions were centrifuged (10,000 x g for 10 min) and the supernatant was 
transferred to a fresh tube. An appropriate volume of Ni-NTA agarose resin 
(QIAGEN) was equilibrated with phosphate buffer 1 (50 mM potassium phosphate 
[pH 6.0]; 300 mM KCl; 5 mM ß-mercaptoethanol; 10% (v/v) glycerol; 8 M urea) for 
10 min and loaded onto a chromatography column (BioRad), the resin was allowed 
to settle in the column before being washed again with 10 volumes of phosphate 
buffer 1. Supernatants from the cell lysis step were loaded onto the column and 
allowed to flow through at approximately 1 mL/min. The resin containing bound 
HIS-tagged protein was then washed with approximately 25 volumes of phosphate 
buffer 1. Elution of the recombinant HIS-tagged protein was carried out by loading 
phosphate buffer 2 (50 mM potassium phosphate [pH 6.0]; 300 mM KCl; 250 mM 
imidazole; 5 mM ß-mercaptoethanol; 10% (v/v) glycerol and 8 M urea) onto the 
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In the CsCl ultracentrifugation method, the recombinant protein was purified from 
the cell lysate by ultracentrifugation to determine if VLP were produced. The Sf9 
insect cells were harvested 72 h p.i. and lysed as previously described. A sucrose 
buffer was initially used to purify VLPs from the debris and the cell lysate was 
layered onto a 40% (w/v) sucrose cushion and centrifuged at 28,000 rpm for 2 h 
(SW55Ti, Beckman) at 18°C. The supernatant was discarded and the pellet 
suspended in PBS and the VLP purified in CsCl gradients according to methods 
described previously for purifying wild-type BFDV (Ritchie et al., 1989c; Raidal and 
Cross, 1994b). The fraction containing the recombinant BFDV Capsid VLPs was 
determined by SDS-PAGE, western immuno-blot, electron microscopy and HA.  
Protein solutions were assayed in duplicate or triplicate using a Protein Assay Kit 
(BioRad) as recommended by the manufacturer.  
To identify the possible presence of VLPs in the CsCl-purified BFDV Capsid protein, 
the protein was coated onto copper 400-mesh Formvar carbon coated grids by 
floating the grids on droplets of the sample for 10 sec. Excess liquid was absorbed 
from the grid onto Whatman filter paper and the sample stained with 1% 
phosphotungstic acid (PTA) by floating the grids on droplets of PTA for 10 sec, the 
excess liquid was removed and the grid allowed to dry for at least 2 h prior to 
viewing by electron microscopy. 
Polyacrylamide gel electrophoresis (SDS-PAGE) and Western 
immunoblotting 
Protein samples were diluted in SDS-PAGE sample buffer (Laemmli, 1970) and 
separated by 12.5% denaturing sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE; Laemmli, 1970), electrophoresed at 200 V for 1 h and 
either stained with Coomassie brilliant blue (Bio-Rad) and then destained with 
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proteins, or subjected to Western immunoblotting. Western immunoblot analysis 
was performed using the procedure originally developed by Towbin et al. (1979). 
Unstained SDS-PAGE gels were transferred to 0.45 µm nitrocellulose membranes 
using a mini Trans-Blot apparatus (BioRad) and ice-cold transfer buffer (25 mM 
Tris, 192 mM glycine, 20% [v/v] methanol). Transfer was performed for either 40 V 
for 6 h at 4°C or 15 V for 30 min at room temperature for each apparatus, 
respectively. The membrane was then blocked in 5% (w/v) skim milk in PBST 
(PBS, 0.05% [w/v] Tween-20) at 4°C overnight and then washed in PBST. Primary 
antibody was added to the membrane at a dilution of 1:200 for chicken anti BFDV, 
or 1:5,000 for mouse anti-HIS IgG, and the membrane incubated at 37°C for 2 h. 
After 3 washes in PBST a horseradish peroxidase (HRP) conjugated secondary 
antibody was added to the membrane at a dilution of 1:2,500 for anti-mouse (goat 
anti-mouse IgG-HRP conjugate; Sigma), or 1:2,500 for chicken anti-BFDV (rabbit 
anti-chicken IgG-HRP conjugate; ICN) and incubated at 37°C for 1 h. The 
membrane was then washed twice in excess PBST and once in excess PBS for 5 
min with gentle agitation. A Western blot detection buffer containing 4-chloro-
naphthol (4-CN) substrate (BioRad) was added to the membrane and the colour 
reaction allowed to develop.  The reaction was stopped by rinsing the membrane 
under distilled and deionised water and the membrane was then allowed to dry. For 
assay of field serum samples, purified recombinant fusion protein was applied to an 
SDS-PAGE gel with no wells, producing a continuous band of antigen across the 
gel. All Western immunoblot assays were performed using reference positive 
antisera on one strip from each batch of strips obtained from one nitrocellulose 
membrane.   
Naïve chicken and chicken anti-BFDV sera with a HI titre of 5,120 HI units/50 µL 
was kindly provided by Dr. Gary Cross, University of Sydney and the goat anti-
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Dr Sarah Plant, Department of Agriculture and Food. Western Australia.  
Immunisation of chickens with recombinant BFDV Capsid protein 
Equal volumes of purified baculovirus recombinant protein and incomplete Freund’s 
adjuvant (Sigma) was emulsified using glass syringes. Four clinically normal 
chickens were injected into the pectoral muscle with 0.5 ml of the emulsion and this 
was repeated 22 days later. Blood samples were collected from the wing veins onto 
filter paper (Whatman No.3) 7 days before the initial immunisation, 0 days, 16 days 
and 29 days after the first injection of the emulsion.  An antibody response was 
detected by HI using plasma extracted from the filter paper as described in Chapter 
3.  
Results 
Expression of BFDV Capsid protein by baculovirus expression system 
The BFDV Capsid protein was successfully expressed and purified using the 
baculovirus expression system, as shown in Figures 5.5 and 5.6. Optimal 
conditions for the expression of recombinant BFDV Capsid involved infecting Sf9 
cell cultures in mid-logarithmic phase with the recombinant baculovirus at an MOI 
of 5 pfu/cell and allowing the culture to incubate at 28°C for 72 h.   
The various purification steps involved in isolating the recombinant protein with a 
nickel resin are shown in Figures 5.5 (Coomassie blue stained) and 5.6 (Western 
immunoblot utilising a monoclonal anti-HIS antibody to detect the HIS-tagged 
recombinant BFDV Capsid protein). A number of wash steps was required to 
remove as much of the contaminating cellular proteins as possible, and the final 2 
wash steps (Figures 5. 5 and 5.6, lanes 8 and 9) contained a low concentration of 
imidazole (50 mM) assisted in eluting any HIS-rich proteins from the nickel resin. 
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imidazole at a final concentration of 250 mM (Lanes 11, 12). The concentration of 
imidazole was determined empirically after examining the effects of 0.1-1 M 
imidazole on elution of the protein. As shown in Figures 5.5 and 5.6, protein was 
not eluted immediately in the first 0.5 mL fraction but was found subsequently in the 
second and third 0.5 mL fractions.  
The recombinant protein was purified from the Sf9 lysate using Ni-NTA high-affinity 
interaction between the HIS-tag and nickel and the recombinant protein was eluted 
from the Ni-NTA using elution buffer containing 300 mM imidazole. SDS-PAGE 
demonstrated the purification of single protein of approximately 32 kDa (Figure. 
5.7).  This protein was not present in the control and baculovirus wild-type infected 
Sf9 cells.  
The maximum concentration of the final purified recombinant protein achieved was 
estimated at 41 μg/mL.    
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Figure 5.5. Coomassie blue stained gel showing recombinant HIS-tagged BFDV Capsid 
protein. Lane 1, Precision Plus Protein Standards (BioRad); lane 2 and 3, harvested 
recombinant baculovirus Sf9 infected cell after 24 h with MOI=1 and MOI=5; lane 5 and 6, 
harvested infected cell after 48 h with MOI=1 and MOI= 5; lane 4, 7 and 10: uninfected Sf9 
cell culture pellet; lane 8 and 9, harvested infected cell after 72 h with MOI=1 and MOI=5; 
lane 11 and 12, harvested infected cell after 72 h with MOI=1 and MOI=5, lane 13, Precision 
Plus Protein Standard Unstained (BioRad). The sizes of the protein bands within the 
ladder are indicated in kDa on the LHS. The position of the BFDV Capsid protein is 
indicated on the RHS. 
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Figure 5.6.  Western immunoblot of the protein purification steps using anti-HIS antibody 
as the primary antibody and anti-mouse HRP as the secondary antibody. Lane 1, 
Precision Plus Protein Standards Dual Colour (BioRad); lane 2, uninfected Sf9 cell culture 
pellet; lane 3, recombinant baculovirus infected Sf9 cell culture pellet; lane 4, unbound 
protein fraction; lane 5, wash step 1; lane 6, wash step 2; lane 7, wash step 3 containing 
50 mM imidazole; lane 8, wash step 4 containing 50 mM imidazole; lane 9, eluted protein 
fraction 1; lane 10, eluted protein fraction 2; lane 11, eluted protein fraction 3.  The sizes 
of the protein bands within the pre-stained ladder are indicated (LHS) in kDa.   
 
 
 
 
 
 
 
 
Figure 5.7. SDS-PAGE analysis of the expression and purification of recombinant BFDV 
Capsid from Sf9 insect cells. Lanes: 1, molecular mass markers; lane 2, supernatant of lysed 
Sf9 insect cells infected with Ac-BFDV ORFC1; lane 3, cellular pellet of lysed Sf9 insect cells 
infected with Ac-BFDV ORFC1; lane 4, unbound fraction; lane 5, wash 1; lane 6, wash 2; 
lane 7, wash 3; lane 8, elution E1; lane 9, elution E2; lane 10, elution E3. 
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Detection of antibodies against recombinant BFDV Capsid protein in 
psittacine species and inoculated chickens  
Purified HIS-tagged BFDV Capsid reacted specifically in Western immunoblots with 
polyclonal chicken anti-BFDV. Without exception, sera of known anti-BFDV HI titres 
from psittacine birds all recognised the 32 kDa recombinant protein (Figure 5.8) 
providing further evidence that the recombinant protein was antigenically equivalent 
to wild-type virus.  
 
 
 
 
      
 
 
Figure 5.8. Western immuno-blot analysis of recombinant BFDV Capsid protein Lanes: 1 
molecular mass markers; lane 2, naïve polyclonal sheep antisera (1:200); lane 3, polyclonal 
sheep anti-BFDV Capsid (1:200); lanes 4–15 include known HI antibody sera diluted 1:30 
from a range of psittacine bird species (4, 5, 10 and 11 were from long-billed corellas 
(Cacatua tenuirostris), 6–9,12 and 13 were from sulphur crested cockatoos (Cacatua 
galerita); 14 and 15 were from a western corella (Cacatua pastinator). In lanes 5, 7, 9, 11, 13 
and 15 the antibodies were diluted in 5% (w/v) skim milk PBST. 
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To determine if the recombinant BFDV Capsid self-assembled to form VLP, the Sf9 
cell lysate containing the recombinant protein was purified by a sucrose cushion and 
CsCl gradient ultracentrifugation (described above). Fractions were analysed by 
electron microscopy. VLPs formed by the recombinant BFDV Capsid were 
predominately found in fractions collected with CsCl densities between 1.215 and 
1.325 g/mL. Direct electron microscopy of PTA negatively-stained samples 
demonstrated that the capsid proteins formed VLPs (Figure. 5.9). The VLPs were 
also visible in the fractions purified with the Ni-NTA resin (data not included). 
Electron micrographs showed the presence of spherical virus-like particles 
measuring 18–20 nm that appeared identical to wild-type BFDV amongst other 
spherical particles of variable size but ranging from 16 to 22 nm.  
 
 
 
 
 
Figure 5.9. Electron micrograph of PTA-stained BFDV recombinant Capsid expressed in Sf9 
insect cells demonstrating the formation of spherical virus-like particles (VLP) measuring 
approximately 18–20 nm in diameter and morphologically similar to wild-type BFDV (A). 
Small alignments and aggregations of VLPs were noted in some preparations (insert). In 
some preparations there were also variably sized (16–22 nm) spherical particles (B). 
 
 
  107Recombinant BFDV Capsid haemagglutinating activity  
Recombinant BFDV Capsid purified by either the Ni-NTA column method or by CsCl 
purification demonstrated haemagglutination activity when used as the antigen in HA 
(Figure 5.10). As expected the negative control of the elution buffer, the PBS (Figure 
5.10) and the lysate from Sf9, Sf9 infected with wild-type Ac-NPV and recombinant 
Ac-NPV expressing PCV1 ORFC1 did not cause haemagglutination, indicating that 
the BFDV Capsid protein was responsible for the agglutination and not 
contamination by the Sf9 cells or Ac-NPV. The BFDV Capsid from the Ni-NTA 
elutions (Elution E1, Elution E2 and Elution E3) all maintained the ability to cause 
haemagglutination (Figure 5.10). Each 0.5 mL collected from the CsCl demonstrated 
the ability to cause haemagglutination to varying degrees. The first 3 fractions had 
limited ability which was perhaps due to the incomplete formation of the VLPs while 
in comparison the lower fractions demonstrated a strong ability to cause 
haemagglutination (Figure 5.10). Serially diluted (2-fold, 3-fold, 5-fold, 10-fold and 
100-fold) BFDV Capsid quantified by a Bradford assay was used to detect the 
minimum amount of protein needed to cause HA. Haemagglutination was detected 
at concentrations between 15.2 and 21.2 ng but not below dilutions containing 14 ng 
or less.  
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Figure 5.10. Haemagglutination titres of recombinant BFDV Capsid purified by using either 
Ni-NTA column (A) or CsCl purification (B) in round bottom microtitre trays. Two-fold serial 
dilutions of each sample were made across the rows. (A) Rows: 1, BFDV purified from a 
persistent BFDV-infected psittacine bird; row 2, PBS control; row 3, elution buffer control; row 
4, elution E1; row 5, elution E2; row 6, elution E3; row 7, elution E1; row 8, elution E2. (B) 
Row 1, elution E3; row 2, fraction 1 CsCl purification; row 3, fraction 2 CsCl purification; row 
4, fraction 3 CsCl purification; row 5, fraction 4 CsCl purification; row 6, fraction 5 CsCl 
purification; row 7, fraction 6 CsCl purification; row 8, fraction 7 CsCl purification. 
 
 
Use of recombinant BFDV Capsid in HI assay  
Based on the HA results above, 100 ng of the recombinant BFDV Capsid was 
needed to provide 2-4 haemagglutination units required for HI, and this was 
validated by HA back titration (Figure 5.11)  Accordingly, 100 ng of recombinant 
BFDV Capsid was required as the antigen in a series of HI assays against sera 
known to contain anti-BFDV HI antibodies. The haemagglutination activity of the 
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known titre (Figure 5.11) and the expected titre was consistently achieved for each 
serum sample. The controls including PBS, elution buffer and sera from psittacine 
species that were known anti-BFDV HI negative all caused haemagglutination (data 
not shown).  
 
 
 
Figure 5.11.  Haemagglutination inhibition assay using recombinant BFDV Capsid as the 
antigen (rows 3–8) in round bottom microtitre trays. Rows 1 and 2 show back titrations of 
wild-type BFDV purified from an infected psittacine bird and a back titration of recombinant 
BFDV Capsid protein. Rows 3–8 show expected HI titres in sera of known HI antibody titre 
obtained from experimentally and naturally BFDV-infected birds.  
 
Baculovirus expressed recombinant BFDV ORF C1 was used to inoculate 4 adult 
chickens. All 4 chickens were HI antibody negative 7 days prior to and at the time of 
inoculation and no local tissue reactions were detected at the sites of inoculation. 
Two of the 4 birds developed a detectable HI antibody titre within 16 days of the 
second vaccination when tested against both whole virus HA antigen and the 
recombinant baculovirus-expressed protein antigen. One chicken (C210) developed 
a HI antibody titre of 80 HI units/50 μL 16 days after the second inoculation against 
the whole virus HA antigen and the recombinant baculovirus-expressed protein 
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units/50 μL 16 days after the first and 7 days after the second inoculation, 
respectively, when tested with the whole virus HA antigen, and a titre of 40 HI 
units/50 μL 7 days after the second injection of antigen when tested against the 
recombinant baculovirus-expressed protein antigen (Table 5.2, Figure 5.12, Figure 
5.13). 
 
Table 5.2. Haemagglutination inhibition (HI) antibody titres (HI units/50 μL) to native HA 
antigen and recombinant protein HA antigen in 4 chickens 7 and 0 days before vaccination 
and 16 and 29 days after the initial vaccination with the recombinant BFDV Capsid protein. 
           Time after initial inoculation of antigen  Chicken  Type of antigen used  
as HA antigen  -7 0  16  29 
D74 Native  0  0  0  0 
 Recombinant   0  0  0 0 
E28 Native  0  0  0  0 
 Recombinant 0  0  0 0 
C210 Native  0  0  0  80 
 Recombinant 0  0  0 80 
F312 Native  0  0  80  320 
 Recombinant 0  0  0 40 
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Figure 5.12. HI activity in chicken sera against recombinant protein antigen in round bottom 
microtitre trays. Rows 1, 2, 3, 4 (chick C210) were sera 7 days before vaccination, day 0 
(first vaccination), day 16 and day 29 (final bleeding), respectively. Rows 5, 6, 7, 8 (chick 
F312) were sera 7 days before vaccination, day 0 (first vaccination), day 16 and day 29 (final 
bleeding), respectively. 
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Figure 5.13. HI activity in chicken sera against recombinant protein antigen in round bottom 
microtitre trays. Rows 1, 2, 3, 4 (chick C210) were sera 7 days before vaccination, day 0 
(first vaccination), day 16 and day 29 (final bleeding), respectively. Rows 5, 6, 7, 8 (chick 
F312) were sera 7days before vaccination, day 0 (first vaccination), day 16 and day 29 (final 
bleeding), respectively. 
 
 
 
Discussion 
In this study, the major aim was to produce a BFDV ORF C1-encoded recombinant 
Capsid protein that would have application as a potential vaccine and as a specific 
antigen for serological diagnostic tests such as ELISA and Western 
immunoblotting. One of the reasons for selecting the baculovirus system was that 
this frequently results in the production of soluble proteins that are more suitable as 
serological antigens (than insoluble proteins) and that it allows post-translational 
modifications that can result in correct folding that mimics the native protein (see 
Introduction).  
A soluble recombinant BFDV Capsid protein was successfully expressed in insect 
cells using a baculovirus expression system and purified using Ni-NTA columns. 
The protein was easily purified by affinity chromatography from native cellular 
proteins due to the presence of an N-terminal HIS-tag. Many attempts were made 
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  112to produce the protein and the maximum estimated yield achieved was 41 μg/mL; as 
it was determined that a minimal concentration of 15 ng/mL was required to produce 
haemagglutination, this would be adequate for the production of antigen.  However, 
for the production of vaccine, further optimisation of the methods of expression 
might be required to achieve greater yields. The protein appeared to be specific as 
it reacted strongly in HI and Western immunoblot assays with the serum of 
chickens that had been inoculated with an Australian strain of BFDV.  When 
inoculated into chickens it resulted in the production of antibodies that inhibited 
haemagglutination both by the purified protein and a native virus preparation. 
However, when inoculated into chickens, only 2 of 4 inoculated chickens produced 
antibody after 2 injections of the protein emulsified in incomplete Freund’s adjuvant. 
It is likely this low response rate was a combination of a low protein concentration 
administered to the chickens and that the response could be improved by an 
increase in the amount of protein administered.  It might also be improved by 
increasing the period between injections to 28 days (rather than the 22 days used 
in these experiments) and perhaps by the use of alternative adjuvants.  There was 
insufficient time to pursue these studies further personally but studies of the 
immunisation of galahs with this protein are continuing in this laboratory and 
excellent seroconversion rates are being obtained (Nicolai Bonne, personal 
communication). 
The BFDV Capsid protein has potential application as a vaccine.  There is 
precedent for this: previously an oil emulsion inactivated BFDV vaccine was shown 
to protect nestling galahs (Eolophus roseicapillus) and sulphur crested cockatoos 
(Cacatua galerita) chicks (Raidal et al., 1993a). Development of a vaccine utilising 
the recombinant BFDV Capsid protein will require further testing and will need to 
include assessment of a suitable adjuvant.  The titre of HI antibodies induced with 2 
doses of the protein in chickens was as high as 1:320 HI units/50 µL, even though 
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of titres obtained here and in other studies is not possible, it is noted that neonates 
from hens with HI antibody titres greater than 1:280 HI units/50 µL were shown to be 
protected from challenge with live virus (Ritchie et al., 1992b).  Further optimisation 
of the antigen concentration and method of administration and adjuvant used should 
result in titres in breeding psittacine hens sufficient to result in protective levels of 
maternal immunity in progeny.   
The protein produced also has application as an antigen for serological tests, 
including ELISA and Western immunoblotting.  The purified protein produced was 
shown to cause haemagglutination, as does native whole virus antigens, and to 
induce antibodies in chickens that inhibited the haemagglutination.  A HI assay for 
the detection BFDV antibody (Riddoch et al., 1996) has become the standard tool 
for detecting and quantifying antibody to BFDV in psittacine birds. The recombinant 
baculovirus-expressed protein would overcome the problems associated with the 
production of native whole virus proteins for the assay, and there are precedents for 
this.  For example, a recombinant ORF C139-224-encoded HIS-tagged truncated 
BFDV Capsid protein with an apparent molecular weight of 27 kDa was expressed 
in a prokaryotic (E. coli) system (Johne et al., 2004) and found to provide a suitable 
antigen for HI tests; it was also utilised as an ELISA and Western immunoblotting 
antigen. 
The results demonstrate that like PCV2 (Nawagitgul et al., 2000), BFDV ORF C1 
encodes a structural capsid which is able to self-assemble into VLPs. PCV and 
BFDV virions consist of 60 units of the monomeric capsid arranged in a T = 1 
symmetry which produce similar capsid structures with flat pentameric 
morphological units that result in a smooth spherical surface seen by electron 
microscopy (Crowther et al., 2003). The VLP were found predominately in fractions 
collected with CsCl densities between 1.215 and 1.325 g/mL whereas wild-type 
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decrease in density between the VLP and wild-type virus is likely due to the lack of 
nucleic acid and partially formed particles. Similar to the findings published by 
Nawagitgul et al. (2000) some of the self-assembled VLPs observed in our study 
were variable in size and shape compared to wild-type BFDV preparations. Similar 
findings have been reported for PCV (Crowther et al., 2003) and parvovirus B19 
(VP1) expressed in baculovirus, and this is probably due to improper or partial 
assembly (Wong et al., 1994).  
  115Chapter 6.  General discussion 
Psittacine beak and feather disease (PBFD) is a major problem in psittacine birds 
worldwide and it is now threatening the extinction of some species like the swift 
parrot (Lathamus discolor) which are already endangered. This situation requires 
the development of improved diagnostics and vaccines for the detection and control 
of disease and the studies reported in this thesis will contribute to the improvements 
that are needed.  The contributions made will contribute to the selection of and 
interpretation of appropriate diagnostic tests (reported in Chapter 3) and the 
production of a recombinant BFDV Capsid protein that has application as an 
alternative source of antigen for HI tests and for the future development of a vaccine 
(reported in Chapter 5). 
Two main diagnostic methods, a PCR and an HA assay, are used to detect virus in 
the feather follicles or blood of clinically affected and asymptomatically infected birds 
(Todd et al., 2000).  Riddoch et al. (1996) considered that PCR was probably the 
most sensitive for detecting latent or incubating BFDV infection but no direct 
comparison was made by this group. In Chapter 3, a direct comparison was made of 
PCR and HA as methods for the detection of BFDV in tissues of 623 birds in a 
variety of types of Psittaciformes (Cacatuidae, Loriidae and Psittacidae) and virus 
was detected in a variable percentage of the samples, ranging from 6.8% to 30.9%, 
depending on which genera were sampled.  There was a strong correlation between 
the 2 assays (kappa = 0.757 p<0.000). However, while generally the 2 assays 
yielded comparable results, the results showed that PCR was more sensitive with 
blood than with feather samples.  Other interesting observations were also made, 
including differences in the prevalence of virus in different species than has been  
reported previously.  However, it is difficult to compare prevalence data detected in 
this current survey with that reported by others as this would require much more 
information on the disease status in the birds from which the samples were collected 
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feather lesions (Hess et al., 2004).  Hess et al. (2004) reported a much higher 
prevalence of BFDV DNA in feather samples collected from budgerigars 
(Melopsittacus undulatus) and in this current survey there was a higher prevalence 
of BFDV DNA in lovebirds (Agapornis sp.) compared to budgerigars.  Overall, the 
PCR prevalence data obtained was similar to that reported by Bert et al. (2005) but 
much lower than reported by Rahaus and Wolff (2003) who detected BFDV DNA in 
39% of feather samples collected from 146 clinically normal psittacine birds and 
some non-psittacine birds in Germany.  
While the results of the 2 assays, PCR and HA, were reasonably comparable, the 
HA assay has the advantage that it can be performed in laboratories with very basic 
equipment and as the use of PCR led to the production of false-positive and false-
negative results, indicating that the preferred assay if only one assay was used 
would be the HA assay.  The false-negative and false-positive PCR results, while 
they occurred in a small number of samples, suggests that PCR assays need to be 
supported by HA whenever possible.   
Of 132 HA positive samples, 6 were PCR negative.  Four false-positive PCR results 
were also obtained in a batch of 4 feather samples from the same source and one 
false negative PCR result was obtained when there was a high HA titre; all the PCR 
false-positives were presumed to be due to cross-contamination during sample 
collection or during processing of the samples in the laboratory, and the false 
negatives to inhibitors such as heparin or other biological materials (Holodniy et al., 
1991; Konet et al., 2000; Kondiah et al., 2005) or to errors made during the PCR 
procedure.  It is recognised, however, that some birds that have recognisable PBFD 
lesions may be PCR negative.  These birds generally have severe infections with a 
majority of their feathers being abnormal and they may be negative because the 
high concentration of nucleic acid in the sample may overwhelm the test reagents, 
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resulting in an insufficient number of virus-positive cells to enable its detection 
(Dalhausen and Radabaugh, 1993). Some of these problems could be overcome by 
standardisation of the amount of extracted DNA utilised in each PCR mix. Care 
should be exercised during interpretation of results, especially with what appear to 
be PCR-false positives.  Captive birds that are virus-positive and have no feather 
abnormalities should be retested in 90 days (Dalhausen and Radabaugh, 1993) as 
they may either be incubating the infection or being continuously exposed to virus, 
and clearance of non replicating DNA from the blood stream may take 3 months 
(Lazizi and Pillot, 1993). 
Serological results can provide important data on the status of infection in individual 
birds or groups of birds, and the HI assay is useful for this purpose.  For example, 
Raidal et al. (1993b) used the HI assay to determine the seroprevalence of BFDV 
infection in flocks of clinically normal free-ranging psittacine birds and showed that 
this ranged from 41-94%. However, care should be exercised during the 
interpretation of HI results, especially where these do not seem to correlate with the 
detection of virus.  A positive PCR blood test in birds that do not have feather 
abnormalities may indicate that the birds are latently infected or that they have 
recently been exposed to the virus and are viraemic.  This was illustrated by the low 
seroprevalence (16%) and high blood PCR prevalence (83.9%) in 56 peach face 
lovebirds (Agapornis roseicollis) flock (Chapter 3), suggesting that the flocks were 
probably infected by BFDV in the pet shop where they had been located.  
The interpretation of virus detection results obtained by utilising PCR is dependent 
on whether the PCR is always capable of detecting all strains of the virus.  It is for 
this reason that constant monitoring of the sequence of possible new strains of 
BFDV is required, and especially from birds that are PCR negative but HA positive. 
There is a high degree of nucleotide identity in BFDV strains, for example, the 
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nt identity and 87-98% aa similarity with other isolates, and the ORF V1 of 10 BFDV 
isolates, from different psittacine species and from various regions around Australia, 
demonstrated 88-99% identity (Ypelaar et al., 1999).  Hess et al. (2004) 
demonstrated a close (91-96%) relationship between the replication associated 
gene (ORF V1) of BFDV strains from budgerigars (Melopsittacus undulatus) and 
other BFDV isolates.  Others, however, have shown by phylogenetic analysis of the 
nucleotide sequence of BFDV strains that they cluster into a number of groups 
(Bassami et al., 1998; Ritchie et al., 2003) indicating there is genetic variation in 
BFDV.  However, it is unclear whether this variation has significance in terms of the 
occurrence of biotypes adapted to replicate in certain species, or variation in 
antigenicity or pathogenicity.  Phylogenetic analysis of the sequence data generated 
from ORF V1 of 36 strains of virus identified 3 distinct clusters associated with 
Loriidae, Cacatuidae and Psittacidae strains. Based on the ORF V1 sequence, 
Ritchie et al. (2003) identified 3 ancestral lineages, one associated with cockatoos, 
one with budgerigars (Melopsittacus undulatus) and with one lorikeets (Trichoglossus 
sp.). Heath et al. (2006) identified recombination events in the Rep gene and 
suggested that it is these events that may contribute more to the genetic variation 
observed in the Rep gene than genetic drift.  
In Chapter 4, an investigation of the genotype of viruses detected in swift parrots, 
lorikeets and a grey cockatiel was described. The existence of species-specific 
biotypes has been hypothesised (de Kloet and de Kloet, 2004; Raue et al., 2004) 
but the 2 swift parrot (Lathamus discolor) isolates examined in this study did not 
exhibit any genotype-specific clustering.  One clustered with a Loriidae group but 
another grouped with BFDV genotypes in a separate phylogenetic group (Chapter 
4).  The results suggest that swift parrots were infected by transfer of infection from 
lorikeets (Trichoglossus sp.) or other psittacine species and that there was no strain 
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Cockatiels (Nymphicus hollandicus), a type of parrot most closely related to 
cockatoos, seem to have a strong innate resistance to BFDV infection.  In this current 
study, infection in captive grey cockatiels (Nymphicus hollandicus) was identified and 
the complete sequence of one isolate (NH-Australia) was determined. While the 
length of the genome (1996 nt) was 3 nt more than other previously sequenced 
Australian isolates (Bassami et al., 1998), the virus was genetically similar to 
previously sequenced strains from a Cacatua leadbeateri (Major Mitchell cockatoo, 
MMC-AUS) and a Cacatua galerita (sulphur crested cockatoo, SCC1-Aus) 
suggesting that the strains infecting cockatiels are those derived from other 
psittacine species and as in swift parrots, that there is no cockatiel-specific 
genotype. 
In Chapter 5, the expression of a recombinant BFDV Capsid protein in insect cells 
using a baculovirus vector was reported. Baculovirus systems offer many 
advantages over other expression systems: safety, as baculoviruses seem non-
pathogenic to mammals and plants (Ignoffo, 1975); ease of scale up (Smith et al., 
1983a; Smith et al., 1983b); high levels of expression; frequent solubility of the 
recombinant proteins in contrast to the insoluble proteins often obtained from 
bacteria; lack of contaminating proteins as they can be recovered from infected cells 
late in infection when host protein synthesis is diminished; it enables post-
translational modification of proteins not obtained in bacterial systems (Smith et al., 
1983a; Smith et al., 1983b).  Baculovirus systems, however, do have some 
disadvantages, for example, high-level expression is discontinuous and short lived.  
The recombinant BFDV Capsid antigen that was produced would be simpler to 
prepare than that prepared by harvesting whole virus from infected tissues, and 
could also be used for future attempts at vaccination as a means of PBFD control.  
The recombinant BFDV Capsid protein appeared as a band of approximately 32 
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raised in 2 chickens by inoculation of the recombinant purified BFDV Capsid protein 
in Freund’s incomplete adjuvant, providing evidence that the recombinant protein 
has potential application as a vaccine for induction of antibodies against the virus 
and hopefully the control of PBFD.  The expression of the BFDV Capsid protein as a 
VLP is also very significant as VLPs are potentially advantageous in the 
development of vaccines as they are immunologically processed in the same way as 
native virus (Ulrich et al., 1998; Noad and Roy, 2003; Tegerstedt et al., 2005) and do 
not contain infectious virus nucleic acid. 
The potential for use of this protein as a vaccine is currently being evaluated by 
others in this laboratory but proof of concept for vaccination as a means of control of 
PBFD has been previously demonstrated.  In one study, adult and neonate 
psittacine birds were inoculated intramuscularly or subcutaneously with ß-
propiolactone-treated PBFD virus (Ritchie et al., 1992b); all vaccinated birds had 
increased concentrations of HI antibodies by 21 days after inoculation. They further 
showed that progeny chicks from vaccinated hens were resistant to disease over a 
50-day test period following challenge with purified virus, whereas chicks from 
unvaccinated hens developed clinical and histological lesions of PBFD. In another 
similar study (Raidal et al., 1993a), adult psittacine birds injected with  whole virus 
derived from the affected feathers of a cockatoo, developed antibodies to the virus 
within 2 weeks and galah (Eolophus roseicapillus) and sulphur-crested cockatoo 
(Cacatua galerita) nestling chicks vaccinated as early as 14 to 21 days after 
hatching were found to develop antibodies to the virus, although the titres that 
occurred in chicks were lower than the titres that developed in adults. The 
immunised chicks challenged with live virus by the combined oral and 
intramuscular routes at 6-8 week of age were found to be protected from disease, 
while unvaccinated chicks exposed to live virus developed gross and microscopic 
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found to persist in some vaccinates for 6 months, and an HI antibody titre as low as 
1:80 HI units/50 µL was considered protective. Raidal and Cross (1994b) also 
reported an evaluation of an oil emulsion adjuvant vaccine in a flock of lovebirds 
(Agapornis sp.) and the results obtained indicated that although it would not be 
possible to eradicate BFDV from a flock, use of the vaccine in combination with other 
biosecurity measures would be a safe and effective aid for controlling PBFD.  
Future studies on the use of the BFDV Capsid protein as a vaccine will be required 
not only to determine the efficacy of inducing a protective immune response but 
also to enhance the immunogenicity of the recombinant capsid antigen, including 
careful selection of adjuvants and other immunomodulators and determining the 
minimal effective vaccine dose(s) of recombinant protein that will induce a persistent 
effective immunity. Factors such as the optimal time between doses, the number of 
doses required and the method of administration will also need to be considered.  
The major advantage of the recombinant protein as a vaccine will be to overcome 
problems of production and remove the necessity of harvesting whole virus from 
tissues of affected birds, which is not only ethically questionable and expensive but 
also of variable quality and limited availability. 
The protein produced also has future application as a diagnostic antigen, which 
could be adapted to either HI or ELISA methodologies. The development of ELISA 
for BFDV has been reported previously and there seems no reason why the BFDV 
Capsid produced using the baculovirus system could not also be used in ELISA. 
Johne et al. (2004) previously cloned part of the ORF C1 encoding the BFDV 
Capsid protein and used this as an antigen to test for BFDV-specific antibodies by 
an indirect ELISA and immunoblotting.  The results obtained by Johne et al. (2004) 
correlated well with the BFDV-specific HI activity of the sera, suggesting the protein 
had value as an antigen for BFDV-specific serological tests. The ability to 
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activity would have significant advantage over HA antigens prepared by purification 
of wild-type virus from infected tissues such as feathers and liver. While there 
appears to be no evidence of BFDV serotypes (Khalesi et al., 2005), variations in 
HA antigen sources and contamination with host proteins can interfere with 
serological testing.  
Future studies on the use of the baculovirus-expressed BFDV Capsid protein as a 
diagnostic antigen will be required, including not only the development of ELISA but 
the development of a monoclonal antibody to facilitate the construction of specific 
diagnostic assays such as immunoperoxidase or immunofluorescence assays for 
the detection of virus antigens in tissue. 
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